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ABSTRACT 
Diet-induced obesity (DIO) due to a high caloric diet (HCD) predisposes an individual to the 
development of diabetes and cardiovascular diseases, with high prevalence in young populations. 
Existing evidence supports the sentiment that insulin resistance and hypertension (HT) affect male 
reproduction. A greater understanding of the influence of insulin resistance and/or HT on male 
reproduction is required in order to prevent or treat male infertility. Due to the limitations of orthodox 
drugs, there is currently a strong movement towards and support for studies on phytomedicine. 
Rooibos (Aspalathus linearis) has been used in several studies and is known to have natural 
antioxidant effects and anti-obesogenic, antidiabetic, anti-hypertensive and anti-infertility activities. 
Currently, the company Afriplex (Pty) Ltd is producing an aspalathin-rich laboratory standardized 
extract prepared from green rooibos called Afriplex GRTTM (GRT). However, there is very little 
knowledge regarding the use of GRT in obesity-related insulin resistance and/or HT, and specifically, 
its effects on male reproductive health. 
Aim 
This study aimed to explore the effect of GRT on the reproductive function in obesity-induced insulin 
resistant and hypertensive male Wistar rats.  
Methods 
A prospective randomized control and experimental animal study design was used. Two different 
diets were used to induce obesity-related insulin resistance with or without HT in male Wistar rats. 
Subsequently, the possible protective properties of GRT on the male reproductive system were 
evaluated. Animals (weighing 120 ±10 g, approximately 7 weeks old) were randomly assigned to 
seven groups with seven rats each. All rats had unrestricted access to their respective diets and water 
for 16 weeks. At baseline (week 0–10), we had three groups: 1) lean control (LC) – animals that 
received standard rat chow; 2) obese (OB) – animals that received a diet to induce obesity associated 
with insulin resistance; and 3) obese with hypertension (OBHT) – animals were placed on a slightly 
modified DIO and additionally developed HT. 
From weeks 11 to 16, one LC, OB and OBHT group were each treated with GRT (prepared and 
supplied by Afriplex (Pty) Ltd) at 60 mg/kg/day as a dietary supplement in the form of jelly blocks. 
An additional group of OBHT animals was treated during the same period for 6 weeks with Captopril, 
an angiotensin-converting-enzyme (ACE) inhibitor (positive control for HT) at 60 mg/kg per day. 
Food and water intake were monitored on a daily basis. An oral glucose tolerance test was performed 
during the 10th week after the onset of the respective diets and during the 16th week, after which the 
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animals were sacrificed. Blood pressure measurements were taken once per week throughout the 
experimental period. After the 16-week period, animals were killed and blood, testis and epididymal 
tissue were harvested for further analysis. Body weight, intra-peritoneal fat, non-fasting glucose 
levels, IL-1β, IL-6, IL-12, IL-18 and TNFα, oxidative stress (OS) markers (superoxide dismutase and 
catalase activity, malondialdehyde), testosterone and estradiol, sperm concentration, viability, 
morphology, total motility, progressive motility and various velocity parameters were measured. 
Results and conclusion  
Both diets successfully induced insulin resistance with or without hypertension and demonstrated 
detrimental effects on male reproductive function as evidenced by OS and hormone dysregulation. 
Treatment with GRT reversed OS and balanced the androgens. This study provided insight into the 
pharmacological effects of GRT in the treatment of pathophysiological changes that occur in DIO 
associated with insulin resistance or HT. These findings will hopefully inspire further research into 
the clinical setting related to the GRT and could possibly lead to the development of new drugs from 
this compound. 
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OPSOMMING 
Dieet-geïnduseerde vetsug (DGV) as gevolg van ŉ hoë kalorie-dieet (HKD) maak individue vatbaar 
vir die ontwikkeling van diabetes en kardiovaskulêre siektes, met hoë voorkoms in jong populasies. 
Bestaande bewyse ondersteun die sentiment dat insulienweerstand en hipertensie (HT) manlike 
voortplanting beïnvloed. ’n Beter begrip van invloed van insulienweerstand en/of HT op manlike 
voortplanting is nodig om manlike onvrugbaarheid te voorkom of te behandel. As gevolg van die 
beperkings van ortodokse medisyne is daar tans ŉ sterk beweging na en ondersteuning van die studie 
van fitomedisyne. Rooibos (Aspalathus linearis) is in verskillende studies gebruik en is bekend vir 
sy natuurlike antioksidant-effek en anti-obesogeniese, anti-diabetiese, anti-hipertensiewe en anti-
onvrugbaarheidsaktiwiteite. Tans vervaardig die maatskappy Afriplex (Edms.) Bpk. ŉ aspalatienryke 
laboratorium gestandaardiseerde ekstrak, wat uit groen rooibos ekstrak voorberei is, genaamd 
Afriplex GRTTM (GRT) ekstrak. Daar is egter baie min kennis aangaande die gebruik van GRT-
ekstrak in obesiteitverwante insulienweerstand en/of hipertensie en spesifiek wat die effek daarvan 
op manlike voorplantingsgesondheid is. 
Doelstelling  
Die doel van hierdie studie is om die effek van GRT-ekstrak op die voortplantingsfunksie van 
obesiteit-geïnduseerde insulienweerstandige en hipertensiewe manlike Wistar-rotte te ondersoek. 
Metodes  
Hierdie studie het ŉ prospektiewe ewekansige kontrole en eksperimentele ontwerp. Twee 
verskillende diëte is gebruik om obesiteit-verwante insulienweerstandigheid en/of hipertensie in 
manlike Wistar-rotte te bewerkstellig. Vervolgens is die moontlike beskermende eienskappe van 
GRT-ekstrak op die manlike voortplantingstelsel geëvalueer. Diere (120 ± 10g gewig, ~ 7 weke oud) 
is lukraak toegewys aan sewe groepe en elke groep het sewe rotte bevat. Alle rotte het vir 16 weke 
onbeperkte toegang tot hul onderskeie diëte en water gehad. By aanvang (week 0–10) was daar drie 
groepe: 1) maer kontrole (LK) diere wat standaard rotvoer ontvang het; 2) obees (OB) rotte wat ŉ 
dieet ontvang om vetsug te veroorsaak wat verband hou met insulienweerstandigheid; en 3) obees 
met hipertensie (OBHT) was diere wat op ŉ aangepaste dieet geplaas is om sodoende ook HT te 
veroorsaak.  
Van weke 11 tot 16 is een LK, OB- en OBHT-groep elk met 60 mg/kg/dag GRT-ekstrak (vervaardig 
en verskaf deur Afriplex (Edms.) Bpk.) as ŉ dieetaanvulling in die vorm van jellie-GRT-blokke 
behandel. ŉ Verdere groep OBHT-diere is gedurende dieselfde tydperk vir 6 weke daagliks behandel 
met 50 mg/kg Captopril, ŉ ACE-inhibeerder (positiewe kontrole vir HT) (Huisamen et al., 2013). 
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Voedsel- en waterinname is daagliks gemonitor. ŉ Orale glukose-toleransietoets is gedurende die 
10de week na die aanvang van die onderskeie diëte en gedurende die 16de week uitgevoer, waarna 
die diere doodgemaak is. Bloeddrukmetings is een keer per week tydens die eksperimentele periode 
geneem. Na die 16-week periode is die diere doodgemaak en is bloed, testis en epididimale weefsel 
geoes vir verdere analise. Liggaamsgewig, intraperitoneale vet, nie-vastende glukosevlakke, IL-1β, 
IL-6, IL-12, IL-18 en TNFα, superoksied dismutase en katalase aktiwiteit, malondialdehied, 
testosteroon en estradiol, spermkonsentrasie, lewensvatbaarheid, morfologie, totale motiliteit, 
progressiewe motiliteit en verskeie snelheidsparameters is gemeet. 
Resultate en gevolgtrekking 
Albei diëte was suksesvol in die bewerkstelling van insulienweerstandigheid met of sonder 
hipertensie en het nadelige uitwerkings op manlike voortplantingsfunksie, soos gesien in OS en 
hormoondisregulasie, veroorsaak. Behandeling met GRT-ekstrak het OS omgekeer en het 
androgeenvlakke gebalanseer. Hierdie studie het insig gebied in die farmakologiese effekte van GRT 
in die behandeling van patofisiologiese veranderinge wat voorkom gedurende DGV wat verband hou 
met insulienweerstandigheid of hipertensie. Die resultate sal hopelik verdere kliniese studies oor 
GRT-ekstrak inspireer en kan moontlik lei die ontwikkeling van nuwe medisyne gemaak van hierdie 
samestelling. 
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CHAPTER ONE 
INTRODUCTION 
1.1 Background and problem statement 
Factors that contribute to abnormalities in male reproductive function are diverse and not only cause 
infertility, but also aggravate existing reproductive problems (Alves et al., 2013; Shi et al., 2017). 
Infertility is characterized by the failure to achieve a clinical pregnancy after twelve months of regular 
unprotected sexual intercourse (Zegers-Hochschild et al., 2017). This disease has been a major 
medical and social concern since the dawn of humanity (Verma & Baniya, 2016). Agarwal et al. 
(2015) have reported the global prevalence of 48.5 million infertile couples and 30 million infertile 
men, with the highest rates in Africa and Eastern Europe (Agarwal et al., 2015). Furthermore, 
between 60–75% of male infertility cases are idiopathic, because the molecular mechanisms 
underlying the defects remain unknown (Filipponi & Feil, 2009; Hamada et al., 2011; Mansour et al., 
2017). 
Numerous literature reviews and scientific investigations have explored the pathophysiological 
conditions underlying causes and mechanisms of male reproductive disorders (Eladak et al., 2018; 
Skakkebaek et al., 2015). Testicular and epididymal disorders are mainly caused by genetic and 
anatomical abnormalities, physical injuries and physiological alterations. However, some of these 
conditions are caused by other underlying metabolic disorders such as cardiovascular diseases 
(CVDs) and diabetes mellitus (DM). CVDs and DM have also been proposed as possible contributors 
to idiopathic male infertility (Kasturi et al., 2008). 
In recent years, the incidence of CVDs and DM became a large-scale threat to human health as there 
has been a tremendous increase in the consumption of processed food in addition to sedentary lifestyle 
practices (World Health Organization, 2017). These diseases are accompanied by metabolic disorders 
such as high blood pressure, high blood sugar, excess body and abdominal fat and abnormal 
cholesterol or triglyceride levels, thereby affecting physiological homeostasis (Cheung & Li, 2012). 
These metabolic disorders are interlinked and generate a state of oxidative stress (OS), which is 
commonly known as aetiology of disease development. Furthermore, CVDs and DM comorbidity 
form key components of the metabolic syndrome (MetS), commonly as a sequel to obesity (Cheung 
& Li, 2012). CVDs are a group of disorders that affect the heart and blood vessels, thereby generating 
different medical conditions, including hypertension (Hermida et al., 2018). During hypertensive 
conditions, the vasculature experience persistently raised pressure due to extra fluid in the blood and 
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blood vessels that are narrow, stiff or clogged (Medley & Wilson, 2016). This state is accompanied 
by many complications, including male reproductive disorders (Weissheimer et al., 2012). It is 
speculated that hypertension could affect reproductive health through different mechanisms, 
including OS and alteration of endogenous hormones (Azu, 2015). 
According to the American Diabetes Association (2010), DM is defined as a metabolic disorder due 
to abnormal function of the insulin hormone or inadequate insulin production by the pancreatic β cells 
and is characterized by hyperglycaemia. DM is classified into type-1 (T1DM) and type-2 (T2DM) 
respectively. T1DM is caused by the absence of insulin, while T2DM is characterized by insulin 
resistance (American Diabetes Association, 2010). Hyperglycaemia results in autoxidation, thereby 
generating free radicals which are harmful to organ function (Phaniendra et al., 2015; Rolo & 
Palmeira, 2006). Moreover, patients often suffer from both diabetes and hypertension, necessitating 
pharmacological therapeutic treatment and further complicating the underlining cause of sexual 
dysfunction (Konzem et al., 2002). 
As mentioned previously, the MetS is a group of pathological conditions or diseases that attack 
individuals at the same time, and these conditions are capable of disturbing physiological homeostasis 
of the body by, among others, the onset of OS. OS is characterized by an imbalance in oxidants and 
antioxidants (AOX) due to overproduction of free radicals, including reactive oxygen species (ROS) 
and reactive nitrogen species (RNS) and the body’s failing AOX defence mechanisms. It is also well 
documented that OS impacts upon androgen biosynthesis, spermatogenesis and sperm maturation in 
mammalians (Rani G et al., 2016). 
ROS and RNS are constitutively produced under physiological conditions; however, they may reach 
supraphysiological levels due to certain pathophysiological conditions (Di Meo et al., 2016). The 
anatomy and physiology of the testes make them susceptible to OS because the testicular cells use 
mitochondrial respiration which can be a source of ROS. Furthermore, immature spermatozoa 
generate ROS (Agarwal et al., 2014). Spermatozoa contain limited cytoplasmic AOX enzymes, while 
the plasma membrane consists mostly of polyunsaturated fatty acids (PUFAs), thereby making it 
highly susceptible to a free radical attack (Agarwal et al., 2014). These free radicals can induce lipid 
peroxidation (LPO) and DNA fragmentation thereby not only impairing spermatogenesis, but also 
disturbing sperm quality (Agarwal et al., 2014). The management of male fertility disorders includes 
medications, fertility counselling, and assisted reproductive technologies (ART) (Jungwirth et al., 
2012). However, these treatments are expensive and, in some instances, not available or accessible to 
all infertile couples (Inhorn & Patrizio, 2015). Furthermore, it has been indicated that some of these 
medications aggravate the root cause of OS (Tremellen, 2008). 
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Several investigations have proposed alternative medications, nutritional advice or derivatives of 
plant material to alleviate ROS-induced injury, as some plant extracts have biological properties 
which can scavenge ROS. The plant extracts upregulate AOX defence systems, thereby protecting 
the body against excessive free radical formation and attack (Mahajan & Gajare, 2012). Moreover, 
the supplementation or treatment with phytomedicine acts naturally or nonaggressive without 
interfering with the normal physiology, thereby rendering them safe in controlled dosages (Khan et 
al., 2016; Kristanc & Kreft, 2016). Also, phytomedicine works together/synergistically with synthetic 
medication in order to highlight the significant effect of curative medication to target diseases (Van 
Vuuren & Viljoen, 2011; Wiesner et al., 2002; Zhou et al., 2016). 
Rooibos (Aspalathus linearis) belongs to the fabaceae family of plants and is a very popular tea 
indigenous to South Africa (SA). It is mostly grown in the Cederberg mountain region of SA (Kanu 
et al., 2014; Wyk & Gorelik, 2017). Traditionally, rooibos is used both as beverage and for medical 
purposes (Joubert & De Beer, 2011). Phytochemical screening of green rooibos extracts (GRE) has 
shown that it is extremely rich in polyphenolic compounds, especially aspalathin, while it does not 
contain any tannins (Joubert & De Beer, 2011). Various studies have investigated the role of GRE as 
a possible therapeutic agent, and to date it has shown great potential in promoting health properties 
(Awoniyi et al., 2012; Joubert & De Beer, 2011; Muller et al., 2018; Opuwari & Monsees, 2014). 
 
1.2 Rationale of the study 
Existing evidence supports the sentiment that diabetes and CVDs play a role in male infertility (Dias 
et al., 2014; Guo et al., 2017). It has been found that insulin resistance in men with unexplained 
infertility can be a possible cause of hypogonadism and oligozoospermia. Nevertheless, knowledge 
regarding the underlying molecular mechanisms concerning insulin resistance and male infertility is 
limited (Filipponi & Feil, 2009; Hamada et al., 2011; Mansour et al., 2017; Omolaoye & Du Plessis, 
2018). 
Hypertension is believed to be associated with erectile dysfunction, but the direct effects on other 
parts of the male reproductive system, if any, are not well understood (Guo et al., 2017). Hypertension 
on its own (untreated) or the use of anti-hypertensive medications (treated) have been linked to 
impaired hormone regulation and semen parameters (Filipponi & Feil, 2009; Hamada et al., 2011; 
Mansour et al., 2017). Consequently, it becomes difficult to distinguish if there is a possible 
association between male infertility and HT or between male infertility and the treatment of HT. 
Further investigation is therefore needed to determine whether these associations are valid. 
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A greater understanding of underlying causative mechanisms between insulin resistance and/or 
hypertension and male reproduction is required in order to design target molecules to prevent or cure 
male infertility. Due to the limitations (side effects, availability and cost) of orthodox drugs, there is 
currently a strong movement towards and support for studies on phytomedicine (Mahomoodally, 
2013; Muller et al., 2018; Wyk & Gorelik, 2017). Sustained investigations into plants with 
antioxidant, anti-obesogenic, antidiabetic, anti-hypertensive and anti-infertility activities are 
necessary. GRE has been used in various studies and is known as a natural AOX with curative 
properties. Currently, the company Afriplex (Pty) Ltd is producing an aspalathin-rich laboratory 
standardized extract prepared from green rooibos called Afriplex GRTTM (GRT). However, there is 
very little knowledge regarding the use of GRT in obesity-related insulin resistance and/or 
hypertension and specifically its effects on male reproductive health. 
Considering the multiple benefits of rooibos, we hypothesize that GRT supplementation/treatment 
can ameliorate male reproductive complications developed due to obesity associated insulin 
resistance or hypertension. Therefore, this research project could potentially contribute towards the 
development of a treatment regime for men with fertility-related issues due to obesity and associated 
metabolic disorders. 
 
1.3 Research questions 
 Does a 16-week obesogenic diet cause insulin resistance and/or hypertension in male Wistar 
rats? 
 Does an obesity-induced insulin resistant and/or hypertensive male Wistar rat develop OS that 
may impair reproductive function within 16 weeks? 
 Can GRT supplementation of 6 weeks reverse OS and improve male reproductive function in 
insulin resistant and/or hypertensive Wistar rats? 
 
1.4 Research aim and objectives  
The aim of this study was to explore the effect of GRT on the reproductive function in obesity-induced 
insulin resistant and hypertensive male Wistar rats.  
The study was driven by four objectives: 
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Objective 1: To evaluate the contribution of two different diets on the development of obesity 
associated with insulin resistance and/or hypertension in male Wistar rats, and a subsequent 6-week 
treatment period with GRT. This was assessed by determining the following parameters: 
 Biometric changes in body weight and intraperitoneal fat weight 
 Oral glucose tolerance test (OGTT) 
 Blood pressure 
 Pro-inflammatory cytokine levels: IL-1β, IL-6, IL-12, IL-18 and TNFα 
Objective 2: To determine the effect of obesity-induced insulin resistance and hypertension as well 
as GRT on testicular tissue function parameters by evaluating: 
 Histological and morphometrical changes of testicular tissue 
 Testosterone and oestrogen levels  
Objective 3: To determine a possible mechanistic link induced by insulin resistance and/or 
hypertension on testicular disorders by evaluating:  
 The expression and activation of signalling intermediates of the insulin signalling pathway: 
protein kinase B (PKB) and adenosine monophosphate-activated protein kinase (AMPK) 
 Apoptotic markers, including caspase 7 and cleaved poly Adenosine diphosphate (ADP) ribose 
polymerase (PARP) 
 Oxidative stress (OS) parameters by means of the end product of lipid peroxidation (LPO); 
malondialdehyde (MDA), and antioxidant enzymes, including superoxide dismutase (SOD) and 
catalase (CAT) 
Objective 4: To determine the effect of obesity-induced insulin resistance and/or hypertension as 
well as GRT treatment on epididymal sperm function by assessing motility, viability, morphology 
and concentration. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 Introduction 
Lifestyle factors, such as a high-energy diet and physical inactivity, are linked to the development of 
obesity and are associated with MetS features, including insulin resistance, hypertension and 
dyslipidaemia. The association between MetS with CVD and male infertility may be explained by 
overlapping disease pathways, including OS and chronic inflammation. In this context, treatments 
which target these pathways may decrease the cumulative risk for both conditions (Du Plessis et al., 
2010; Leisegang et al., 2014; Palmer et al., 2012). 
Indeed, many pharmacological treatments for T2DM and hypertension are known to possess anti-
inflammatory properties and combat OS. However, there is also interest in natural products, including 
GREs, which are rich in the AOX compound aspalathin, and which hold promise as a treatment for 
conditions associated with inflammation and OS. 
In this chapter, an overview of the mechanistic link between MetS features (i.e. obesity, insulin 
resistance and hypertension) and male infertility is presented, with a focus on inflammation and OS. 
Emphasis is placed on the association of hypertension and insulin resistance with testicular and 
spermatogenic pathology. In addition, the potential role of GRE as a future treatment to improve male 
infertility is discussed.  
 
2.2 Male infertility: sperm and testicular pathologies  
There are multiple causes of infertility, including physiological (e.g. obesity, MetS) and 
environmental (e.g. unhealthy diet, low physical activity, drug use) (Durairajanayagam, 2018; Kasturi 
et al., 2008). The etiology of impaired sperm production and function can be related to factors acting 
on pre-testicular, post-testicular or directly on the testicular level. Primary testicular failure accounts 
for about 75% of all male factor infertility (Krausz, 2011; Mittal et al., 2017). Altered testicular 
function is reflected anatomically by various abnormalities in spermatogenesis, including 
spermatogenic arrest, which is often associated with germinal aplasia. There are several disorders that 
affect testicular structure and function, thereby leading to the incidence of testicular pathology. These 
include testicular torsion, varicocoele and testicular cancer as well as hypogonadism and hydrocele 
(Mittal et al., 2017). 
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Primary testicular pathology should always be considered as a cause of altered testosterone 
biosynthesis and sperm production in infertile patients. Standardized protocols as described by the 
Word Health Organization (WHO) are routinely used in most andrology laboratories to perform 
sperm analysis in infertile males according to WHO criteria (Cooper et al., 2009). Male infertility 
patients display azoospermia (absence of sperm in the ejaculate), oligozoospermia (low concentration 
of spermatozoa in the ejaculate, i.e. <15 million sperm per millilitre), asthenozoospermia (reduced 
percentage of motile sperm in the ejaculate, i.e. <40%) and teratozoospermia (reduced percentages 
of morphologically normal sperm in the ejaculate, i.e. <4%) (Cooper et al., 2009) (Figure 2.1). 
 
Figure 2.1: Sperm function parameters under physiological and pathophysiological conditions 
(Cooper et al., 2009)  
 
2.3 Obesity and etiological factors for diseases  
2.3.1 Background on obesity 
Obesity is a growing global health epidemic, and its prevalence has nearly tripled since 1975 (Smith, 
2016). The high prevalence is caused by an absence of proper management of this epidemic, 
compounded by a western diet. Epidemiologically, it was predicted that 1 billion people worldwide 
will be obese by 2030 (Kelly et al., 2008). This increase in obesity is observed not only in the middle-
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aged population, but also increasingly in younger individuals. Obesity is therefore common among 
people of reproductive age (Hruby & Hu, 2016). 
A hallmark of obesity is an excessive increase in body fat, attributable to a chronic intake of high-
energy diets (HED), combined with a sedentary lifestyle (Hruby & Hu, 2016). The HED includes 
high levels of sugar and saturated fats, which in turn, favours the accumulation of white adipose tissue 
(WAT) (Paniagua, 2016). The condition of being overweight or obese is determined by calculating 
the ratio between weight and the square of the height (kg/m2), i.e. body mass index (BMI) or body 
fat percentage (BF%) (Lin et al., 2018). The WHO considers individuals overweight when their BMI 
is over 25 kg/m2, and as obese when the BMI is over 30kg/m2. Moreover, BMI is associated with 
lipid profiles, leptin and cytokines production levels. Severe health conditions, including T2DM, high 
blood pressure and male infertility, have been linked to adipose tissue metabolites (Paniagua, 2016). 
 
2.3.2 Adipose tissue in the development of obesity: focus on male fertility 
Adipose tissue includes brown adipose tissue (BAT), which generates body heat (Lidell et al., 2014), 
and WAT, which stores energy (Lee et al., 2015). These tissues are distributed in different parts of 
the body and their distribution depends on the species (Lee et al., 2015). WAT is mostly distributed 
around visceral or intra-peritoneal organs (Lee et al., 2015). It is not only a place where excess 
fats/triglycerides is stored, but is also an active endocrine organ which secretes adipokines/cytokines 
and chemokines (Kwok et al., 2016). Hyperplasia and hypertrophy of WAT in obesity is accompanied 
by high formation of free fatty acids (FFAs) and upregulation of pro-inflammatory cytokines (TNF-
α, mcp-1,TGF-β, IL-1, IL-6, IL-18, leptin, resistin and angiotensin) as well as downregulation of anti-
inflammatory cytokines (Adiponection, IL-10) (Jung & Choi, 2014). This imbalance contributes to 
visceral obesity and its related metabolic disorders, including inflammation, hyperinsulinaemia, 
hyperglycaemia, hyperestrogenaemia, aromatization, hyperleptinaemia, sleep apnoea, dyslipidaemia, 
thermoregulation defects and scrotal lipomatosis. These conditions can overlap in the same 
individual, thereby resulting in MetS and subsequently affect male fertility. Most MetS components 
interact with the hypothalamus-pituitary-gonadal (HPG) axis, resulting in the alteration of energy 
homeostasis and the impairment of androgen biosynthesis and spermatogenesis (Craig et al., 2017; 
Tsatsanis et al., 2015). Likewise, hypogonadism, oligozoospermia and increased sperm DNA 
fragmentation have been observed in obese men (Craig et al., 2017). 
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2.3.3 Adipose tissue and aromatization: testicular steroidogenesis 
In the testis, the steroid hormones are produced from cholesterol substrate via a series of enzymatic 
reactions in Leydig cells during foetal and neonatal development (Dong & Hardy, 2003) (Figure 2.2). 
Steroids include testosterone (T) and oestrogen (E), which are normally produced at different levels. 
T levels are higher than that of E in men. The T influences physiological activities of men, including 
muscles and bone density, heart, brain and blood vessels. Furthermore, target tissues and cells to 
steroid are much more controlled by sex hormone-binding globulin (SHBG) (Anheim et al., 2006). 
T has a higher affinity for SHBG than for albumin. Approximately 50–70% serum T binds to SHBG, 
20–30% to albumin and less than 2% is free (Li et al., 2016). The T bioavailability includes both free 
T and the fraction bound to albumin (Anheim et al., 2006; Li et al., 2016). 
Circulating T in the body is the substrate for E, which is produced by aromatization in the liver, 
muscles, brain and the fat cells. Importantly, T production increases during male puberty and 
thereafter declines with age (Li et al., 2016). Also, obesity and its metabolic disorders have been 
reported to reduce T and increase E (Katib, 2015). Therefore, low T with high E levels cause abnormal 
male reproductive function (Siegel et al., 2008). 
Metabolic disorders, including biometric parameters (e.g. body weight, BMI, blood circulation) and 
abnormalities in the enzymes involved in steroid synthesis (aromatase cytochrome P450 enzyme, 
17β-hydroxysteroid dehydrogenases) affect T levels in men. These parameters interact with one 
another, for instance, overweight and high BMI are correlated with increased production of the 
aromatase cytochrome P450 enzyme (Hilborn et al., 2015; Vihma et al., 2017), thereby leading to 
increased aromatization of T to E (Figure 2.2). Aromatase enzymes are naturally secreted by adipose 
tissue, with production being proportional to the amount of adipose tissue. In obese men, high 
production of aromatase cytochrome P450 enzymes are positively correlated with elevated E levels 
(Katib, 2015). Hypersecretion of oestrogens results in inhibition of the HPG axis via kisspeptin 
neurons, and subsequently affects testosterone levels and impairs spermatogenesis. Subfertile men, 
with a significantly higher BMI (≥30) due to obesity, have shown reduced testicular volume, reduced 
semen quality and lower sperm count (oligozoospermia) as well as lower motility 
(asthenozoospermia) when compared to the general population (Eisenberg et al., 2014; Hammiche et 
al., 2012). 
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Figure 2.2: Testicular steroidogenesis 
 
2.4 Insulin resistance and male infertility  
2.4.1 Insulin and energy homeostasis 
Insulin is an anabolic hormone secreted by the beta (β) cells of the pancreas. This hormone regulates 
blood glucose levels. Glucose is a source of energy used by bodily systems to perform specific 
functions, including male reproduction (Dupont et al., 2014). Glucose is produced from digested or 
metabolized carbohydrate nutrients and is stored in liver cells and skeletal muscles as glycogen. 
However, glycogen stores are limited and excess glucose is converted into fats/triglycerides through 
lipogenesis. Triglycerides are stored in adipose tissues. When blood glucose concentrations are low, 
glycogen is mobilized and converted to glucose by glycogenolysis. Glucose is also produced from 
amino acids or fatty acids through the process of gluconeogenesis, especially during starvation and 
intense exercise. Hence, the body maintains plasma glucose concentration within a narrow range by 
balancing oxidative metabolism, glycogenesis, glycogenolysis and lipogenesis. Energy metabolism 
homeostasis is further controlled by molecular signalling pathways, including the insulin-dependent 
pathway (PI3K/AKT) and insulin-independent pathway (AMPK) (Berridge, 2014; Dupont et al., 
2014; Yu & Cui, 2016) (Figure 2.3). 
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Figure 2.3: Insulin signalling and energy homeostasis involved in the regulation of testicular 
function (Dupont et al., 2014) 
GLUT: glucose transporter, IRS: insulin receptor substrate, PI3K: phosphatidylinositol 3-kinase, PKB: 
protein kinase B, mTOR: mammalian target of rapamycin, AMP: adenosine monophosphate, ATP: adenosine 
triphosphate, AMPK: adenosine monophosphate-activated protein kinase, PPAR: peroxisome proliferator-
activated receptor 
 
2.4.2 Insulin-dependent pathway  
The male reproductive system requires balanced energy and metabolic signals for the modulation of 
testicular steroidogenesis, proliferation and survival of somatic testicular cells, as well as the 
maturation of spermatozoa (Nguyen, 2017). Insulin signalling is an important mechanism which 
maintains metabolic homeostasis and influences testicular physiology through insulin receptors (IRs), 
which are located on the hypothalamus, testicular cells (Leydig, Sertoli, peritubular/myoid cells) and 
spermatozoa (Alves et al., 2013). 
Fat cells 
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Insulin signalling encompasses different molecules which interact through phosphorylation 
(Berridge, 2014; Boura-Halfon & Zick, 2009). Attachment of insulin to its IRs causes transformative 
changes at both cellular and molecular levels. The IR has two external alpha (α) domains and two 
intracellular beta (β) domains. Attachment of insulin to the α-domains results in tyrosine kinase auto-
phosphorylation of the β-domains. These β domains become active and recruit the insulin receptor 
substrates (IRS). IRS phosphorylation results in the activation of two different pathways, namely the 
Ras-Raf-MAPK and the PI3K/Akt pathway. The Ras-Raf-MAPK pathway controls cellular 
proliferation and gene regulation, while the PI3K/Akt pathway plays a role in glucose uptake and 
storage (Berridge, 2014; Yu & Cui, 2016). 
Phosphorylated Akt/PKB stimulates translocation of glucose transporters to the cell membrane. The 
isoforms of glucose transporters (GLUT), responsible for mediating passive glucose transport (GLUT 
1, 3 and 8), are expressed specifically in Sertoli cells (Dupont et al., 2014). GLUT 1 and 3 are 
localized on the cell membrane and are able to carry glucose from the external milieu to the 
cytoplasm, while GLUT 8 is an internal glucose transporter and therefore glucose is converted into 
lactate within Sertoli cells. During translocation of GLUT to the cell membrane, the cell becomes 
permeable to glucose and this facilitates the cells to produce energy. Furthermore, PKB interacts with 
mammalian target of rapamycin (mTOR) to regulate protein synthesis and cell growth in response to 
growth factors, nutrients and increased energy levels (Figure 2.3). 
 
2.4.3 Insulin-independent pathway  
The AMPK pathway is an insulin-independent signalling pathway (Berridge, 2014). AMPK is the 
master energy regulating molecule, which is expressed in muscle and liver, but also in the ovaries 
and testes (Bertoldo et al., 2015). AMPK detects and indicates cellular energy levels in the cell 
through biochemical and molecular mechanisms. When ATP production is inadequate, AMPK 
restores energy homeostasis by switching on catabolic pathways and switching off anabolic pathways. 
Catabolic pathways include glucose uptake, glycolysis, fatty acid oxidation, oxidative metabolism, 
mitochondrial biogenesis and autophagy that generate ATP. Anabolic pathways include fatty acid 
synthesis, triglyceride/phospholipid synthesis, steroid synthesis, glycogen synthesis, rRNA synthesis 
and protein synthesis that consume energy required for cell growth and proliferation (Galardo et al., 
2007; Hardie, 2017). AMPK can be activated by metabolic hormones (i.e. leptin, adiponectin and 
ghrelin) and natural substances such as polyphenols, as well as by antidiabetic medication (e.g. 
metformin) (Hardie, 2017; Rice et al., 2013). Therefore, AMPK is considered an important potential 
therapeutic agent for the treatment of obesity, prediabetes and male factor infertility. 
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AMPK isoforms α1 and γ1, α2 and γ3 are expressed in testicular cells and spermatozoa (Nguyen, 
2017; Ross et al., 2016). The activation of AMPK α1 by toxic substances links to the mTOR 
signalling pathway and therefore both AMPK and mTOR signalling pathways are involved in the 
regulation of autophagy and apoptosis in Sertoli cells (Nguyen, 2017). AMPK activation leads to an 
increase in lactate production in response to an increase in glucose uptake, and accordingly results in 
increased levels of GLUT 1 and monocarboxylate transporter 4 (MCT4) (Galardo et al., 2007). 
 
2.4.4 Mechanisms of insulin resistance linked to male infertility 
Insulin resistance refers to the perturbation of insulin signalling due to the dysfunction of insulin 
receptors and protein kinases of target cells (Berridge, 2014). Obesity is the main cause of insulin 
resistance where free fatty acids stimulate elevated IL-1, 6, 12, 18 and TNF-α levels, which inhibit or 
supress insulin signalling (Kwok et al., 2016). The intracellular expression and activation of 
signalling proteins, including PKB and AMPK, are decreased (Berridge, 2014). Moreover, it has been 
reported that obesity-induced insulin resistance suppresses the action of luteinizing hormone (LH) in 
the testis, which significantly reduces circulating testosterone levels (Grossmann et al., 2014). 
Hyperinsulinaemia and hyperglycaemia occur when the target cell is unable to respond to insulin 
action and both insulin and glucose levels in the blood stream increase. This insulin resistance acts as 
a precursor for both prediabetes and T2DM (American Diabetes Association, 2010). When the blood 
sugar/glucose levels are slightly increased above the normal levels, this condition is called 
prediabetes. Over time, the blood glucose levels become high enough to be diagnosed as T2DM. 
Different tests can confirm prediabetes or diabetes in fasted and non-fasted blood samples by 
measuring glucose levels (American Diabetes Association, 2010) (Table 2.1). 
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Table 2.1: Diagnosis and classification of T2DM (American Diabetes Association, 2010) 
Tests Prediabetes Diabetes  
FPG (after 8 hours of fasting) 100–125 mg/dL 
5.6 mmol/L–6.9 mmol/L 
>125 mg/Dl 
>6.9 mmol/L 
OGTT after fasting 8 hours and 
administrating 50–75 g of 
glucose  
140 mg/dL–199 mg/dL 
7.8 mmol/L–11 mmol/L 
>199 mg/dL 
>11 mmol/L 
HbA1c 5.7%–6.4% >6.4% 
T2DM: type 2 diabetes mellitus, HbA1c: hemoglobin A1c, OGTT: oral glucose tolerance test, FPG: fasting 
plasma glucose 
 
2.4.4.1 Hyperglycaemia: oxidative stress (OS), inflammation and apoptosis in male infertility 
OS, inflammation and apoptosis are closely interlinked in hyperglycaemic conditions and 
consequently cause histological damage to the testes, with a negative impact on hormone and sperm 
production. High glucose levels lead to an increased glycolysis and glucose autoxidation, which 
generate elevated levels of free radicals (Berdja et al., 2016; Rolo & Palmeira, 2006). AXO defence 
mechanisms become weak due to the overwhelming free radicals and therefore contribute to OS. 
Likewise, protein kinase C (PKC) via diacylglycerol (DAG), the hexosamine pathway flux (N-
acetylglucosanimine), advanced glycation end-products (AGE) and the polyol pathway flux (sorbitol, 
fructose) are activated and increased in their expression (Berdja et al., 2016). Subsequently, this 
activation of biological mechanisms with alteration of their functionalities contribute to the 
development of male infertility (Berdja et al., 2016; Rolo & Palmeira, 2006). Furthermore, high ROS 
production may accelerate the process of germ cell apoptosis, LPO, protein oxidation and DNA 
damage (Aprioku, 2013; Maneesh & Jayalekshmi, 2006). Therefore, it can lead to impaired and poor 
fertility outcome due to reduced sperm count, motility and viability (Agarwal et al., 2014; Aprioku, 
2013; Maneesh & Jayalekshmi, 2006) (Figure 2.4). 
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Figure 2.4: Hyperglycaemia-induced ROS generation and the effect on male fertility 
ROS: reactive oxygen species, AOX: antioxidant, OS: oxidative stress, PKC: protein kinase C, DAG: 
diacylglycerol, AGE: advanced glycation end-products 
 
 2.5 Hypertension and male infertility  
2.5.1 Background on hypertension 
Hypertension (HT) is a condition characterized by persistently elevated blood pressure in arterial 
vessels (Mucci et al., 2016). According to the American Heart Association (AHA) and Medical 
Guidelines (2017), HT in humans refers to a systolic pressure (SP) that is higher than 130 mmHg and 
a diastolic pressure (DP) higher than 80 mmHg (>130/80 mmHg). HT is a global health problem and 
even the younger population of reproductive age are predisposed to HT (Grad et al., 2015). HT is 
associated with complications such as stroke, vision loss, heart failure/heart attack, kidney 
diseases/failure and sexual dysfunction (Guo et al., 2017). 
 
2.5.2 Causes of hypertension  
There is no single known cause of HT. Excessive weight gain, especially when associated with 
increased visceral adiposity, is a major cause of HT, accounting for 65 to 75% of the risk for human 
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primary hypertension. Western food consumption causes obesity, which in turn induces HT through 
the alteration of renal pressure natriuresis (Hall et al., 2015). Accumulation of fatty acids inside and 
around the kidney impairs renal pressure natriuresis, increases sodium reabsorption, decreases 
sodium excretion and increases water uptake (Hall et al., 2014; Hall et al., 2015). These conditions 
are the risk factors resulting in increased blood pressure (BP), consequently activating the 
sympathetic nervous system, renin-angiotensin-aldosterone system (RAAS) and renal compression. 
Moreover, overexpression of angiotensinogen, hyperleptinaemia, insulin resistance, dyslipidaemias, 
glucose intolerance and inflammation mechanisms link obesity to the development of HT (Yanai et 
al., 2008). 
 
2.5.3 RAAS 
The RAAS is one mechanism that the body uses to regulate blood pressure and fluid balance (Yanai 
et al., 2008). This mechanism starts with the renin enzyme which is secreted by the kidney and 
released into the blood stream. Renin converts the plasma protein angiotensinogen to angiotensin I 
(ATI). The lung produces converting enzyme; ACE, which converts ATI to angiotensin II (ATII). 
Furthermore, ATII has several effects: increased vasoconstriction, decreased glomerular filtration rate 
and thirst. ATII also stimulates the release of aldosterone from the adrenal gland and causes 
reabsorption of Na+ and water, thereby increasing blood volume. ATII interacts with the 
hypothalamus and releases antidiuretic hormone (ADH), which causes reabsorption of water and as 
a secondary function, also vasoconstriction. Both aldosterone and ADH hormones increase blood 
volume. However, abnormal activation of the RAAS causes the high BP (Figure 2.5). 
The presence of all the components of the RAAS has been reported in the testis and epididymis via 
receptors, implying a relationship between RAAS dysfunction and male infertility (Weissheimer et 
al., 2012). Previous studies have shown that abnormal expression of ACE and ATI/II results in 
hypertension and male reproductive disorders. The stimulation of ATII receptors in Leydig cells 
inhibits the ability of LH to stimulate testosterone production. Moreover, this stimulation inhibits the 
cAMP pathway, thereby modifying seminiferous tubule contraction (Rossi et al., 2002). 
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Figure 2.5: RAAS (adapted from Yanai et al.(2008)) 
ACE: angiotensin converting enzyme, ADH: antidiuretic hormone, ATI: angiotensinogen to angiotensin I, 
ATII: angiotensin II 
 
2.5.4 Hypertension and male reproductive function 
The direct end-organ effects of hypertension have been studied in depth on the arteries and kidneys, 
but little is known about the effect on the testes (Guo et al., 2017). Prior research has addressed the 
relationship between hypertension and the endocrine axis, which may affect reproductive ability. 
Normally, blood and nerve supply for the epididymis and testis are found on the posterior side. The 
testes receive blood supply from the testicular arteries, the cremasteric arteries and the deferential 
arteries (Patel, 2017). The testicular artery arises from the abdominal aorta just below the renal artery 
and becomes a component of the spermatic cord above the internal inguinal ring. It is furthermore 
intimately associated with a network of anastomotic veins, which eventually form the pampiniform 
plexus. Testicular cells receive nutrients and perform multiplication, steroidogenesis and 
spermatogenesis. Any disconnection between blood supply and testicular cells may impact the HPG 
axis by altering androgen biosynthesis and sperm production. 
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The testis and epididymis may be susceptible to oxidative damage, as the blood vessels supplying 
blood to these tissues often show sclerotic changes (Azu, 2015). Such vascular anomalies have been 
observed in a variety of mammals, such as the spontaneously hypertensive rat. Mainly, disturbances 
of the seminiferous epithelium lead to testicular atrophy and the impairment of hormone and sperm 
production (Adedara et al., 2018; Azu, 2015). A Brazilian group employed a rat model for 
renovascular hypertension to demonstrate impaired spermatogenesis, which they attributed to 
imbalances in T and E as well as in the follicle stimulating hormone (Guo et al., 2017). 
Importantly, HT, dyslipidaemia and inflammation are also associated with decreased endogenous 
testosterone production. For example, several studies have reported an inverse association between 
testosterone levels and indicators of hypertensive vascular change, including arterial wall thickening, 
vessel wall stiffness and endothelial dysfunction (Dockery et al., 2003; Fogari et al., 2005; Kyriazis 
et al., 2011; Muraleedharan & Jones, 2010; Oskui et al., 2013; Svartberg et al., 2004; Traish et al., 
2009). In addition, metabolic risk factors which commonly co-occur with hypertension (e.g. obesity) 
have been associated with impaired sperm quality, although descriptions of the individual effects of 
high BP on sperm functioning remain sketchy (Schisterman et al., 2014; Sermondade et al., 2013). 
Testosterone replacement therapy has been accordingly shown to ameliorate these adverse effects on 
the vascular system as well as on male reproductive health (Oskui et al., 2013). However, it is 
important to note that the use of certain anabolic steroids supplements or medications may also 
increase BP (Rockhold, 2002), suggesting a bi-directional relationship between metabolic risk factors 
and testosterone levels. 
As mentioned previously, HT can result from obesity-induced insulin resistance, which may in turn 
induce OS via changes in intracellular signalling and macromolecules. Additionally, inflammation 
and apoptosis may result in this dysregulation, or vice versa, and thereby cause hypogonadism and or 
lead to a varicocele. 
 
2.6 Management of hypertension and male reproductive function 
Some anti-hypertensive medications are aimed at interrupting different steps in the RAAS system to 
lower BP. These mechanisms include (i) diuretics: by removing excess sodium and water from the 
body via the kidneys; ii) beta blockers (BBs): by helping the heart to beat slower and with less force, 
stabilizing systolic and diastolic cycles; (iii) ACE inhibitors: by blocking the conversion of ATI into 
ATII in most target vessels, the adrenal glands and hypothalamus; (iv) angiotensin II receptor 
blockers (ARBs): by blocking ATII receptors thereby protecting the cardiovascular system from the 
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effects of ATII; and v) calcium channel blockers (CCBs): by preventing calcium from entering the 
cardiomyoctes and blood vessels (Konzem et al., 2002).  
Patients with DM have a much higher rate of HT than would be expected in the general population 
(Konzem et al., 2002). Regardless of the anti-hypertensive agent used, a reduction in BP helps to 
prevent diabetic complications. Barring contra-indications, ACE inhibitors are considered first line 
therapy in patients with DM and HT because of their well-established renal protective effects. The 
ACE inhibitor Captopril is often used to treat HT and DM, together with atenolol (a beta-adrenergic 
antagonist). It was found that the two agents are very similar in terms of reducing microvascular and 
macrovascular complications (Konzem et al., 2002). 
 
 2.6.1 The effect of anti-hypertensive drugs on male reproductive function  
According to a systematic literature review of the most common anti-hypertensive drugs, various 
positive and negative effects have been reported on male reproductive function. 
The available data suggest that calcium channel antagonists, ACE inhibitor and ARBs do not have 
detrimental effects on sexual function. For instance, hypertensive patients treated with an ACE 
inhibitor or ARBs showed an increase in sexual activity compared with patients who use other 
therapies such as β-blockers (Baumhäkel et al., 2008; Becker et al., 2001; Fogari et al., 1996). ARBs 
seem to have beneficial effects on sexual function and can be used to combat sexual side effects from 
other cardiovascular agents or in men with pre-existent ED. ACE inhibitors, particularly Captopril, 
have been associated with improved sexual function (Fogari et al., 1996; Rastogi et al., 2005). The 
fact that ACE inhibitors work independently of the sympathetic nervous system in lowering BP 
potentially explains their reduced impact on sexual function. Alternatively, it was demonstrated that 
activation of RAAS in the testicular tissue (Bader & Ganten, 2008; Franke et al., 2003) is involved 
in the pathophysiology induced by OS (Fischer et al., 2000; Liu et al., 2007; Scribner et al., 2003). 
ACE inhibitors have been reported to reverse endothelial dysfunction by preventing the effects of 
angiotensin II, prolonging the half-life of nitric oxide and decreasing degradation of bradykinin 
(Mancini et al., 2012). Captopril also decreases the circulating and tissue levels of angiotensin II. 
Furthermore, Captopril contains a thiol or sulfhydryl group which scavenges different types of ROS 
and prevents lipid peroxidation (Fischer et al., 2000). 
In contrast, anti-hypertensive drugs such as CCBs, BBs and diuretics have been implicated in male 
infertility through various mechanisms. CCBs act directly on the reproductive tissues and cells 
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without interacting with HPG axis in male rats, resulting in a reversible anti‐fertility (Morakinyo et 
al., 2009). 
BBs have shown to negatively impact sperm functional parameters in clinical studies via alteration 
of HPG axis combined with hormone imbalance (Aitken, 2016; Guo et al., 2017). BBs resulted in 
lower semen volume, concentration, motility, total sperm count and total motile sperm count, 
compared to men receiving other anti-HT medications. Furthermore, BB can also cause anxiety and 
inhibit the sympathetic nervous system, which results in poor integration of erection, emission and 
ejaculation, dysregulation of LH secretion and poorer stimulation of T release (Barksdale & Gardner, 
1999). Diuretics can also negatively affect penile blood flow, erectile dysfunction and desire, thereby 
diminishing quality of life and often resulting in noncompliance with the therapy (Nicolai et al., 
2014). Therefore, a search for alternative medications has been undertaken to minimise high cost and 
side effects caused by synthetic anti-hypertensive medications. Alternative treatments have been 
suggested, including plant-derived medications and lifestyle changes (Mahomoodally, 2013; Muller 
et al., 2018; Wyk & Gorelik, 2017). 
 
2.7 Management of male infertility 
In the event that a woman is unable to fall pregnant after twelve months of sexual intercourse with 
the intent to conceive, infertility in one or both partners should be considered. It is estimated that 30–
40% of couples seeking fertility treatments are diagnosed with male factor infertility (Kumar & Singh, 
2015). The different approaches used in clinical diagnosis and treatment of male factor infertility 
depend on the original cause. Either testis or sperm abnormalities are evaluated physically and 
biologically. 
To understand and characterise these causes, semen analysis is performed according to WHO 
guidelines in terms of the primary-care level for infertility diagnosis (WHO, 2010). The following 
criteria are adapted to evaluate the semen analysis: physical parameters (volume, liquefaction, 
appearance, constancy, pH and agglutination) and biological parameters (sperm viability, 
concentration, motility and kinematics, morphology and auto-antibodies). Furthermore, a reported 
case from semen analysis should be treated by using counselling, pharmacological drugs, assisted 
reproductive technologies (ARTs) and alternative medications. 
Drugs used to treat male infertility change the male hormonal system by primarily increasing the 
bioavailable T and decreasing estradiol (E2) levels. Anti-oestrogen drugs/aromatase inhibitors (AI) 
block the conversion of T to E2 and of androsterone to estrone. These drugs are prescribed to patients 
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with low T and high E2 levels to help increase T levels, as well as to facilitate spermatogenesis. For 
instance, obese males have high levels of aromatase, which cause the transformation of T into the 
female hormone, E. Therefore, it is recommended in certain instances that this enzyme is blocked in 
obese men in order to regulate the male sex hormones (Cheshenko et al., 2008; Lephart, 2015). 
With modernization and the advances in technology since 1980, ARTs have been employed to help 
infertile couples fall pregnant (Wahlberg, 2016). ARTs include in vitro fertilization (IVF), intra-
cytoplasmic sperm injection (ICSI) and gamete intra-fallopian transfer (GIFT) (Ombelet & Van 
Robays, 2015; Wahlberg, 2016). 
Pharmacological anti-infertility and ART applications are costly, can have side effects and are 
sometimes not successful. Several researchers have suggested that micronutrients and antioxidant 
supplementations can be used as alternative male infertility management treatments (Agarwal et al., 
2004). Male reproductive organs contain naturally free radical scavengers, including vitamins C and 
E, uric acid, superoxide dismutase (SOD), catalyse (CAT) and glutathione. However, this natural 
mechanism can fail and requires supplementation of antioxidants to upgrade the system. 
Supplementation with synthetic antioxidants includes vitamins C, D3 and E, folic acid, zinc, selenium 
and L-carnitine. However, these synthetic antioxidant supplementations may or may not be effective, 
depending on the pathology of the infertility (Agarwal et al., 2004). 
Currently, researchers worldwide are investigating plant extracts to ascertain their antioxidant 
activities and ability to treat male infertility. Some indigenous African medicinal plants have been 
used to treat male reproductive pathology, most of which are rich in polyphenol/flavonoid 
compounds. 
 
2.8 Rooibos (Aspalathus linearis) 
Aspalathus linearis (rooibos) is a member of the fabaceae family, which comprises more than 270 
species indigenous to the Cederberg mountain region of SA (Jaman et al., 1981) (Figure 2.7A). The 
leaves of the rooibos plant are used to make herbal tea (Joubert & De Beer, 2011). Depending on the 
method of processing, rooibos is either fermented (red) (Figure 2.7B) or unfermented (green) (Figure 
2.7C). The production of unfermented GRT requires special handling and processing to avoid 
oxidation and preserve the natural activities of important phytocompounds (Joubert & De Beer, 2011; 
Joubert et al., 2010; Miller et al., 2017). GRT retains its natural colours and has a higher polyphenol 
content and antioxidant properties compared to fermented rooibos tea (Miller et al., 2017). Rooibos 
tea is consumed worldwide, and is highly regarded due to its taste, absence of caffeine and high levels 
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of the polyphenolic antioxidant compound aspalathin. In addition, green rooibos is used as a raw 
material in the pharmaceutical industry to make cosmetic products and dietary supplements (Joubert 
& De Beer, 2011). 
A nutraceutical company, Afriplex Pty Ltd, produces Afriplex GRTTМ (GRT in short) from 
unfermented rooibos. This is a standardized spray dried GRT product containing high levels of 
apsalathin. Phytochemical screening of GRT with high-performance 
liquid chromatography (HPLC) analysis have identified different polyphenolic compounds (g/100 
dry matter): phenylpyruvicacid-2-Oglucoside (0.423265), aspalathin (12.78348), nothofagin 
(1.974419), isoorientin (1.427281), orientin (1.255839), ferulic A (nq), vitexin (0.338513), isovitexin 
(0.298022), quercetin-3- robinobioside (1.040565), hyperoside (0.398773), rutin (0.496034) and 
isoquercitrin (0.572251852) (SAMRC laboratory, 2012). 
 
 
 
 
 
 
 
Figure 2.6: Aspalathus linearis (A), fermeted rooibos (B) and unfermented rooibos (C) (Rooibos 
tea – Cape Point Press, 2015) 
 
2.8.1 Phenolic compounds and mechanisms 
GRT is rich in polyphenol compounds, which are classified in different categories, including 
dihydrochalcones/flavonoids (aspalathin, nothofagin), flavones (orientin, iso-orientin, vitexin, 
isovitexin, luteolin, luteolin-7-O-β-D-glucoside, chrysoeriol) and flavonols (quercetin, hyperoside, 
rutin). Importantly, the aspalathin (C-glucoside) (Figure 2.7C) content is 10-fold higher compared to 
the other phytochemicals in green rooibos (Joubert & De Beer, 2011). Rather than exerting direct 
antioxidant effects, the mechanisms by which polyphenols express these beneficial properties appear 
to involve their interaction with cellular signalling pathways and related machinery that mediate cell 
function under both normal and pathological conditions (antioxidant and redox, PKB, AMPK and 
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apoptotic signalling molecules) (Hong et al., 2014; Vauzour et al., 2010). Therefore, the diversity of 
biological properties of flavonoids depends on the chemical structures, as well as on the number, 
nature, position and substituents of hydroxyl groups and unsaturated bonds (Kumar & Pandey, 2013; 
Treml & Šmejkal, 2016). 
 
2.8.2 Health benefits 
In a study done by Marnewick et al. (2011), 40 human adults at risk of cardiovascular disease 
consumed six cups of fermented rooibos per day for a period of 6 weeks and were shown to have 
increased total blood plasma polyphenol levels, and improved redox status and lipid profiles 
(Marnewick et al., 2011). Another study showed that antioxidant capacity in the blood was elevated 
after the consumption of 500 mL of both fermented and unfermented rooibos tea (Villaño et al., 
2010). This study also compared the two types of rooibos in an in vitro study and found that green 
rooibos tea has a higher ability to boost antioxidant system defences than red rooibos tea (Villaño et 
al., 2010). Furthermore, in a study done on male rat reproductive function, green rooibos was also 
shown to enhance sperm concentration, viability and motility (Opuwari & Monsees, 2014). 
GRE retains a particular biochemical structure (a dihydrochalcone C-glucoside) (Figure 2.7) and is 
rich in aspalathin (Joubert et al., 2008). These features make GRE a potential antioxidant (Dludla et 
al., 2014; Muller et al., 2018), a stimulant of glucose clearance in muscle cells (Muller et al., 2012) 
and a regulator of energy metabolism (Son et al., 2013). Aspalathin is absorbed and metabolized and 
its glucuronidated and sulfonated conjugated metabolites are excreted in urine (Courts & Williamson, 
2009). Furthermore, these aspalathin characteristics highlight its role in the treatment of diseases 
associated with OS, including CVDs, T2DM and male infertility. Similar to other flavonoids, 
aspalathin suppresses ROS formation either by inhibition of NADPH oxidases, chelation of trace 
elements or upregulation and protection of antioxidant defences (Mishra et al., 2013) including CAT 
and SOD enzymes. Furthermore, it prevents lipid peroxidation and could act as an antioxidant. 
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Figure 2.7: Structure of aspalathin. Image adapted from Joubert and colleagues (2008) 
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CHAPTER THREE 
METHODOLOGY 
3.1 Study design 
This study used a prospective randomized control and experimental animal study design. Two 
different diets were used to induce obesity-related insulin resistance with or without HT in male 
Wistar rats. Subsequently, the possible protective properties of GRT on the male reproductive system 
were evaluated. Animals (120±10g weight, ~7 weeks old) were randomly assigned to seven groups, 
which each group had seven rats. All rats had unrestricted access to their respective diets and water 
for 16 weeks (Figure 3.1). At baseline (week 0–10), three groups were established: 1) lean control 
(LC) animals received standard rat chow, 2) obese (OB) rats received a diet able to induce obesity 
associated with insulin resistance, 3) obese with HT (OBHT) received a diet aimed at inducing obesity 
(DIO) as well as HT (Table 3.1). From weeks 11 to 16, one LC, OB and OBHT group were each 
treated with GRT (manufactured and supplied by Afriplex Pty (Ltd)) at 60 mg/kg/day as a dietary 
supplement in the form of jelly GRT blocks while an equivalent group received jelly blocks without 
treatment. A further group of OBHT animals were treated during the same period for 6 weeks with 
the Captopril, an ACE inhibitor (positive control for HT) of 50 mg/kg per day (Huisamen et al., 2013). 
After the 16-week period, animals were euthanized and blood, testis and epididymal tissue were 
harvested for further analysis. 
 
 
 
 
Figure 3.1: Schematic representation of the experimental groups  
LC: lean control rats, OB: obese rats, OBHT: obese with hypertension, GRT: Afriplex GRTTM extract, 
LC+GRT: LC treated with GRT, OB+GRT: obese rats treated with GRT, OBHT+GRT: obese hypertensive 
rats treated with GRT, OBHT+Cap: obese hypertensive rats treated with Captopril.  
 
Male 
Wistar rat
(120±10g)
LC
(n=14)
LC
(n=7)
LC+GRT
(n=7)
OB
(n=14)
OB
(n=7)
OB+GRT
(n=7)
OBHT
(n=21)
OBHT
(n=7)
OBHT+GRT
(n=7)
OBHT+Cap
(n=7)
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3.2 Ethics 
This project resorted under two larger ongoing studies with existing ethical clearance (Number SU-
ACUD 15-00102 and SU-ACUD 16-000-80). Amended ethical approval was subsequently obtained 
for this project from the Animal Research Ethics Committee of the Faculty of Medicine and Health 
Sciences at Stellenbosch University. 
 
3.3 Organizing of research activities 
Animals were housed at the Central Research Facility of the Faculty of Medicine and Health Sciences 
on the Tygerberg Campus of Stellenbosch University. The candidate received specialized training in 
the handling of animals and was accredited by the veterinarian from the Central Research Facility. 
Training with regards to experimental techniques were provided by the supervisors and research 
assistants, while self-optimization of assays was performed by the candidate. 
 
3.3.1 Feeding and animal care 
The Wistar strain of rats was identified as early as 1906 as a suitable animal model for experimental 
purposes and for the teaching physiology. Since then, Wistar rats have been used extensively in 
numerous in vivo studies in various fields of research with great success, as data are highly 
reproducible and reliable. The development, growth and lifespan of rats are much shorter than that of 
humans. However, it is comparable to that of humans. Rats reach sexual maturity between 6 to 8 
weeks of age and it is believed that a single rat month equates to approximately three human years 
(Yoon et al., 2014). The use of these rats as an experimental model thus allows researchers to predict 
and control the development of diseases within a short period. Furthermore, it has been documented 
that male Wistar rats have morphological and physiological reproductive organ features similar to 
those of humans (Yoon et al., 2014). 
Healthy adult male Wistar rats (n=49) were used in this in vivo study (Figure 3.2). The animals were 
housed 4 to 5 to a cage in the ethically approved and accredited Animal Research Facility. This 
allowed for control of the environment with 12 hours light and dark cycles, humidity between 45% 
to 55% and an ambient temperature of 22oC to 28oC. The cages consisted of stainless steel wire roofs 
and plastic bottoms and were equipped with water bottles and feeders. The cages were also furnished 
with sufficient bedding material composed of sterilized ground maize cobs and were cleaned at least 
twice per week or as necessary. All the rats were fed with commercial pellets and tap water prior to 
dietary manipulation. The food, water, body weights (BWs), blood pressure (BP) and blood glucose 
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were regularly monitored during the 16-week feeding period. Any abnormality was reported to the 
veterinary staff in order to avoid injury or death of the rats. 
On completion of the study, the rats were euthanized with a lethal dose of sodium pentobarbital (160 
mg/kg). The aforementioned procedure minimised animal distress and was in accordance with the 
recommendations of the Laboratory Animal Care of the National Society of Medical Research and 
the National Institute of Health’s Guide for the Care and Use of Laboratory Animals of the National 
Academy of Sciences (National Institutes of Health publication no. 80-23, revised 1978). 
 
 
  
 
 
 
Figure 3.2: Example of a healthy male Wistar rat as was used in this experimental animal model 
(Rat Strains, 2012) 
 
3.3.2 Preparation of diets  
The current study adopted the modified protocol which has been previously used in our laboratories 
to induce obesity and insulin resistance via diet (Salie et al., 2014). The source of nutrients was 
modified in order to induce obesity/insulin resistance with or without HT by referring to the specially 
formulated high caloric diet (HCD) (Table 3.1). The DIO associated with insulin resistance diet was 
prepared from water and pellets supplemented with sucrose, condensed milk and HolsumTM cooking 
fat, while the DIO associated with hypertension diet was prepared from pellets supplemented with 
fructose, HolsumTM cooking fat, casein and cholesterol. Refer to Table 3.1 for the specific 
composition of the three diets.  
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Table 3.1: Composition of standard and HCD to induce obesity/insulin resistance with or 
without hypertension 
 
Fat 
(g/100 g) 
Cholesterol 
(mg/100 g) 
Protein 
(%) 
Fructose 
(g/100 g) 
Sucrose 
(g/100 g) 
Carbohydrate 
(%) 
Standard rat 
pellets 
4.8 - 17.1 - 5.3 34.6 
DIO 11.5 6.4 8.3 - 20.4 42 
DIO 
associated 
with HT 
27.9 13 14.6 11 - 29.5 
DIO: diet-induced obesity, HT: hypertension   
 
3.3.3 Preparation of jelly blocks, GRT blocks and Captopril blocks  
The GRT was made by the company Afriplex (Pty) Ltd and supplied by the South African Medical 
Research Council (SAMRC). Captopril was obtained from Sigma, while food grade strawberry jelly 
and gelatine were purchased locally. The compositions of diets were analysed by Microchem, SA. 
Normal strawberry jelly blocks, GRT blocks and Captopril blocks were freshly prepared every day 
according to the relative weight of each rat and the daily dosage requirements. Jelly blocks were made 
from a mixture of jelly powder (5.6 g) and gelatine powder (5.6 g), which was dissolved in 35 mL of 
boiling water. After cooling, the GRT was added to the mixture in accordance with the dosage 
determined for each animal. A GRT dose of 60 mg/kg/day was used, which is similar to that of 
previously published studies (Kamakura et al., 2015; Muller et al., 2012). Furthermore, Captopril 
was prepared and administered in the same way as the GRT. The respective solutions were pipetted 
(1 mL) into an ice tray and left overnight in a fridge to set. This positive control anti-hypertensive 
medication was administered at a dose of 50 mg/kg/day, as was previously used in our laboratories 
in the Division of Medical Physiology (Huisamen et al., 2013). Lastly, unsupplemented strawberry 
jelly/gelatine blocks were prepared for the untreated groups (LC, OB, OBHT) in order to normalise 
for the additional sugar content present in the jelly/gelatine blocks. Jelly blocks were fed to each 
individual animal to ensure treatment adherence. 
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3.3.4 Body weight, food and water intake 
Animals were fed a specific amount of food every morning. The daily food and water intake were 
monitored over a 24-hour period by weighing leftover food and measuring the water consumption. 
BWs were also recorded on a weekly basis throughout the study period. 
 
3.3.5 BP 
The BPs of all animals were regularly recorded, i.e. once per week throughout the experimental 
period, with a CODA® non-invasive BP acquisition system (Kent Scientific). This system uses a 
volume pressure recording (VPR) tail-cuff to measure DP and SP. Prior to monitoring the BPs, the 
animals were habituated to the procedures over a period of 2 weeks. The values recorded two weeks 
before commencing with the treatment were regarded as baseline. During each session, 10 systolic 
and 10 diastolic readings were taken per animal and used to calculate the mean SP, DP and mean 
arterial pressures (MAP). The following formula was used to determine MAP:  
MAP = Mean DP + 1/3 × (Mean SP - Mean DP). 
 
3.3.6 Oral glucose tolerance tests  
Insulin sensitivity was examined by using the OGTT. This is a standard experimental procedure that 
monitors the responsiveness to glucose in the body after oral administration of sugar (Stern et al., 
2002). In this study, OGTTs were performed during the 10th week after the onset of the respective 
diets and during the 16th week before euthanizing the animals. The animals were fasted overnight 
before the procedure with free access to drinking water. 
Animals were anaesthetized by an intra-peritoneal injection of 0.1 μL Euthanize (53 mg/kg sodium 
pentobarbital) and the baseline (0 min or fasting) glucose level was measured. Following this, a 50% 
sucrose solution was administered at 1 g/kg body weight by gastric gavage and the disappearance of 
glucose from the circulation was subsequently monitored. Blood was collected by a tail prick and 
analyzed on a hand-held glucometer (Accu-check, Roche, Germany). The blood glucose readings 
were taken at 3 min, 5 min, 10 min, 15 min, 20 min, 30 min, 45 min, 60 min, 90 min and 120 min 
respectively, whereafter the animals were left to recover from the anaesthezia. 
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3.3.7 Sample collection and preparation  
After the 16-week experimental period, the rats were weighed and anaesthetized via an intra-
peritoneal injection of sodium pentobarbital (160 mg/kg). Blood was collected from the tip of the tail 
and measured with a hand-held glucometer (Accu-check, Roche, Germany). Following complete 
anaesthesia, a trans-abdominal incision was performed and the heart was removed from the chest 
cavity by excising the pulmonary artery, pulmonary vein, vena cavae and aorta (Metallo, 2015). 
Therefore, exsanguination occurred and the blood was collected from the chest cavity with a pasteur 
pipette and placed in vacutainer tubes (yellow top serum collection tubes). Tubes remained at room 
temperature for 15 min before centrifugation (3 500 rpm, 15 min). The serum was transferred into 
cryo-tubes, frozen in liquid nitrogen and stored at -80°C. The intra-peritoneal fat deposits were then 
removed surgically. Both testes and epididymides were removed, freed of fat and connective tissue 
by blunt dissection and placed on ice. The epididymides were separated from the testes and the 
various organs were rinsed in phosphate buffer saline (PBS) and weighed. One testis and epididymis 
were snap frozen in liquid nitrogen and stored at -80°C until further use. The other testis was used for 
histological and histomorphometric analysis, while the remaining epididymis was used for sperm 
isolation. 
 
3.3.8 Sperm isolation and evaluation of basic and functional parameters 
The harvested epididymis was rinsed by placing it in a petri dish containing a 5 mL solution of Hams 
F-12 nutrient media (Sigma Chemicals, St Louis, MO, USA) supplemented with 3% bovine serum 
albumin (BSA) (Roche Diagnostics GmbH Mannheim, Germany) on a hot plate at 37°C. The mature 
sperm was extracted from the caudal part of the epididymis after isolating its most distal part through 
dissection. The distal part of the cauda was placed in 2 mL of 3 % Hams-BSA solution, allowing 
sperm to swim out. Subsequently, sperm motility and kinematics were performed after 30 seconds of 
incubation by sampling the sperm at the edge of the sperm cloud. Directly afterwards, the cauda was 
cut in five equal pieces and incubated in the same solution for 5 min, thereby allowing “all” 
spermatozoa to freely swim into the solution. The retrieved sperm solution was diluted 10x in order 
to perform viability and morphology analysis (SURRG laboratory protocols). 
 
3.3.8.1 Sperm concentration, motility and kinematics 
Sperm concentration, motility and kinematics parameters were measured via computer-aided sperm 
analysis (CASA) using the Sperm Class Analyser (SCA, Microptic, version 5, Barcelona, Span). 
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Sperm motility parameters of interest include percentage motile cells, progressive motility, average 
path velocity (VAP), curvilinear velocity (VCL) and straight line velocity (VSL). In brief, 2.5 µl of 
the sperm suspension was transferred to a pre-warmed (37°C) 20 µm deep Leja slide (Leja, 
Netherlands) and placed on the heated stage of a Nikon E-200 microscope (Tokyo, Japan). The 
settings for the SCA were Pseudo Negative phase, Ph2/3 condenser, 4x objective lens, no filter, 
brightness ±450, contrast ±100 and frame rate of 50 fps. 
 
3.3.8.2 Sperm morphology 
Fixative and Sperm Blue® (Microptic SL, Barcelona, Spain) were used to prepare sperm for 
morphology analysis. Firstly, 10 µL of sperm was pipetted onto a glass slide and thinly smeared. 
After air drying at room temperature, slides were immersed into the fixative for 16 min. Following 
this, the slide was moved from the fixative to the staining tray containing SpermBlue® (Microptic 
SL, Barcelona, Spain) for 16 min. Stained slides were then gently immersed in distilled water for 
3 seconds to remove excess stain, allowed to air-dry overnight and mounted the following day with 
a coverslip using DPX mountant (Merk Millipore, Modderfontein, Gauteng). Sperm morphology 
analysis was performed by means of computer-aided sperm morphometry analysis (CASMA) using 
the SCA Analyser (SCA®; Microptic, Barcelona, Spain) software and a Nikon E-200 microscope 
(Tokyo, Japan) with bright field optics at 600x magnification under a blue filter. The SCA settings 
were as follows: optics ph+; contrast 166; brightness 465; scale 600x; capture 50 images per slide. 
The SCA software automatically analyze spermatozoa by detecting and measuring the head and 
midpiece, classifying them as morphologically normal or abnormal, which is then expressed as the 
percentage of morphologically normal spermatozoa. 
 
3.3.8.3 Sperm viability  
Sperm viability was calculated after staining with eosin-nigrosin. This dye-exclusion staining 
technique depends on the integrity of the spermatozoa’s plasma membranes. All viable spermatozoa 
remain unstained as their membranes are impermeable to eosin, while dead sperm stained pink, 
indicating permeability and a damaged membrane. Sperm (10 µL) was mixed with eosin and nigrosin 
in a 1:2:3 ratio in a 2 mL Eppendorf. The mixture (10 µL) per slide was pipetted onto a glass slide 
and a thin smear was made, allowed to air-dry and mounted with a coverslip using DPX mounting 
medium. The prepared slide was examined using a Nikon Eclipse E-200 light microscope (Tokyo, 
Japan) at 40x magnification. A total of 200 cells (100 in duplicate) were evaluated. Pink-stained dead 
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sperm was differentiated from unstained live sperm, and their numbers were recorded. The number 
of viable sperm was expressed as a percentage of the total number of sperm counted. 
 
3.3.9 Oxidative stress (OS) and antioxidant status 
OS means that an imbalance developed between either ROS or RNS and the antioxidant defence 
mechanisms of the body. Testicular tissue generates ROS under both physiological and 
pathophysiological conditions. Furthermore, the cytoplasmic membrane of sperm cells is rich in 
PUFAs, which are susceptible to ROS attack. Oxidation of lipid membranes or LPO generates 
different products, including MDA. Furthermore, testicular tissue has different defence mechanisms, 
including antioxidant enzymes, which include SOD and CAT. Therefore, it was of interest to check 
the concentrations of MDA levels and antioxidant enzyme activities in lysates from testicular tissue. 
MDA is an end product of LPO and gives an indication how ROS reacted with cytoplasmic membrane 
PUFAs. It has been widely adopted as a measure of free radical formation. 
 
3.3.9.1 Lysate preparation and protein concentration determination 
Samples used to measure antioxidant enzymes SOD and catalase (CAT) as well as MDA were 
prepared using the same method, but a specific buffer was prepared for each assay, namely SOD 
assay (50 mM sodium phosphate, 0.5% (w/v) Triton X-100, pH 7.5), CAT assay (50 mM potassium 
phosphate, 0.5% Triton X-100, pH 7.0) and MDA assay (50 mM Potassium phosphate, 1.15% 
potassium chloride, pH 7.0). 
Frozen tissue samples were thawed on ice in Eppendorf tubes before being cut to a weight ranging 
from 50–60 mg. An equal mass of stainless steel 1.6 mm beads and a double volume of ice-cold 
buffer was successively added to the sample tube. Samples were homogenised with a Bullet Blender 
24 (Next Advance, NY, USA) during the three episodes of 1 minute at speed setting 9, with a 1 minute 
resting interval in between. The homogenates were allowed to stand on ice for 30 min before 
centrifuging to allow for stabilization of the tissue homogenate. Homogenates for SOD and CAT 
analysis were centrifuged (Sigma Laborzentrifugen, type 1-4 K, Germany) at 1 500 rpm for 20 min 
at 4°C. However, samples for MDA analyses were not centrifuged. 
The prepared samples were equally aliquoted into four different tubes for each sample. One tube was 
used for protein determination on the same day of making the lysate. Other remaining tubes were 
kept at -80°C for a maximum period of one month. Protein concentration was determined immediately 
after lysate preparation using a bicinchoninic acid (BCA) kit assay (Sigma) according to the 
Stellenbosch University https://scholar.sun.ac.za
33 
 
manufacturer’s instructions. Absorbance was read at 562 nm using FLUOstar Omega Microplate 
Reader (BMG Labtech, Offenburg, Germany). 
 
3.3.9.2 Thiobarbituric acid reactive substance assay 
The thiobarbituric acid reactive substance (TBARS) assay is used to quantify MDA in a reaction with 
two molecules of thiobarbituric acid (TBA) under acid conditions and a high temperature (95°C). This 
product is calorimetrically quantified through spectrophotometric techniques at a wavelength of 530 
nm. The modified protocol of Esterbauer and Cheeseman (1990) was applied to quantify MDA levels 
according to standard MDA concentrations and the protein contents in the sample. MDA standard 
samples of different concentrations (Table 3.2) were prepared to generate the standard curve in order 
to determine MDA concentrations in the various samples. A 10 mL solution of MDA standard 
solution (500 μM) was prepared by diluting 1.23 μL of the MDA stock solution with 998.77 mL of 
deionised water (deiH2O). From this solution, 2 mL MDA solution (125 μM) was prepared by diluting 
500 μL of MDA (500 μM) in 1.5 mL deiH2O. Subsequently, the MDA (125 μM) was considered as 
initial concentration and used to make a dilution series according to values indicated in Table.3.2. 
Following this, samples were loaded in different glass vials (tubes). A reaction mixture of a 4.2 mL 
comprising 0.1 mL sample, 0.1 mL sodium dodecyl sulfate (SDS; 2%), 2 mL trichloroacetic acid 
(TCA) + butylated hydroxytoluene (BHT; 10% TCA + 0.8 g/mL ethanol) was added to the tubes, 
vortexed and incubated for 10 min at room temperature. Finally, 2 mL of colour reagent, TBA (0.67 
%), was added to the mixture and the tubes were placed in water bath and boiled at 95°C for 60 min. 
After heating, the tubes were removed from the water bath and cooled down by placing them in ice-
cold water for 15 min. The sample tubes were subsequently centrifuged at 3 000 rpm for 15 min at 
40°C. The supernatants were aliquoted into new tubes. Successively, a triplicate assay was run in 96 
plate wells, with each well containing 250 µL of supernatant. The absorbance was read at a 
wavelength of 532 nm on a FLUOstar Omega Microplate Reader (BMG LABTECH, Offenburg, 
Germany). The resultant MDA levels of the samples were calculated from the MDA standard curve 
and expressed as µM/mg protein. 
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Table 3.2: MDA standard curve 
Tubes MDA (µL) Water (mL) [MDA] µM 
A 0 1000 0 
B 2.5 997.5 0.3125 
C 5 995 0.625 
D 10 990 1.25 
E 20 980 2.5 
F 40 960 5 
G 80 920 10 
H 200 800 25 
I 400 600 50 
 
3.3.9.3 SOD activity assay  
SOD is an antioxidant enzyme, which converts the superoxide radical (O2 •−) to hydrogen peroxide 
(H2O2) and molecular oxygen (O2). The activity of SOD in testicular homogenates was assessed 
according to the method modified from previous studies (Ellerby & Bredesen, 2000). This assay is 
dependent on the auto-oxidation of 6-hydroxydopamine (6HOD) and diethylenetriaminepentaacetic 
acid (DETAPAC), both of which are used as sources of superoxide anions with colorimetric variation 
signals in the sample. This implies that the formation of many free radicals indicates less SOD activity 
and vice versa. 
The samples were placed in ice-cold water and diluted 10x with SOD assay buffer (50 μM sodium 
phosphate buffer, pH 7.4). The SOD assay was run in a clean 96-well plate with a maximum of eight 
samples in duplicate. Each well contained a 200 μL mixture consisting of the following components: 
5 μL SOD buffer was added to 10 μL of homogenate and subsequently 170 μL of DETAPAC solution 
(0.4 mg in 10 mL SOD buffer and sonicate) and 15 μL of 6-HOD were respectively added. A pinkish 
colour with different intensities would appear, depending on the amount of SOD in the sample. This 
means that high activity of SOD corresponds to light colour/reduced pinkish colour and less auto-
oxidation. The auto-oxidation and linear increase in absorbance were recorded at a wavelength of 490 
nm by using FLUOstar Omega Microplate Reader (BMG LABTECH, Offenburg, Germany) every 1 
minute for 5 min at 25°C. One unit of SOD is defined as the amount of enzyme needed to exhibit 50% 
Stellenbosch University https://scholar.sun.ac.za
35 
 
dismutation of the O2 •−. The final activity was dependent on the dilution factor and total protein 
content in the sample. The SOD activity was expressed in U/mg protein. 
 
3.3.9.4 CAT activity assay  
The CAT antioxidant enzyme plays a role in converting H2O2 into O2 and water (H2O). In this study, 
CAT activity was determined by using the protocol adapted from the method previously described 
by Ellerby and Bredesen (2000). Tissue homogenates were diluted to 0.1 µg/µL protein using CAT 
assay buffer (50 mM potassium phosphate, pH 7.0). A triplicate assay was run in a 96-well UV plate, 
and each well contained a mixture of 170 µL assay buffer (50 mM KH2PO4, pH 7.0), 5 µL of sample 
and 50 µL H2O2 (34 µL of 30% H2O2 in 10 mL CAT assay buffer). The kinetics assay of CAT activity 
was determined by measuring the change in absorbance every 30 seconds of a period of 5 min of H202 
conversion. The linear decline in absorbance was read at UV light with wavelength of 240 nm with 
microplate reader (BioTek Synergy™ HTX Multi-Mode Microplate Reader with Gen5 Software). 
The CAT activity was determined using the molar extinction coefficient of 43.6 M-1 cm-1 and was 
expressed as µmole H2O2 consumed/min/µg protein. 
 
3.3.9.5 Hormonal level analysis 
Serum samples were used to quantify T and estradiol (E2), which were measured using commercial 
Enzyme-linked Immunosorbent Assays (ELISA) (Elaboscience, USA). Assay sample manipulations 
were performed according to the ELISA principle and the manufacturer’s instructions. Mainly, 
ELISA is used to detect and quantify the concentration of antibodies (enzymes) or antigens (proteins) 
in the sample. The absorbance was read at specific optical density with IMarkTM microplate reader 
(Bio-RAD laboratory, SA), and the results were calculated and interpreted according to the standard 
curve. T and E2 levels were expressed as ng/mL and pg/mL (0.001 ng/mL) respectively. 
 
3.3.9.6 Inflammatory cytokines 
Inflammatory cytokine levels IL-1β, IL-6, IL-12, IL-18 and TNF-α, were analysed in rat serum by 
using Milliplex MAP rat cytokines kit (Merck, SA). Assay sample manipulations were performed 
according to the Luminex technology in 96-well plate. This technique detects multiple cytokines in 
one small amount of the sample by using magnetic beads. Bio-Rad Bio-Plex TM 200 system instrument 
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and data manager 6.1 software were used to analyse these cytokines. The concentration was 
calculated from standard curves and expressed in ng/ mL. 
 
3.3.10 Evaluation of protein expression and phosphorylation in testicular tissue 
Western blotting techniques were used to detect and analyse total PKB (T-PKB; 60 kDa), 
phosphorylated PKB serine 473 (P-PKB; 60 kDa), total AMPK (T-AMPK; 62 kDa), phosphorylated 
AMPK threonine 172 (P- AMPK; 62 kDa), Caspase 7 (45 kDa) and PARP (89 kDa) proteins in the 
testicular extract. These proteins were separated by gel electrophoresis using an SDS- polyacrylamide 
gel (SDS-PAGE). The separated proteins were transferred to a polyvinylidene fluoride (PVDF) 
membrane, whereafter they were probed detected using specific antibodies procured from Cell 
Signalling Technology®. As part of this study, total and phosphorylated PKB and AMPK, caspase 7 
and Cleaved PARP were measured. The following steps summarize the protocol that was used to 
determine the proteins of interest. 
 
3.3.10.1 Sample preparation and protein extraction 
Proteins were extracted from frozen testicular tissue by using lysis buffer, mechanical and enzymatic 
processes. The lysis buffer of 30 mL was prepared with different chemical reagents (Table 3.3). Each 
reagent had a specific role in the mixture. Thirty mL lysis buffer was prepared and 700 µL of the 
buffer was aliquoted into different Eppendorf tubes containing sample tissue. Furthermore, the entire 
process of protein extraction was performed on ice. 
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Table 3.3: Lysis buffer composition for testicular tissue 
Reagent Stock solution 
Concentration of 
working solution 
Amount for 30 
mL lysis buffer 
 
Tris-HCl EGTA (pH 7.5) 200 mM 20.0 mM 3 mL 
EDTA 100 mM 1 mM 300 μL 
NaCl 1 M 150 mM 4.5 mL 
Β-glycerolphosphate  1 mM 0.006 g 
Tetra-Na-Pyrophosphate  2.5 mM 0.03 g 
Na3VO4 0.018 mg/10 mL 1.0 mM 3 mL 
Leupeptin and Aprotinin 10 μg/μL 10 μg/ μL 30 μL 
Triton X-100 10 % 1% 3 mL 
PMSF 50 μg/μL 10 μg/μL 90 μL 
dH2O   fill up to 30 mL 
 
3.3.10.2 Testicular tissue pulverization and homogenization 
Testicular tissue was pulverized using a liquid nitrogen-precooled mortar and pestle in order to 
preserve the intact protein in the sample. Approximately 70 mg of the pulverized powder was weighed 
off and added into an Eppendorf tube together with 700 µL lysis buffer. Seven stainless steel beads 
(SSB16, 1.6 mm in diameter; 1 lb.) (Next Advance, USA) were added to the sample tube which was 
immediately homogenized with a Bullet Blender 24 (Next Advance, NY, USA) at 4ºC for three 
episodes of 1 min at speed setting 9, with a 5 min resting interval in between. Thereafter, the 
homogenized samples were left on ice for 20 min in order to allow their optimal reaction with the 
lysis buffer before centrifuging for 20 min at 15 000 rpm (Sigma Laborzentrifugen, type 1-4 K, 
Germany). The supernatant was aliquoted and 700 µL transferred into clean Eppendorf tubes and 
kept on ice until the Bradford assay was performed. 
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3.3.10.3 Protein concentration determination in the supernatant  
Both a Bradford protein assay (BPA) (Bradford, 1976) and BSA standard curve were used to 
determine the protein concentration in the supernatant.  
Reagents: 100 mg of Coomasie Brilliant Blue G-250, 50 mL 95% Ethanol, 100 mL 85% (w/v) 
Phosphoric Acid, 850 mL dH2O (Bradford Stock Reagent), BSA.  
Bradford stock was prepared by dissolving 500 mg Coomassie Brilliant Blue in 250 mL 95% ethanol, 
whereafter 500 mL phosphoric acid was added and the final volume made up to 1L with distilled 
water and mixed. Subsequently, a prepared Bradford solution was diluted five times (5x) with 
distilled water and filtered twice using Wathman filter papers (0.4 μm pores). A 10 μL of each sample 
supernatant was added to 90 μL of distilled water into luckam tubes to prepare the first ten times 
(10x) dilution in order to dilute any detergents in the lysis buffer that may interfere with the assay. 
From the 10x diluted set, another 5 μL volume was drawn and added to another set of duplicate tubes 
with 95 μL of distilled water for the second dilution (a twenty times (20x) dilution). To prepare 
standards, 100 μL BSA of the known concentration (5 mg/ml) was diluted 5x by adding 400 μL of 
distilled water and preparing it in increasing concentrations. 900 μL of the Bradford solution was 
added, as shown in the table below (Table 3.4). 
900 μL of Bradford solution was also added to the duplicate set of diluted samples, mixed (using a 
vortex) and left to stand for 15 min before absorbance at wavelength of 595 nm was measured using 
a spectrophotometer (Cat. 4001/4, Spectronic Instruments, USA). From the absorbance, protein 
concentrations were calculated against the BSA standard curve (absorbance against concentration). 
From the above concentrations, the volume of supernatant to load on the SDS-PAGE was calculated 
against a standard concentration and a total volume of 50 μg/ 9 μL loaded in each gel well. One third 
of the volume of lysates was composed of the Laemmli sample buffer (62.5 mM Tris-HCl (pH 6.8), 
4% SDS and 10% glycerol, 0.03% bromophenol blue and 5% β-mercaptoethanol), and the volume 
difference was topped up with the lysis buffer. The prepared lysate samples were boiled in a water 
bath for 5 min to denature proteins and were preserved at -80°C. 
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Table 3.4: BSA standard concentrations for BPA 
BSA concentration 
µg/ml 
BSA volume 
(µL) 
Distilled water volume 
(µL) 
Bradford solution 
(µL) 
0 0 (blank) 100 900 
1.25 5 95 900 
2.5 10 90 900 
5 20 80 900 
10 40 60 900 
15 60 40 900 
20 80 20 900 
 
3.3.10.4 Protein separation by gel electrophoresis 
Reagents and their compositions are illustrated in Table 3.5 and this is followed by preparation of the 
gel and sample loading. 
Table 3.5: Reagents used for protein separation and protein transfer 
 
3.3.10.5 Stain free precast gels preparation and sample loading  
A 4–20% Criterion™ TGX™ Precast Midi Protein Gel with 26 wells were procured from Bio-Rad, 
USA, and were used to separate the proteins. Gels were removed from their containers according to 
the manufacturer’s instructions. Thereafter, the gels were placed in a Midi-protean® dual system 
Reagents Composition 
Running buffer 
192 mM Glycine, 0.1% SDS, 25 mM 
Tris-HCl 
 
Trans-Blot Turbo Buffer 
200 mL Ethanol, 200 mL Trans-Blot® 
Turboᵀᴹ buffer 600 mL dH2O 
TBS-Tween Buffer Solution pH 7.6 
137 mM NaCl, 20 mM Tris-HCl, 0.1% 
Tween-20 
Ponceau Red (Sigma-Aldrich) 
5 mL acetic acid, 0.5 g Ponceau Red/ 
100 mL dH2O 
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(Bio-Rad Laboratories Inc., USA) and the tanks were filled with running buffer up to the 
demarcations. 
The samples were loaded into the wells by starting with 5 μL pre-stained protein ladder (molecular 
weight marker) (Thermo Scientific, Lithuania, European Union) in the first well. Subsequently, 9 μL 
of each sample containing 50 μg of protein were loaded; control samples were 3 per group (LC, OB, 
OBHT), treatments samples were 4 per group (LC+GRT, OB+GRT, OBHT+GRT, 
OBHT+Captopril). On completion of sample loading, the outer compartment of the electrophoresis 
system was filled with running buffer and the system was connected to electrodes (matching the anode 
to anode and cathode to cathode) and set to run at 200 V, 200 mA for 40 min. After separation, gels 
were activated in the ChemiDoc™ MP system (Bio-Rad Laboratories Inc., USA) and the image 
stored. Separated proteins were transferred to a membrane. 
 
3.3.10.6 Transfer of gel proteins to a polyvinylidene fluoride membrane 
The Millipore Immobilon-P Transfer membrane is a polyvinylidene fluoride (PVDF) microporous 
membrane (Immobilon®-PMerck KGaA, Darmstadt, Germany) that was used to bind proteins from 
the gel through an electro-transfer system. An appropriate membrane size was cut and placed in a 
dish of fresh methanol for 5 min. Subsequently, the membrane, sponges, blotting paper 
(chromatography paper) and plastic sandwiches were soaked in cold transfer buffer for at least 15 
min to equilibrate before starting the transfer. Thereafter, one sponge was placed on the black side of 
the open plastic sandwiches, followed by three blotting papers and then the gel. The gel was 
continuously soaked with transfer buffer. The membrane was placed on top of the gel and followed 
by three blotting papers and one sponge. The bubbles were removed by using a glass roller before the 
sandwich was closed. The closed sandwich was placed in the transfer cassette. The cassette was 
inserted in the filled transfer tank, and an ice pack placed behind the cassette to maintain the 
temperature at < 10°C. The system was connected to the electrophoresis power supply (Amersham 
Pharmacia Biotech, Cape Town, SA) and transfer was set at 200 V and 200 mA for an hour. The 
membrane was removed from the transfer system and visualized using the ChemidocTM (Bio-Rad) 
imaging system to check whether the transfer was successful. Automatic software Image LabTM 5.2.1 
captured and saved the image for analysis and normalization purposes. The membrane was soaked in 
methanol for 30 sec in order to fix the proteins on the membrane. Membranes were left to air-dry at 
room temperature for 2 min. The membranes were stored at -20°C until later use. 
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3.3.10.7 Primary and secondary antibody incubation 
The membrane was removed from the freezer and left at room temperature for 5 min. The membrane 
was soaked in Ponceau Red for 2 min to visualize all protein bands. After rinsing out Ponceau Red 
with dH20, the bands were visible and subsequent cutting was performed according to the size of the 
proteins of interest. The membrane pieces were washed three times with TBS-Tween buffer for 5 min 
on a shaker (lab rotor V1.00). Following this, 5% fat free milk TBS-Tween solution was used to block 
non-specific binding sites on the membrane. The membrane was left in the milk solution for 60 min 
on a shaker (lab rotor V1.00) and subsequently washed for 15 min (3 x 5 min replacing TBS-Tween 
buffer in between each wash). Thereafter, the membranes were probed overnight (4oC) with the 
respective primary antibody (1:1 000 dilution). 
The following day, the membrane was washed with TBS-Tween buffer for 15 min (3 x 5 min, 
replacing with fresh TBS-Tween buffer in between each wash) on a shaker (lab rotor V1.00). The 
membrane was then probed with secondary antibody/anti-rabbit secondary (1:4 000 dilution) for 1 
hour on shaker at room temperature. The principle of using these two antibodies respectively is that 
the anti-rabbit secondary antibody is linked to horseradish peroxidase. It recognizes and binds to the 
primary antibody. When exposed to a chemiluminescent agent, the reaction produces luminescence 
in proportion to the amount of protein. The emitted light can then be captured by a camera for 
qualitative and quantitative analysis. After the incubation with 2 mL ECL, the membranes were 
transferred to the ChemidocTM (Bio-Rad) imaging system and images were captured using the Image 
LabTM 5.2.1 image acquisition and analysis software. The images were saved and the corresponding 
images with total proteins were used for normalization. 
 
3.3.10.8 Normalization method for quantitative analysis of blots 
Normalization consists of checking equal amounts of loading of samples, transferring protein to the 
membrane and recording values after probing protein with the Ab and exposing to ChemiDoc™ MP 
system (Bio-Rad Laboratories Inc., USA). By using Image Lab Software 6.0.0 Analyser, lanes and 
bands were selected from Chemi-Hi blot and automatically quantified. Next, lanes were only selected 
from original membrane/total stain free membranes (blot before probing) and quantified. Both 
detected lanes on Chemi-Hi blot image and total stain free membranes were subsequently compared 
(Figure 3.3). The software calculates a normalization factor from the amount of protein transferred 
per lane to the PVDF membrane. Using the total amount of transferred protein in each lane to 
normalize negates the use of an additional loading control. The data were exported to Excel and 
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analysis was performed. Firstly, the control samples were averaged. This value was set as one, and 
all other values were calculated and expressed as a ratio. Following this, the ratio between the relative 
amount of phosphorylated proteins and total protein was determined by dividing the phosphorylated 
protein with total protein expression (for example P-PKB/T-PKB). 
 
Figure 3.3: Normalization of total protein per lane (right side) versus total intensity of antibody 
stained sample (left side) 
 
3.3.11 Histology and morphometric analysis  
Haematoxylin and Eosin (H & E) staining techniques were used to analyze the histological and 
morphological characteristics of testicular tissue. Furthermore, this technique facilitated the 
identification of spermatozoa where haematoxylin stained the cell nucleus blue and eosin stained the 
cytoplasm pink. To perform this technique, the following steps were applied: fixation of the tissue, 
processing, embedding, sectioning and staining. 
 
3.3.11.1 Fixation of the tissue 
The right testis was harvested and placed immediately in specimen jars containing a 10% formalin 
solution and left at room temperature for 48 hours. This fixing step prevents tissue degradation, 
deterioration and preserves tissue structure. 
3.3.11.2 Tissue processing 
The fixed tissues were sectioned into smaller pieces and placed in labelled embedding cassettes. An 
automated processing system (Duplex processor, Shandon Elliot; Optolabor (Pty) Ltd, Johannesburg, 
SA) was used to process the tissue. This tissue processing was performed in different solutions, 
Stellenbosch University https://scholar.sun.ac.za
43 
 
including alcohol, xylene and paraffin, which were used successively. Alcohol dehydrated the tissue, 
while xylene removed alcohol from the tissue and paraffin wax infiltrated the “empty” spaces in the 
tissue. Full details and the protocol of tissue processing are listed in the Table 3.6. 
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Table 3.6: Standard tissue processing protocol for H & E staining 
Step Solution 
Time 
(min) 
Temperature 
(°C) 
1 10% Formalin 30 Room temperature 
2 70% Ethanol 30 Room temperature 
3 96% Ethanol 30 Room temperature 
4 96% Ethanol 30 Room temperature 
5 99.9% Ethanol 30 Room temperature 
6 99.9% Ethanol 30 Room temperature 
7 99.9% Ethanol 30 Room temperature 
8 Xylene 30 Room temperature 
9 Xylene 30 Room temperature 
10 Paraffin 60 60 
11 Paraffin 60 60 
12 Paraffin 60 60 
 
3.3.11.3 Embedding 
The processed tissues were embedded in paraffin wax at 60°C using the Leica EG1160 Embedder 
(Leica Biosystems, Germany; supplied by SIMM Instruments (Pty) Ltd, Cape Town, SA). The wax 
mold was placed on an iced surface for it to set and subsequently stored at temperatures ranging from 
20–25°C before sectioning. 
 
3.3.11.4 Tissue block sectioning 
The tissue blocks were placed in a freezer (-20°C) for at least two hours before trimming and 
sectioning. A Leica RM 2125 RT Microtome (Leica Biosystems, Germany; supplied by SIMM 
Instruments (Pty) Ltd, Cape Town, SA) was used to cut uniform 5 μm sections. These cut sections 
were placed in a water bath (40–45°C) to allow the section to stretch, and thereafter they were 
transferred onto a slide. 
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3.3.11.5 Staining 
The slides were incubated at 60°C for 2 min in order for the wax to melt before staining. Filtered 
H&E solutions were placed into the automated stainer, the Leica Auto-Stainer XL (Leica Biosystems, 
Germany; supplied by SIMM Instruments (Pty) Ltd, Cape Town, SA). The staining protocol consists 
of three steps: deparaffinization, rehydration and clearing of the tissue. The H&E protocol is shown 
in the Table 3.7. 
Table 3.7: H&E staining protocol 
Step Solution Time 
(min) 
Repetitions 
1 Oven (60 ºC) 2 x1 
2 Xylene 5 x2 
3 Ethanol (99%) 2 x2 
4 Ethanol (96%) 2 x1 
5 Ethanol (70%) 2 x1 
6 Tap water 2 x1 
7 Haemotoxylin 8 x1 
8 Running water 5 x1 
9 Eosin 4 x1 
10 Running water 1 x1 
11 Ethanol (70%) 0.5 x1 
12 Ethanol (96%) 0.5 x2 
13 Ethanol (99%) 0.5 x1 
14 Xylene 1 x1 
 
3.3.11.6 Mounting 
A cover slip was mounted with DPX (Sigma-Aldrich, USA) onto the slide to protect the tissue and 
left for two days to air-dry. The slides were used to identify the testicular histology and 
histomorphometry under the microscope at 20x and 10x magnification respectively. 
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3.3.11.7 Histological and morphometrical parameters  
Histological evaluation according to the modified Johnsen score was based on 50 cross-sections of 
seminiferous tubules per testis. The degree of spermatogenesis was graded between 1 and 10 
according to the most advanced germ cell in the tubule, where 10 is the normal healthy status and 1 
is the most damaged, i.e. with germ and somatic cell loss. The total score is then determined by 
dividing the total score by the number of evaluated tubules. 
Morphometric parameters, including tubular diameter, tubular height, epithelial height and lumen 
diameter, were evaluated under 10x magnification. Different images were captured and 50 tubules 
and 50 lumens per animal were analyzed by using ZENLite 2.3SP1 software (Figure 3.4). 
 
Figure 3.4: Morphometric analysis of a seminiferous tubule in the testis 
 
3.4 Statistical analysis 
Data were analyzed and expressed as means ± standard error of the mean (mean + SEM). Significant 
difference between mean values of two groups was calculated with Student’s t- test, while mean 
values of different groups were calculated using one-way or two-way analysis of variance (ANOVA). 
Furthermore, the Bonferroni Multiple Comparison analysis was used to compare differences between 
groups with GraphPad TM Prism 5.0 (GraphPad Software, San Diego, CA, USA). 
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CHAPTER FOUR 
RESULTS AND INTERPRETATION 
4.1 Introduction  
This chapter is divided into two parts according to the diet used to induce obesity associated with 
insulin resistance (OB) and obesity associated with hypertension (OBHT). The effects of GRT on 
both animal groups were investigated. The first part included four groups, namely LC, LC+GRT, OB 
and OB+GRT, while the second part comprised five groups, namely LC, LC+GRT, OBHT, 
OBHT+GRT and OBHT+Captopril. Moreover, both parts ran concurrently in order to adhere to 
ethics and limit the number of animals used. Animals were handled similarly, and therefore LC and 
LC+GRT were shared. The difference lies in the diet-induced OB or OBHT (refer to Figure 3.1 and 
Section 3.3.1). 
 
4.2 The effects of a green rooibos extract on the reproductive function of obesity-induced insulin 
resistant Wistar rats 
In this section, the effect of a HCD on the development of obesity associated with insulin resistance 
is described. Obesity-related insulin resistance was hypothesized to have side effects on male 
reproductive function through pathophysiological mechanisms. Subsequently, the 6-week treatment 
period with GRT was evaluated by monitoring different parameters as set out below. 
 
4.2.1 Biometric data before and after initiation of GRT treatment 
Water and food intake as well as the change in body weight and glucose levels were monitored during 
the 16-week treatment period before onset of GRT treatment (from 0 to 10 weeks) and during the 
treatment phase (from week 11–16). Additionally, visceral fat weight in relation to the total body 
weight (adiposity index) were determined in four groups (LC, LC+GRT, OB and OB+GRT). 
 
4.2.1.1 Food intake  
Figure 4.1 illustrates the mean food intake in both lean (LC) and obese (OB) animal groups at 10 
weeks before the start of GRT treatment. The average food intake was significantly higher in the OB 
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compared to the LC group (18.72 ± 0.19 g/rat/day vs. 13.90 ± 0.08 g/rat/day, p<0.001). Treatment 
with GRT was started at 11 weeks of the diet period. Both groups (LC and OB) were further divided 
in two subgroups: LC+GRT and OB+GTR. Food intake was further monitored daily until 16 weeks. 
According to a two-way ANOVA, diet significantly increased food intake between untreated OB and 
LC (16.49 ± 0.59 g/rat/day vs 13.52 ± 0.14 g/rat/day, p<0.001) as well as treated OB+GRT and LC 
group (17.88 ± 0.76 g/rat/day vs 13.52 ± 0.14 g/rat/day, p<0.001). The OB+GRT group showed a 
significant higher food intake when compared to LC+GRT group (17.88 ± 0.76 g/rat/day vs 13.99 ± 
0.77 g/rat/day, p<0.001) (Figure 4.2). However, GRT treatment did not show any effect on food intake 
in the LC+GRT or OB+GRT animals when compared either to the LC or OB animals. 
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Figure 4.1: Mean food intake of the OB and LC animals over 10 weeks 
Data are presented as mean ± SEM. ***p<0.001 according to Student’s t-test, LC: lean control, OB: obese 
group. N=14 per group. 
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Figure 4.2: Mean food intake of the treatment groups from 11 to 16 weeks 
Data are presented as mean ± SEM. ***p<0.001 according to 2-way ANOVA, LC: lean control, LC+GRT: 
lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=7 per group. 
 
4.2.1.2 Water intake  
Before onset of treatment, the OB group consumed less water than the LC group (16.07 ± 0.44 
mL/rat/day vs 22.02 ± 0.42 mL/rat/day, p<0.001) (Figure 4.3). Similarly, after GRT treatment, the 
average water intake in the OB group was less compared to that of the LC group (16.20 ± 1.59 
mL/rat/day vs 20.73 ± 0.50 mL/rat/day, p<0.001) (Figure 4.4). There was no significant difference 
between LC+GRT and the LC group and between OB+GRT and the OB group. The OB+GRT group 
showed a significant decrease in water intake when compared to the LC+GRT group (15.68 ± 1.00 
mL/rat/day vs 20.47 ± 1.04 mL/rat/day, p<0.001) as well as compared to the LC group (15.68 ± 1.00 
mL/rat/day vs 20.73 ± 0.50 mL/rat/day, p<0.001) (Figure 4.4). According to the two-way ANOVA, 
diet, and not GRT treatment, influence water consumption. 
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Figure 4.3: Mean water intake of lean and obese animals over 10 weeks 
Data are presented as mean ± SEM. ***p<0.0001 according to Student’s t-test, LC: lean control, OB: obese 
group. N=14 per group. 
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Figure 4.4: Mean water intake from week 11 to week 16 in treatment groups  
Data are presented as mean ± SEM. ***p<0.001 according to a two-way ANOVA, LC: lean control, LC+GRT: 
lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=7 per group. 
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4.2.1.3 Body weights  
Initially, animal body weights (BWs) were measured (120.00 ± 10.00g) and grouped into different 
treatment groups. The changes in BW were monitored before and after GRT treatment. In week 10, 
the OB group showed a trend of increase in the mean BW at baseline (before the onset of GRT 
treatment) when compared to the LC group (299.00 ± 5.51 g vs 285.40 ± 4.44 g, p>0.05) (Figure 4.5). 
In week 16, the OB animals presented a significant higher BW when compared to the LC animals 
(378.12 ± 11.69 g vs 346.30 ± 7.05 g, p<0.05) (Figure 4.6). The OB+GRT group had a significant 
lower BW compared to the OB group (340.00 ± 9.01 g vs 378.12 ± 11.69 g). Additionally, the 
LC+GRT group did not present with changes in BW compared to the LC group as well as compared 
to OB+GRT groups (Figure 4.6). 
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Figure 4.5: Mean body weight of lean and obese group in week 10 
Data are presented as mean ± SEM. p>0.05 according to Student’s t-test, LC: lean control group, OB: obese 
group. N=14 per group.  
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Figure 4.6: Mean  body weight per experimental group at the time of sacrifice  
Data are presented as mean ± SEM. * p<0.05 according to a one-way ANOVA, LC: lean control, LC+GRT: 
lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=7 per group. 
 
4.2.1.4 Intra-peritoneal fat weight  
Intra-peritoneal (IP) fat weight was expressed as a ratio of the BW and presented as an adiposity index 
(IP/BW*100) expressed in %. The adiposity index was significantly higher in the OB group compared 
to the LC group (3.60 ± 0.10% vs 1.96± 0.32%, p<0.001). The OB+GRT group showed a significantly 
lower adiposity index compared to the OB group (2.06 ± 0.07% vs 3.60 ± 0.10%, p<0.001) and there 
was no difference between OB+GRT and LC groups. The ingestion of GRT in the LC+GRT group 
did not show any significant difference in the adiposity index compared to the LC as well as compared 
to OB+GRT groups (Figure 4.7). 
 
Stellenbosch University https://scholar.sun.ac.za
53 
 
L
C
 L
C
 +
G
R
T
O
B
 
O
B
+G
R
T
0
1
2
3
4 ***
***
Treatment groups
A
d
ip
o
si
ty
  
in
d
e
x
(%
)
 
Figure 4.7: Adiposity index in the experimental groups at the time of sacrifice 
Data are presented as mean ± SEM. ***p<0.001 according to a one-way ANOVA, LC: lean control, LC+GRT: 
lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=7 per group. 
 
4.2.1.5 Insulin sensitivity and glucose levels  
4.2.1.5.1 OGTT results at baseline level in week 10 
After oral administration of the 50% sucrose solution, the monitoring of glucose levels for 2 hours 
OB animals showed higher glucose levels compared to the LC animals at different time points 
respectively: 0 min (5.99 ± 0.24 mmol/L vs 4.87 ± 0.21 mmol/L, p<0.05), 10 min (7.24 ± 0.12 mmol/L 
vs 6.23 ± 0.21 mmol/L, p<0.05), 15 min (7.95 ± 0.16 mmol/L vs 6.31 ± 0.40 mmol/L, p<0.01) and 
30 min 7.64 ± 0.11 mmol/L vs 6.73 ± 0.27 mmol/L, p<0.001) (Figure 4.8). Furthermore, according 
to the area under the curve (AUC), the OB group showed significantly increased blood glucose levels 
compared to the LC group (768.00 ± 17.45 arbitrary units vs 690.80 ± 13.45 arbitrary units, p<0.05) 
(Figure 4.9). 
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Figure 4.8: Glucose levels in two experimental animal groups (LC and OB) at 10th week on diet 
Data are presented as mean ± SEM. *p<0.05 vs OB according to a two-way ANOVA, LC: lean control group, 
OB: obese group. N=7 per group. 
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Figure 4.9: AUC representing the effect of diet on glucose tolerance of LC and OB at week 10 
Data are presented as mean ± SEM. *p<0.05 according to Student’s t-test, LC: lean control group, OB: obese 
group. N=14 per group. 
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4.2.1.5.2 OGTT results after GRT treatment 
In week 15 (i.e. after 5 weeks of GRT treatment), the blood glucose levels in the different treatment 
groups were changed at different time checking points after gavaging animals with 50% sucrose 
solution. The OB group presented with significantly higher glucose levels in the plasma when 
compared to the LC group at 10 min, 15 min, 20 min, 25 min, 30 min and 60 min time points 
respectively (7.77 ± 0.27 mmol/L vs 6.37 ± 0.12 mmol/L, p<0.001), (8.17 ± 0.21 mmol/L vs 6.91 ± 
0.25 mmol/L, p<0.01), (8.17 ± 0.24 mmol/L vs 6.87 ± 0.18 mmol/L, p<0.001),8.00 + 0.30 mmol/L 
vs 6.67+ 0.17 mmol/L, p<0.001), (7.74 ± 0.21 mmol/L vs 6.48 ± 0.25, p<0.01) and (6.97 + 0.33 
mmol/L vs 5.89 ± 0.14 mmol/L, p<0.01), (Figure 10). According to the calculation of AUC, the OB 
presented higher blood glucose levels compared to the LC group (820.70 ± 21.49 arbitrary units vs 
714.00 ± 12.14 arbitrary units, p<0.05) (Figure 4.11). 
GRT treatment in the LC group (LC+GRT) and in the OB group (OB+GRT) did not show any 
significant effect on glucose levels when compared to the untreated group (LC and OB). However, it 
was demonstrated that the two treated groups (OB+GRT and LC+GRT) were significantly different 
at 0 min (6.19 ± 0.20 mmol/L, vs 5.06 ± 0.06 mmol/L, p<0.01), 5 min (7.13 ± 0.25 mmol/L vs 5.83 
± 0.19 mmol/L, p<0.001), 10 min (7.77 ± 0.25 mmol/L vs 6.40 ± 0.21 mmol/L, p<0.001), 15 min 
(8.20 ± 0.27 mmol/L vs 6.36 ± 0.12 mmol/L, p<0.001), 20 min (8.10 ± 0.30 mmol/L vs 6.39 ± 0.13 
mmol/L, p<0.001), 25 min (8.04 ± 0.28 mmol/L vs 6.23 ± 0.18 mmol/L, p<0.001), 30 min (7.81 ± 
0.33 mmol/L vs 6.24 ± 0.19 mmol/L, p<0.001), 45 min (7.29 ± 0.27 mmol/L vs 5.54 ± 0.21, p<0.001), 
60 min (7.09 ± 0.35 mmol/L vs 5.44 ± 0.01 mmol/L, p<0.001) and 90 min (6.34 ± 0.39 mmol/L vs 
5.09 ± 0.16 mmol/L, p<0.01) (Figure 4.10). These significant differences were also observed when 
calculating the AUC where the OB+GRT group showed a significant increase of AUC compared to 
the LC+GRT (839.60 ± 32.64 arbitrary units vs 667.70 ± 14.21 arbitrary units, p<0.001) as well 
compared to the LC group (839.60 ± 32.64 arbitrary units vs 714.00 ± 12.14 arbitrary units, p<0.01) 
(Figure 4.11). 
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Figure 4.10: Glucose levels after treating animals with GRT  
Data are presented as mean ± SEM. *p<0.05, **p<0.01 OB vs LC group, $p<0.05, $$p<0.01, $$$p<0.005 
OB+GRT vs LC+GRT according to a two-way ANOVA. LC: lean control, LC+GRT: lean group treated with 
GRT, OB: obese group, OB+GRT: obese group treated with GRT. N=7 per group. 
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Figure 4.11: AUC representation of the effect of diet in glucose tolerance of LC and OB 
*p<0.05, **p<0.01 according to ANOVA, LC: lean control, LC+GRT: lean group treated with GRT, OB: 
obese group, OB+GRT: obese animals treated with GRT. N=7 per group. 
 
4.2.1.5.3 Non-fasting blood glucose levels 
On the day of sacrifice, an increase in the non-fasting blood glucose levels was observed in the OB 
group compared to the LC group (7.5 ± 0.2 mmol/ L vs 6.7 ± 0.1 mmol/L, p<0.05). GRT treatment 
in OB (OB+GRT) resulted in a significant decrease in glucose levels when compared to the untreated 
OB group (6.8 ± 0.1 mmol/L vs 7.5 ± 0.2 mmol/ L, p<0.05). There was no difference between LC 
and OB+GRT groups. No significant difference in glucose levels was also observed between LC and 
LC+GRT as well as between LC+ GRT and OB+GRT groups (Figure 4.12). 
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Figure 4.12: Non-fasting blood glucose levels in treatment groups 
Data are presented as mean ± SEM. *p<0.05 according to one-way ANOVA, LC: lean control, LC+GRT: lean 
group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=7 per group. 
 
4.2.2 Inflammatory cytokines  
4.2.2.1 IL-1β 
IL-1β was significantly increased in the OB compared to the LC group (73.19 ± 3.12 pg/mL vs 56.10 
± 3.93 pg/mL, p<0.05). GRT treated LC+GRT animals presented with significantly higher IL-1β 
levels when compared to the LC group (70.10 ± 1.85 pg/mL vs 56.10 ± 3.94 pg/mL, p<0.05). 
Furthermore, there was a significantly lower IL-1β level in the OB+GRT group compared to the OB 
group (60.00 ± 3.81 pg/mL vs 73.19 ± 3.12 pg/mL, p<0.05). There was no difference between the LC 
and OB+GRT groups (Figure 4.13). 
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Figure 4.13: IL-1 β levels in treatment groups 
Data are presented as mean ± SEM. *p<0.05 according to ANOVA, LC: lean control, LC+GRT: lean group 
treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=6 per group. 
 
4.2.2.2 IL-6 
A statistical analysis of IL-6 using a one-way ANOVA did not show any significant difference 
between the treatment groups (Figure 4.14). 
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Figure 4.14: Serum IL-6 levels in treatment group 
Data are presented as mean ± SEM. p>0.05 according to one-way ANOVA, LC: lean control, LC+GRT: lean 
group treated with GRT. OB: obese group, OB+GRT: obese animals treated with GRT. N=6 per group. 
 
4.2.2.3 IL-12 
A statistical analysis of IL-12 using a one-way ANOVA did not show any significant difference 
between treatment groups (Figure 4.15). 
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Figure 4.15: Serum IL-12 levels in treatment groups 
Data are presented as mean ± SEM. p>0.05 according to one-way ANOVA, LC: lean control, LC+GRT: lean 
group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=6 per group. 
 
4.2.2.4 IL-18 
The IL-18 levels were significantly increased in the OB group compared to the LC group (280.20 ± 
14.90 pg/mL vs 224.80 ± 2.20 pg/mL). The GRT treated OB+GRT group presented with significantly 
lower IL-18 levels when compared to the OB group (192.10 ± 9.92 pg/mL vs 280.20 ± 14.90 pg/mL, 
p<0.05). There was also a significantly lower IL-18 level in the OB+GRT group compared to the 
LC+GRT group (192.10 ± 9.92 pg/mL vs 230.60 ± 3.80 pg/mL, p<0.05) and the LC group (192.10 ± 
9.92 pg/mL vs 224.80 ± 2.20 pg/mL, p<0.05). Furthermore, there were no significant difference 
between the LC+GRT and LC group (Figure 4.16). 
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Figure 4.16: Serum IL-18 levels in treatment groups  
Data are presented as mean ± SEM. *p<0.05 according to one-way ANOVA, LC: lean control, LC+GRT: lean 
group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=6 per group. 
 
4.2.2.5 TNF-α 
A significantly lower TNF-α level was observed in the OB animals compared to the LC group (3.43 
± 0.33 pg/mL vs 5.33 ± 0.69 pg/mL, p<0. 05). The GRT treated obese rats (OB+GRT) showed 
significantly higher TNF-α levels when compared to the OB group (5.20 ± 0.54 pg/mL vs 3.43 ± 0.33 
pg/mL, p<0.05), and there was no difference between the OB+GRT and LC groups. There was no 
significant difference in TNF-α levels between LC+GRT vs LC group, and OB+GRT vs LC+GRT 
respectively (Figure 4.17). 
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Figure 4.17: Serum TNF-α in treatment groups  
Data are presented as mean ± SEM. *p<0.05 according to one-way ANOVA, LC: lean control, LC+GRT: lean 
group treated with GRT. OB: obese group, OB+GRT: obese animals treated with GRT. N=6 per group. 
 
4.2.3 Testicular weight and body weight ratio 
There was no significant difference in testicular weight (TW) between treatment groups (Figure 4.18). 
However, TW:BW was significantly lower in the OB group when compared to the LC group (0.0070 
± 0.0008 vs 0.0086 ± 0.0008, p<0.05). An ingestion of GRT in the OB+GRT group resulted in an 
increase in TW:BW, with no such increase in the untreated OB group (0.0085 ± 0.0005 vs 0.0070 ± 
0.0008, p<0.05). However, the GRT supplementation in LC+GRT group did not change the TW:BW 
significantly when compared to untreated LC group (Figure 4.19). 
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Figure 4.18: TWs in experimental groups  
Data are presented as mean ± SEM. p>0.05 according to ANOVA, LC: lean control, LC+GRT: lean group 
treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=7 per group. 
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Figure 4.19: TW and body weight ratio  
Data are presented as mean ± SEM. *p<0.05 according to one-way ANOVA, LC: lean control, LC+GRT: lean 
group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=7 per group. 
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4.2.4 Testicular histology and morphometry 
The Johnsen scoring system for 50 cross-sections of seminiferous tubules per testis did not show any 
statistically significant difference between treatment groups (Table 4.1). Significant differences were 
only observed in seminiferous tubule parameters. There was a significant increase in seminiferous 
tubule area in the OB group when compared to the LC group (296587 ± 82452 µm² vs 118347 ± 6073 
µm², p<0.05) (Table 4.2). Similarly, seminiferous tubule diameter was significantly increased in the 
OB group compared to the LC group (631.9 ± 95.6 µm vs 386.2 ± 9.5 µm, p<0.05). The treatment 
with GRT in the OB+GRT showed a significantly lower area and diameter of seminiferous tubules 
respectively when compared to OB animals [(98770 ± 2934 µm² vs 296587 ± 82452 µm², p<0.05), 
354.2 ± 5.3 vs 631.9 ± 95.6 µm, p<0.05)]. Moreover, OB+GRT group had a smaller area and diameter 
than the LC group (98770 ± 2934 µm² vs 118347 ± 6073 µm², 354.2± 5.34 µm vs 386.2 ± 9.451 µm, 
p<0.05). 
Table 4.1: Histomorphometric analysis of seminiferous tubules and lumen  
 LC LC +GRT OB OB+GRT 
Johnsen scores 
Mean of 50 seminiferous 
tubule/testis 
9.20 ± 0.01 9.10 ± 0.02 9.20 ± 0.04 9.10 ± 0.04 
Seminiferous tubule area 
(µm²) 
118347 ± 6073 111270 ± 1591 296587 ± 
82452* 
98770 ± 
2934# * 
Seminiferous tubule 
diameter 
(µm) 
386.2 ± 9.5 375.9 ± 2.7 631.9 ± 95.6* 354.2± 5.3#* 
Lumen areas 
(µm²) 
30058 ± 3639 23084 ± 3561 43869 ± 
14950 
16491 ± 
1016 
Lumen diameter 
(µm) 
191.2 ± 12.2 178 ± 13.5 254.2 ± 45.7 144.2 ± 4.4 
Epithelial height 
(µm) 
115.4 ± 9.0 112.3 ± 6.5 157.7 ± 28.4 113.2 ± 6.2 
All data is expressed as mean ± SEM. * p<0.05 vs LC, #p<0.05 vs OB according to one-way ANOVA. LC: lean 
control, LC+GRT: lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with 
GRT. N=5 per group. 
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4.2.5 Testosterone and estradiol  
There was a significantly lower T hormone level in the OB group compared to the LC group (16.25 
± 0.23 ng/mL vs 17.37 ± 0.11 ng/mL, p<0.01). The T hormone level of the OB+GRT group was 
significantly higher when compared to the OB group (17.36 ± 0.15 ng/mL, vs 16.25 ± 0.23 ng/mL, 
p<0.01). There was no difference between the LC and the LC+GRT, OB+GRT and LC+GRT groups 
(Figure 4.20). 
The E2 hormone level was significantly increased in the OB group compared to the LC group (0.74 
± 0.01 ng/mL vs 0.67 ± 0.02 ng/mL, p<0.05). GRT treatment did not show any significant effect on 
the treated OB+GRT group when compared to the untreated OB group. Furthermore, there was no 
difference in E2 level of OB+GRT compared to that of the LC groups. However, GRT 
supplementation in LC+GRT animals showed a significantly higher E2 hormone level when 
compared to the LC animals (0.07 ± 0.01 ng/mL vs 0.74 ± 0.01 ng/mL, p<0.05) (Figure 4.21). 
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Figure 4.20: Serum testosterone levels in treatment groups 
Data are presented as mean ± SEM. **p<0.01 according to one-way ANOVA, LC: lean control, LC+GRT: 
lean group treated with GRT. OB: obese group, OB+GRT: obese animals treated with GRT. N=6 per group. 
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Figure 4.21: Serum estradiol levels in treatment groups 
Data are presented as mean ± SEM. *p<0.05 according to one-way ANOVA, LC: lean control, LC+GRT: lean 
group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=6 per group. 
 
4.2.6 Testosterone and estradiol ratio  
The testosterone and estradiol (T:E2) ratio was significantly lower in the OB group compared to the 
LC group (21.69 ± 0.37 vs 24.40 ± 0.18, p<0.001). Treatment with GRT resulted in a significantly 
higher T:E2 ratio when compared to untreated OB group (23.99 ± 0.99 vs 21.69 ± 0.37, p<0.05), and 
there was also no difference between OB+GRT and LC. Additionally, a significantly lower T:E2 ratio 
in the LC+GRT group compared to the LC group was observed (22.60 ± 0.28 vs 24.40 ± 0.18, p<0.01) 
(Figure 4.22). 
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Figure 4.22: Testosterone and estrogen ratio in treatment groups 
Data are presented as mean ± SEM. *p<0.05; **p<0.01; ***p<0.001 according to one-way ANOVA, LC: 
lean control, LC+GRT: lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with 
GRT. N=6 per group. 
 
4.2.7 Testicular protein expression and phosphorylation 
4.2.7.1 Total PKB expression, PKB phosphorylation and P-PKB/T-PKB ratio 
The expression of testicular total PKB (T-PKB) in treatment groups are presented in Figure 4.23. The 
statistical results showed that there was no significant difference in T-PKB in the OB when compared 
to the LC group. The LC+GRT showed a significantly lower T-PKB expression compared to the LC 
group (0.22 ± 0.05 Densitometry units vs 1.22 ± 0.27 Densitometry units, p<0.01). The OB+GRT 
group did not show a significant difference compared to the OB group. However, a significantly 
higher T-PKB expression in OB+GRT was observed when compared to the LC+GRT (0.56 ± 0.06 
vs 0.22 ± 0.05 Densitometry units, p<0.05). 
Figure 4.24 and Figure 4.25 represent the respective PKB phosphorylation (P-PKB) and P-PKB/ T-
PKB ratio in testicular tissue of rats subjected to different treatments. No significant differences were 
observed in the P-PKB and in P-PKB/T-PKB ratio. 
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Figure 4.23: Testicular T-PKB expression in the treatment groups 
Data are presented as mean ± SEM. *p<0.05; **p<0.01 according to one-way ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=3–
4 per group. 
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Figure 4.24: Testicular P-PKB in the treatment groups 
Data are presented as mean ± SEM. p>0.05 according to one-way ANOVA, L+GRT: lean group treated with 
GRT, OB: obese control group, OB+GRT: obese group treated with GRT. N=3–4 per group. 
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Figure 4.25: Testicular P-PKB and T-PKB ratio in the treatment groups 
Data are presented as mean ± SEM. p>0.05 according to one-way ANOVA, LC: lean control, LC+GRT: lean 
group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=3–4 per group. 
 
4.2.7.2 Total AMPK and phosphorylated AMPK 
A significantly lower T-AMPK expression was observed in the OB group when compared to the LC 
group (0.04 ± 0.01 densitometry units vs 1.00 ± 0.19 densitometry units, p<0.001). The GRT 
decreased T-AMPK levels in the LC+GRT (0.28 ± 0.06 vs 1.00 ± 0.19, p< 0.01). GRT did not have 
any effect on the OB+GRT group when compared to the OB group. However, a significantly lower 
T-AMPK was observed in OB+GRT when compared to the LC+ GRT group (0.06 ± 0.01 ensitometry 
units vs 0.28 ± 0.06 densitometry units, p<0.05) (Figure 4.26). No phosphorylated AMPK could be 
detected in the samples. 
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Figure 4.26: Testicular total expression of T-AMPK in treatment groups 
Data are presented as mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 according to one-way ANOVA, LC: 
lean control, LC+GRT: lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with 
GRT. N=3–4 per group. 
 
4.2.7.3 Cleaved PARP expression in testicular tissue  
The western blot and statistical results of testicular Cleaved PARP are presented in Figure 4.27. 
Cleaved PARP was significantly reduced in the OB group when compared to the LC (0.47 ± 0.15 vs 
1.88 ± 0.06, p<0.001). Treatment of LC rats with GRT (LC+GRT) showed a significant difference in 
Cleaved PARP when compared to the LC (0.45 ± 0.05 densitometry units vs 1.88 ± 0.06 densitometry 
units, p<0.001), while no differences were observed in the levels of Cleaved PARP in OB rats treated 
with GRT (OB+GRT) vs untreated OB animals. There was a significantly higher Cleaved PARP 
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expression in animals from the OB+GRT group compared to the LC+GRT group (0.72 ± 0.08 
densitometry units vs 0.45 ± 0.05 densitometry units, p<0.05). 
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Figure 4.27: Cleaved PARP expression in testicular tissue 
Data are presented as mean ± SEM. *p<0.05, ***p<0.001 according to one-way ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=3–
4 per group. 
 
4.2.7.4 Caspase 7 expression in testicular tissue  
The untreated OB group showed a significant decrease in caspase 7 expression when compared to the 
untreated LC group (0.43 ± 0.08 densitometry units vs 1.35 ± 0.29 densitometry units, p<0.01). 
Administration of GRT to LC animals (L+GRT) lowered caspase 7 expression significantly compared 
to the untreated LC (0.10 ± 0.03 densitometry units vs 1.35 ± 0.30 densitometry units, p<0.001). 
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However, no significant differences were observed in caspase 7 expression between treated OB with 
GRT (OB+GRT) when compared to untreated OB group (Figure 4.28)  
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Figure 4.28: Testicular caspase 7 expression in treatment groups 
Data are presented as mean ± SEM. **p<0.01; *** p<0.001 according to one-way ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=3–
4 per group. 
 
4.2.8 Testicular oxidative stress (OS)  
4.2.8.1 Testicular SOD activity 
Testicular SOD activity in treatment groups is presented in Figure 4.29. The SOD activity was 
significantly lower in the OB group than in the LC group (52.25 ± 1.69 U/mg protein vs 91.65 ± 5.22 
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U/mg protein, p<0.001). GRT supplementation resulted in a significantly lower SOD activity in the 
LC+GRT group compared to that of the LC group (63.48 ± 4.08 U/mg protein vs 91.65 ± 5.22 U/mg 
protein, p<0.001). Moreover, a significantly higher SOD activity was observed in the OB+GRT group 
when compared to the OB group (70.13 ± 3.19 U/mg protein vs 52.25 ± 1.69 U/mg protein, p<0.05).  
The OB+GRT group presented lower SOD activity compared to the LC group (70.13 ± 3.19 U/mg 
protein vs 91.65 ± 5.22 U/mg protein, p<0.05). No significant difference in SOD activity was 
observed between OB+GRT vs LC+GRT groups. 
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Figure 4.29: Testicular SOD activity in treatment groups 
Data are presented as mean ± SEM. *p<0.05, ***p<0.001 according to one-way ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=7 
per group. 
 
4.2.8.2 Testicular CAT activity 
Figure 4.30 represents testicular CAT activity of the treatment groups. The OB animals showed 
significantly lower CAT activity in testicular tissue compared to the LC group (10.51 ± 1.34 µmole 
H2O2 consumed/min/µg protein vs 53.08 ± 4.10 µmole H2O2 consumed/min/µg protein, p<0.001). 
CAT activity in the LC+GRT group was not significantly changed when compared to either LC group 
or OB+GRT group. Furthermore, OB+GRT group showed significantly higher CAT activity when 
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compared to the OB group (54.80 ± 4.84 µmole H2O2 consumed/min/µg protein vs 10.51 ± 1.34 
µmole H2O2 consumed/min/µg protein, p<0.001), while the OB+GRT group did not differ 
significantly from the LC group. 
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Figure 4.30: Testicular CAT activity in the treatment groups 
Data are presented as mean ± SEM.***p<0.001 according to one-way ANOVA, LC: lean control, LC+GRT: 
lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=7 per group. 
 
4.2.8.3 Testicular MDA levels 
The statistical results of MDA levels in the testis are presented in Figure 4.31 for all treatment groups. 
The testicular MDA level was significantly higher in the OB group compared to the LC group (4.94 
± 0.45 μmol/mg protein vs 3.06 ± 0.31 μmol/mg protein, p<0.01). The MDA level in the testes of LC 
supplemented with GRT was not significantly different compared to that of the LC group. There were 
significantly lower testicular MDA levels in the OB+GRT group of rats compared to that of the OB 
group (3.49 ± 0.11 μmol/mg protein vs 4.94 ± 0.45 μmol/mg protein, p<0.05), while the OB+GRT 
group did not differ from either the LC or the LC+GRT groups. 
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Figure 4.31: Testicular MDA levels in the treatment groups 
Data are presented as mean ± SEM. *p<0.05, **p<0.01 according to one-way ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=7 
per group. 
 
4.2.9 Epididymal weight 
Epididymal weight of the OB animals was significantly higher when compared to that of the LC 
animals (1.29 ± 0.04 g vs 1.14 ± 0.03 g, p<0.05). OB+GRT animals had significantly higher 
epididymal weights when compared to the OB animals (1.39 ± 0.02 g vs 1.29 ± 0.04, p<0.05), and 
also, the OB+GRT animals presented with a higher epididymal weight compared to the LC animals 
(1.39 ± 0.02 g vs 1.14 ± 0.03, p<0.001). Interestingly, the epididimides of LC animals supplemented 
with GRT were significantly heavier than those of their counterparts (1.24 ± 0.02 g vs 1.14 ± 0.03 g, 
p<0.05). However, the weight of LC+GRT was lower than OB+GRT (1.23 ± 0.02 g vs 1.39 ± 0.02 
g, p<0.001) (Figure 4.32). 
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Figure 4.32: Total epididymal weights in the treatment groups 
Data are presented as mean ± SEM. *p<0.05, ***p<0.001 according to one-way ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=7 
per group. 
 
4.2.10 Epididymal sperm parameters  
The results in Table 4.2 represent sperm parameters: sperm concentration, viability, normal 
morphology, head defects, midpiece defects, and teratozoospermy index, total motility, progressive 
motility, curvilinear velocity (VC), straight line velocity (VSL) and average path velocity (VAP). 
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Table 4.2: Summary of basic and functional sperm parameters 
 LC LC+GRT OB 0B+GRT 
Sperm concentration 
(106 sperm /mL) 
1.79 ± 0.15 1.72 ± 0.13 1.22 ± 0.14* 2.15 ± 0.16# 
Viability  
(%) 
57.14 ± 2.75 61.00 ± 3.61 42.71 ± 
2.28** 
55.14 ± 2.08# 
Normal morphology  
(%) 
52.55 ± 3.45 56.33 ± 3.24 45.45 ± 3.24* 64.75 ± 2.73##* 
Head defects  
(%) 
47.12 ± 3.26 41.71 ± 3.36 56.84 ± 1.91* 33.93 ± 2.46### ** 
Midpiece defects  
(%) 
1.33 ± 0.84 1.67± 0.33 3.30 ± 0.87 3.88 ± 0.97$ 
Teratozoospermy index 
(%) 
1.02 ± 0.02 1.06 ± 0.01 1.05 ± 0.02 1.03 ± 0.01 
Total motility 
 (%) 
81.16 ± 4.91 89.85 ± 2.18 76.95 ± 3.71 81.94 ± 3.03 
Progressive motility  
(%) 
59.21 ± 2.82 72.0 ± 5.0* 48.19 ± 2.57* 65.86± 4.36## $ 
VCL 
 (µm/s) 
183.80 ± 
13.20 
169.20 ± 9.31 144.50 ± 
8.39* 
180.30 ± 5.32# 
VSL  
(µm/s) 
46.97 ± 2.44 55.59 ± 2.55* 38.26 ± 3.52* 51.98 ± 2.14## 
VAP 
 (µm/s) 
76.07 ± 2.52 88.29 ± 3.48* 71.42 ± 2.25* 83.60 ± 5.02# 
All data is expressed as mean ± SEM. * p < 0.05, ** p < 0.01 vs LC, $p<0.05, $$p<0.01, $$$p<0.001 vs LC + 
GRT, #p<0.05, ##p<0.01 vs OB according to one-way ANOVA. LC: lean control, LC+GRT: lean group treated 
with GRT, OB: obese group, OB+GRT: obese animals treated with GRT. N=7 per group. 
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4.2.10.1 Sperm concentration  
OB animals showed a significant decrease in sperm concentration when compared to the LC animals 
(1.22 ± 0.14 x 106 sperm/mL vs 1.98 ± 0.14 x 106 sperm/mL, p<0.05). OB+GRT group showed 
significantly higher sperm concentration compared to the untreated OB (2.15 ± 0.16 x 106 sperm/mL 
vs 1.22 ± 0.14 x 106 sperm/mL, p<0.05). Furthermore, there was no significant difference between 
the OB+GRT and LC+GRT groups, and the LC+GRT and LC groups (Table 4.2). 
 
4.2.10.2 Sperm viability  
The animals from the OB group showed significantly lower sperm viability compared to that of the 
LC group (42.71 ± 2.28% vs 57.14 ± 2.75%, p<0.01). The sperm viability of LC+GRT animals was 
not significantly different than that of the LC group. Furthermore, there was a significantly higher 
sperm viability in the OB group treated with GRT (OB+GRT) when compared to the untreated OB 
(55.14 ± 2.08% vs 42.71 ± 2.28%). The OB+GRT did not differ from L+GRT and LC groups (Table 
4.2). 
 
4.2.10.3 Sperm morphology  
Normal sperm morphology in the OB group was decreased compared to that of the LC group (45.45 
± 3.24% vs 52.55 ± 3.45%, p<0.05). The normal sperm morphology of LC animals subjected to GRT 
(LC+GRT) did not show any significant difference compared to the untreated LC animals. The 
OB+GRT group showed a significantly higher normal sperm morphology when compared to the 
untreated OB animals (64.75 ± 2.73% vs 45.45 ± 3.24%, p<0.01), and the OB+GRT group had a 
higher % of normal morphology than the LC group (64.75 ± 2.73% vs 52.55 ± 3.45%, p<0.05) (Table 
4.2). 
 
4.2.10.3.1 Sperm head defects 
OB animals presented with significantly higher sperm head defects when compared to the LC animals 
(56.84 ± 1.91% vs 47.12 ± 3.26%, p<0.05). No significant differences were observed between the 
LC+GRT and LC groups. Interestingly, the OB+GRT group presented with significantly decreased 
sperm head defects when compared to the OB group (33.93 ± 2.46% vs 56.84 ± 1.91%, p<0.001), 
while the OB+GRT group presented with low head defects compared to LC group (33.93 ± 2.46% vs 
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47.12 ± 3.26%, p<0.01). There were no statistically significant differences between the OB+GRT and 
LC+GRT groups (Table 4.2). 
 
4.2.10.3.2 Sperm midpiece defects 
The statistical results showed that the only significant difference in sperm midpiece defects was 
observed between OB+GRT and LC+GRT groups (3.88 ± 0.97% vs 1.67 ± 0.33%, p<0.05) (Table 
4.2). 
 
4.2.10.3.3 Teratozoospermy index  
No statistically significant difference in teratozoospermy index was observed between the four 
treatment groups (Table 4.2). 
 
4.2.10.4 Sperm motility 
From the statistical analysis in Table 4.2, it can be ascertained that the total motility across four 
treatment groups did not differ significantly, despite an increasing trend after GRT treatment. 
 
4.2.10.4.1 Progressive motility  
The statistical results of progressive motility are shown in (Table 4.2). The progressive motility was 
significantly lower in the OB than in the LC group (48.19 ± 2.57% vs 58.12 ± 3.03%, p<0.05). A 
significantly higher percentage in progressive motility was observed in the LC+GRT when compared 
to the LC group (72.0 ± 5.0 ± 2.21% vs 58.12 ± 3.03%, p<0.05). The OB+GRT group showed a 
significantly higher percentage of progressive motility when compared to the OB group (65.86 ± 
4.36% vs 48.19 ± 2.57%, p<0.01). Furthermore, OB+GRT animals presented a significantly lower 
percentage of progressive motility when compared to the LC+GRT group (65.86 ± 4.36% vs 72.0 ± 
5.0± 2.20%, p<0.05). 
 
4.2.10.4.2 Sperm kinematics/velocity parameters  
VCL: The VCL of the OB group was significantly reduced compared to that of the LC group (144.5 
± 8.4 µm/s vs 183.8 ± 13.2 µm/s, p<0.05). The VCL of animals from LC+GRT was not significantly 
Stellenbosch University https://scholar.sun.ac.za
82 
 
different to that of the LC group and OB+GRT. A significantly higher VCL was observed in 
OB+GRT when compared to the OB group (180.3 ± 5.3 µm/s ± 144.5 ± 8.4 µm/s, p<0.05) (Table 4.2). 
VSL: The OB group showed a significantly reduced VSL when compared to the LC group (38.26 ± 
3.52 µm/s vs 46.97 ± 2.44 µm/s, p<0.05). A significantly higher VSL was observed in the LC+GRT 
group when compared to the LC group (55.59 ± 2.55 µm/s vs 38.26 ± 3.52 µm/s, p<0.05). Also, the 
OB+GRT group showed a significantly higher VSL than that of the OB group (51.98 ± 2.14 µm/s vs 
38.26 ± 3.52 µm/s, p<0.01) (Table 4.2). There was no significant difference between the OB+GRT 
group and the L+GRT or between the OB+GRT and the LC groups.  
VAP: Table 4.2 indicates that the VAP of the spermatozoa of the OB group was significantly lower 
when compared to that of the LC group (71.42 ± 2.25 µm/s vs 76.07 ± 2.52 µm/s, p< 0.05). A 
significantly higher VAP was observed in the LC+GRT when compared to the LC group (76.07 ± 
2.52 µm/s vs 88.29 ± 3.48 µm/s, p<0.05). The VAP of OB+GRT was significantly higher compared 
to that of the OB group (83.60 ± 5.02 µm/s vs 71.42 ± 2.25 µm/s, p<0.05). 
 
4.3 The effects of a green rooibos Extract on the reproductive function of obesity-induced 
hypertensive Wistar rats 
4.3.1 Biometric data before and after initiation of GRT treatment 
The biometric parameters that were monitored during the 16-week experimental period were water 
and food intake, the change of BWs, IP fat weights and glucose levels. 
 
4.3.1.1 Food intake 
Figure 4.33 shows the mean food intake in both LC and OBHT groups before the start of GRT 
treatment. The average food intake was significantly higher in the OBHT compared to the LC group 
(16.84 ± 0.26 g/rat/day vs 13.90 ± 0.08 g/rat/day, p<0.001). At 11 weeks, the animals started to 
receive the GRT treatment and therefore the food intake was subsequently monitored over the next 6 
weeks in the four treatment groups (LC, LC+ GTR, OBHT, OBH+GRT). The OBHT animals showed 
a significant increase in food intake when compared to the LC animals (16.49 ± 0.59 g/rat/day vs 
13.52 ± 0.14 g/rat/day, p<0.001). GRT treatment did not show any effect on food intake when 
compared either to the LC or OBHT animals. However, there was a significant difference between 
OBHT+GTR and LC+GRT (16.32 ± 0.69 g/rat/day vs 13.99 ± 0.77 g/rat/day, p<0.05) (Figure 4.34). 
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Figure 4.33: Mean food intake of the obese hypertensive and lean animals over 10 weeks 
Data are presented as mean ± SEM. *** p<0.001 according to a Student’s t-test, LC= lean control group 
OBHT: obesity associated with hypertension group. N=14–21 per group. 
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Figure 4.34: Mean food intake of the treatment groups from week 11 to week 16 
Data are presented as mean ± SEM. *p<0.05, ***p<0.001 according to one-way ANOVA test, LC: lean 
control, LC+GRT: lean group treated with GRT, OBHT: Obesity-induced hypertensive animal group, 
OBHT+GRT: obesity-induced hypertensive animals treated with GRT. N=7 per group. 
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4.3.1.2 Water intake  
Water intake of all the experimental animals was monitored once per week. Before the onset of 
treatment, the OBHT group consumed less water than the LC group (12.86 ± 0.31 mL/rat/day vs 
22.02 ± 0.42 mL/rat/day, p<0.001) (Figure 4.35). Similarly, after GRT treatment, the average water 
intake of the OBHT group was less compared to that of the LC group (10.83 ± 0.54 mL/rat/day vs 
20.73 ± 0.50 mL/rat/day, p<0.001) (Figure 4.36). The LC+GRT animals consumed more water than 
OBHT+GRT (20.47 ± 1.04 mL/rat/day vs 11.00 ± 0.55 mL/rat/day, p<0.001). A significantly lower 
water intake was observed in the OBHT+GRT group when compared to LC group (11.00 ± 0.55 
mL/rat/day vs 20.73 ± 0.50 mL/rat/day, p<0.001). However, no significant difference in water intake 
was observed between the OBHT+GRT and OBHT groups (Figure 4.36). 
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Figure 4.35: Mean water intake of LC animals and OBHT animals over 10 weeks 
Data are presented as mean ± SEM. ***p<0.001 according to a Student’s t-test, LC: lean control animals, 
OBHT: Obesity-induced hypertensive animal group. N=14–21 per group. 
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Figure 4.36: Mean water intake from week11 to week 16 in treatment groups 
Data are presented as mean ± SEM. ***p < 0.001 according to one-way ANOVA, LC: lean control, LC+GRT: 
lean group treated with GRT, OBHT: obesity-induced hypertensive animal group, OBHT+GRT: obesity-
induced hypertensive animals treated with GRT. N=7 per group. 
 
4.3.1.3 Body weights  
The change of BW was monitored before and after GRT treatment. In week 10 (before the onset of 
GRT treatment), the OBHT group showed a significantly higher mean BW compared to that of the 
LC group (322.9 ± 8.5 g vs 285.4 ± 4.4 g, p< 0.001) (Figure 4.37). 
Figure 4.38 shows a statistical analysis of mean total BW after 6 weeks of GRT treatment (week 11–
16) in week 16 (when the animals were euthanized). The mean BW of OBHT animals was 
significantly higher than that of the LC group (402.5 ± 11.7 g vs 346.3 ± 7.05 g, p<0.01). Treatment 
of OBHT+GRT with GRT resulted in a significantly lower BW than that of the untreated OBHT 
group (337.4 ± 12.21 g vs 402.5 ± 11.7 g, p<0.01). It was also observed that Captopril treatment 
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reduced mean BW in OBHT+Captopril group when compared to both the untreated OBHT group 
(254.6 ± 7.7 g vs 402.5 ± 11.7 g, p<0.001) and the OBHT+GRT group respectively (254.6 ± 7.7 g vs 
337.4 ± 12.2 g, p< 0.001). However, there was no significant difference between the LC+GRT and 
LC groups; the LC+GRT and OBHT+GRT groups; or the LC and OBHT+GRT groups. 
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Figure 4.37: Mean total body weight of LC and OB group in week 10 
Data are presented as mean ± SEM. *** p<0.001 according to Student’s t-test, LC: lean control, OBHT: 
obesity-induced hypertensive animal group. N=14–21 per group. 
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Figure 4.38: Mean total BW of treatment in week 16 
Data are presented as mean ± SEM. **p<0.01, ***p<0.001 according to one-way ANOVA test, LC: lean 
control, LC+GRT: lean group treated with GRT, OBHT: obesity-induced hypertension group, OBHT+GRT: 
obesity-induced hypertension animals treated with GRT, OBHT+Captopril: obesity-induced hypertension 
animals treated with Captopril. N=7 per group. 
 
4.3.1.4 Intra-peritoneal fat weight  
The mean IP fat in relation to the BW per group was measured and expressed in percentage (%) as 
an adiposity index. IP fat % was higher in OBHT experimental groups than in the LC groups (5.34 ± 
0.39% vs 1.96 ± 0.32%, p<0.001). It was observed that the adiposity index of OBHT+GRT was 
significantly lower compared to that of the OBHT group (3.73 ± 0.14% vs 5.34 ± 0.39%, p<0.01). 
Furthermore, adiposity index in OBHT+Captopril was significantly lower than both the OBHT group 
(2.36 ± 0.09% vs 5.34 ± 0.39% p<0.001) and the OBHT+GRT group respectively (2.36 ± 0.09% vs 
3.73 ± 0.14%, p<0.05). There was no difference between the LC+GRT and LC groups, and between 
OBHT+GRT and LC (Figure 4.39). 
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Figure 4.39: Adiposity index in different treatment groups 
Data are presented as mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 according to one-way ANOVA. LC: 
lean control, LC+GRT: lean group treated with GRT, OBHT: obesity-induced hypertension group, 
OBHT+GRT: obesity-induced hypertension animals treated with GRT, OBHT+Captopril: obesity-induced 
hypertension animals treated with Captopril. N=7 per group. 
 
4.3.1.5 Insulin sensitivity and glucose levels  
4.3.1.5.1 OGTT results at baseline level in week 10 
From Figure 4.40, it is clear that the blood glucose levels of the OBHT animals were significantly 
increased from 10 min and 15 min after oral administration of sucrose solution when compared to the 
LC group (7.7±0.5 mmol/L vs 6.2 ± 0.2 mmol/L, p<0.001) and 8.3 ± 0.3 mmol/L vs 6.3 ± 0.4 mmol/L. 
Moreover, AUC in the OBHT group was higher than in the LC (728.8 ± 10.3 arbitrary units vs 690.8 
± 13.5 arbitrary units, p<0.05) (Figure 4.41). 
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Figure 4.40: Oral glucose tolerance test results at baseline level in week 10 in the two 
experimental groups 
Data are presented as mean ± SEM. ***p<0.001 vs LC according to a two-way ANOVA, LC: lean control 
group, OBHT: obesity-induced hypertensive animal group. N=14–21 per group. 
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Figure 4.41: AUC representation of the effect of diet in glucose tolerance of LC and OBHT 
animals 
Data are presented as mean ± SEM. *p<0.05 according to a Student’s t-test, LC: lean control group, OBHT: 
obesity-induced hypertensive animal group. N=14–21 per group. 
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4.3.1.5.2 OGTT results after GRT treatment 
In week 15, the curves of the groups, generated after gavaging animals with 50% sucrose solution, 
differed. The plasma glucose levels of the OBHT group was significantly higher than that of the LC 
group at 10 min (7.9 ± 0.4 mmol/L vs 6.4 ± 0.1 mmol/L, p<0.01) (Figure 4.42). The OBHT group 
presented significantly higher AUCs than the LC group (754.5 ± 12.8 arbitrary units vs 714.0 ± 12.1 
arbitrary units p<0.05) (Figure 4.43). GRT treatment in the LC group did not show any significant 
change in glucose levels when compared to the untreated LC group. On the other hand, after only 20 
min of the OGTT test, GRT treatment reduced glucose levels in OBHT+GRT group significantly 
when compared to that of the untreated OBHT group (6.0 ± 1.0 mmol/L vs 7.5 ± 0.4 mmol/L, p<0.01) 
(Figure 4.42). However, its AUC did not change significantly (Figure 4.43). According to AUC and 
ANOVA test, only diet (and not the GRT) had an effect on blood glucose levels. 
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Figure 4.42: Glucose levels in treatment groups at 15th week in experimental group 
Data are presented as mean ± SEM. **p < 0.01 vs LC animals, ##p<0.01 vs OBHT animals, $p < 0.05 vs 
LC+GRT animals according to a two-way ANOVA, LC: lean control, LC+GRT: lean group treated with GRT, 
OBHT: obesity-induced hypertension group, OBHT+GRT: obesity-induced hypertension animals treated with 
GRT, N=7 per group. 
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Figure 4.43: AUC representation of the effect of diet and GRT on glucose tolerance. 
Data are presented as mean ± SEM. **p<0.05 according to one-way ANOVA test, LC: lean control, LC+GRT: 
lean group treated with GRT, OBHT: obesity-induced hypertension group, OBHT+GRT: obesity-induced 
hypertension animals treated with GRT, N= 7 per group. 
 
4.3.1.5.3 Non-fasting blood glucose levels 
An increase in non-fasting blood glucose levels were observed in OBHT animals compared to the LC 
group (8.2 ± 0.4 mmol/mL vs 6.7 ± 0.1 mmol/mL, p<0.05). Treatment with either the GRT or 
Captopril did not affect the blood glucose levels of the treated LC or OBHT animals. However, a 
significant difference was observed between the OBHT+GRT and LC+GRT groups (8.4 ± 0.2 
mmol/mL vs 6.6 ± 0.2 mmol/mL, p<0.001) (Figure 4.44). 
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Figure 4.44: Non-fasting blood glucose levels 
Data are presented as mean ± SEM. *p<0.05, **p<0.01 according to one-way ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OBHT: obesity-induced hypertension group, OBHT+GRT: obesity-
induced hypertension animals treated with GRT, OBHT+Captopril: obesity-induced hypertension animals 
treated with Captopril. N=7 per group. 
 
4.3.1.6 Inflammatory cytokines 
The statistical analysis of inflammatory cytokine levels in rat serum, which includes 1 IL-1β, IL-6, 
IL-12, IL-18 and TNF-α, are presented in Table 4.3. IL-1β and IL-18 were significantly increased in 
OBHT group compared to the LC group (p<0.05). The LC+GRT group showed significantly higher 
IL-1β and IL-18 levels in comparison to the LC group (p<0.05). However, treatment of OBHT with 
either GRT or Captopril did not change IL-1β and IL-18 levels (no difference to that of the untreated 
OBHT group). 
There was no significant difference in IL-6 levels between OBHT and LC animals. The GRT 
supplementation in LC+GRT animals did not significantly change IL-6 levels when compared to the 
LC group; however, GRT significantly reduced IL-6 levels in OBHT+GRT animals when compared 
to the untreated OBHT group (1897 ± 68 pg/mL vs 2310 ± 114). Consecutively, Captopril-treated 
OBHT animals showed a significantly lower IL-6 level compared to that of the untreated OBHT 
group (1617 ± 153 pg/mL vs 2310 ± 114 pg/mL, p< 0.05). 
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There was not a significant difference between the IL-12 and TNF-α levels of the treatment groups. 
Table 4.3: Cytokines levels in different treatment groups  
Cytokines LC LC+GRT OBHT OBHT+GRT 
OBHT+ 
Captopril  
IL-1β 
(ng/mL) 56.10 ± 3.93 
68.82 ± 
1.81* 
79.99 ± 
5.04* 65.99 ± 4.15 
60.68 ± 
18.66 
IL-6 
(ng/mL) 2303 ± 142 1740 ± 265 2310 ± 114 1897 ± 68# 
1617 ± 
153# 
IL-12 
(ng/mL) 257.0 ± 10.5 
238.2 ± 
14.8 253.2 ± 7.1 234.1 ± 11.8 
196.7 ± 
12.7 
IL-18 
(ng/mL) 224.0 ± 2.2 
285.3 ± 
54.9* 
243.3 ± 
31.0* 232.4 ± 19.4 
201.3 ± 
16.0 
TNF-α 
(ng/mL) 4.65 ± 0.19 5.16 ± 0.31 4.37 ± 0.19 4.36 ± 0.23 
3.37 ± 
0.15 
All data are expressed as mean ± SEM. * p < 0.05 vs LC, # p < 0.05 vs OBHT according to one-way-ANOVA. 
LC: lean control, LC+GRT: lean group treated with GRT, OBHT: obesity-induced hypertension group, 
OBHT+GRT: obesity-induced hypertension animals treated with GRT, OBHT+Captopril: obesity-induced 
hypertension animals treated with Captopril. N=7 per group. 
 
4.3.2 Monitoring of blood pressure (BP) during treatment period  
4.3.2.1 Systolic BP, diastolic BP and mean arterial pressure before GRT treatment 
The statistical results of BP measurements before GRT treatment are summarized in Table 4.4. A 
significant high systolic (Figure 4.45), diastolic (Figure 4.46) and mean arterial pressure (Figure 4.47) 
were respectively observed in OBHT animals when compared to LC animals. 
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Table 4.4: Mean systolic, diastolic and arterial pressure of the OBHT and lean group  
Groups 
Mean systolic pressure 
(mmHg) 
 
Mean diastolic 
pressure 
(mmHg) 
Mean arterial 
pressure (mmHg) 
LC 127.5 ± 2.6 79.4 ± 2.1 98.6 ± 2.3 
OBHT 135.2 ± 1.8** 91.9 ± 2.9** 107.7 ± 1.6** 
All data are expressed as mean ± SEM. **p < 0.01 vs LC according to a Student’s t-test. LC: lean control, 
OBHT: obesity-induced hypertension. N=14–21 per group. 
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Figure 4.45: Mean systolic BP of the OB and LC animals 
Data are presented as mean ± SEM. **p<0.01 according to a Student’s t-test, LC: lean control, OBHT: 
obesity-induced hypertensive animal group. N=14–21 per group. 
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Figure 4.46: Mean diastolic BP of the OBHT and LC animals 
Data are presented as mean ± SEM. **p<0.01 according to a Student’s t-test, LC: lean control, OBHT: 
obesity-induced hypertensive animal group. N=14–21 per group. 
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Figure 4.47: Mean arterial pressure of the OBHT and lean animals 
Data are presented as mean ± SEM. **p<0.01 according to a Student’s t-test, LC: lean control, OBHT: 
obesity-induced hypertensive animal group. N=14–21 per group. 
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4.3.2.2 Systolic BP, diastolic BP and mean arterial pressure after 6 weeks of GRT treatment 
Table 4.5 represents the BP measurements of all experimental groups after 6 weeks of GRT treatment. 
Mean systolic BP (Figure 4.48), diastolic BP (Figure 4.49) and arterial pressure (Figure 4.50) were 
significantly increased in the OBHT group when compared to that of the LC group. GRT treatment 
significantly reduced the mean systolic (Figure 4.48), diastolic (Figure 4.49) and arterial pressure 
(Figure 4.50) in the OBH+GRT group when compared to that of the untreated OBHT group (Table 
4.5). Furthermore, OBHT treated with Captopril showed a significantly lower mean systolic, diastolic 
and arterial pressure when compared to the untreated OBHT group. There was only a significant 
difference in mean systolic pressure between OBHT+Captopril and OBHT+GRT (Figure 4.48). The 
systolic, diastolic and arterial pressure of the LC animals supplemented with GRT (LC+GRT) were 
not significantly different to that of the lean animals (Table 4.5). 
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Table 4.5: Systolic BP, diastolic BP and mean arterial pressure after 6 weeks of GRT treatment 
Groups 
Mean systolic 
pressure 
(mmHg) 
 
Mean diastolic 
pressure 
(mmHg) 
Mean arterial pressure 
(mmHg) 
LC 122.1 ± 1.0 83.2 ± 1.1 96.4 ± 1.6 
LC+GRT 119.6 ± 1.5 83.2 ± 2.7 95.5 ± 2.2 
OBHT 130.6 ± 3.1* 91.8 ± 1.8* 104.2 ± 2.3* 
OBHT+GRT 122.5 ± 0.6# 85.6 ± 1.5# 98.0 ± 1.2# 
OBHT+ Captopril 111.6 ± 2.3###&& 80.9 ± 1.6## 90.9 ± 1.4### 
All data is expressed in mean ± SEM. * p<0.05 vs LC, #p<0.05 vs OBHT, ##p<0.01 vs OBHT, ###p<0.001 vs 
OBHT, &&p< 0.01 vs OBHT+GRT according to one-way ANOVA. LC: lean control, LC+GRT: lean group 
treated with GRT, OBHT: obesity-induced hypertension group, OBHT+GRT: obesity-induced hypertension 
animals treated with GRT, OBHT+Captopril: obesity-induced hypertension animals treated with Captopril. 
N=7 per group. 
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Figure 4.48: Mean systolic of experimental groups after GRT treatment 
Data are presented as mean ± SEM. *p < 0.05, **p<0.01, ***p<0.001 according to one-way-ANOVA, LC: 
lean control, LC+GRT: lean group treated with GRT, OBHT: obesity-induced hypertension group, 
OBHT+GRT: obesity-induced hypertension animals treated with GRT, OBHT+Captopril: obesity-induced 
hypertension animals treated with Captopril. N=7 per group. 
 
Stellenbosch University https://scholar.sun.ac.za
99 
 
L
C
L
C
+G
R
T
O
B
H
T
O
B
H
T
+G
R
T
O
B
H
T
+ 
C
ap
to
pr
il 
0
20
40
60
80
100
*
**
*
Treatment groups
M
ea
n
 d
ia
st
o
li
c 
p
re
ss
u
re
(m
m
H
g
)
 
Figure 4.49: Mean diastolic pressure of experimental groups after GRT treatment 
Data are presented as mean ± SEM. *p < 0.05, **p<0.01 according to one-way-ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OBHT: Obesity-induced hypertension group, OBHT+GRT: obesity-
induced hypertension animals treated with GRT, OBHT+Captopril: obesity-induced hypertension animals 
treated with Captopril. N=7 per group. 
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Figure 4.50: Mean arterial pressure of experimental groups after GRT treatment 
Data are presented as mean ± SEM. *p<0.05, ***p<0.001 according to one-way-ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OBHT: Obesity-induced hypertension group. OBHT+GRT: obesity-
induced hypertension animals treated with GRT, OBHT+Captopril: obesity-induced hypertension animals 
treated with Captopril. N=7 per group. 
 
4.3.3 TW and body weight ratio 
There was no significant difference in the TWs of the treatment groups (Figure 4.51). However, when 
TW is expressed in relation to total BW (shown in Figure 4.52), the OBHT group showed a significant 
decrease in the TW to BW ratio when compared to the LC group (0.0070 ± 0.0002 vs 0.0087± 0.0002, 
p<0.01). Ingestion of GRT by the OBHT group did not show any significant change in TW:BW ratio 
compared to the untreated OBHT group. However, in a similar group treated with Captopril, the 
TW:BW ratio increased significantly (0.0101 ± 0.0003 vs 0.0068 ± 0.0002, p<0.001). The 
OBHT+Captopril group also had a higher TW:BW ratio than the OBHT+GRT group (0.0101 ± 
0.0003 vs 0.0074 ± 0.0003, p<0.001). 
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On the other hand, the GRT supplementation in the LC+GRT group did not change the TW: BW ratio 
when compared to the untreated LC group. 
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Figure 4.51: TWs in treatment groups 
Data are presented as mean ± SEM. p>0.05 according to one-way-ANOVA, LC: lean control, LC+GRT: lean 
group treated with GRT, OBHT: obesity-induced hypertension group. OBHT+GRT: obesity-induced 
hypertension animals treated with GRT, OBHT+Captopril: obesity-induced hypertension animals treated with 
Captopril. N=7 per group. 
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Figure 4.52: TW and body weight ratio 
Data are presented as mean ± SEM. **p<0.01, ***p<0.001 according to one-way-ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OBHT: obesity-induced hypertension group, OBHT+GRT: obesity-
induced hypertension animals treated with GRT, OBHT+Captopril: obesity-induced hypertension animals 
treated with Captopril. N=7 per group. 
 
4.3.4 Testicular histomorphometric analysis  
The means of 50 cross-sections of seminiferous tubules per testis did not show any significant 
differences between treatment groups as analyzed according to the Johnsen scoring method (Table 
4.6). Furthermore, morphometric parameters, including seminiferous tubule area, seminiferous 
diameter, lumen areas, lumen diameter and epithelial height were statistically calculated (Table 4.6). 
There was a significant decrease in the seminiferous tubule area in the OBHT group when compared 
to the LC group (97807 ± 1488 µm² vs 118347 ± 6073 µm², p<0.05) (Table 4.6). Similarly, the 
seminiferous tubule diameter was significantly decreased in the OBHT group compared to that of the 
LC group (354.0 ± 3.0 µm vs 386.2 ± 9.5 µm, p<0.05). The lumen area was significantly decreased 
in the OBHT (19891±1717 µm² vs 30058 ± 3639 µm², p<0.01), with a significant decrease in lumen 
diameter (157.8 ± 7.3 µm vs 191.2 ± 12.2 µm, p<0.05) compared to the LC group. Furthermore, the 
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epithelium height was significantly decreased in the OBHT group (99.0 ± 4.8 µm vs 115.4 ± 9.0 µm, 
p<0.05) compared to the LC group. 
The treatment with GRT in the OBHT+GRT group showed a significantly high area and higher 
diameter of seminiferous tubules respectively when compared to OBHT animals [(793501 ± 58820 
µm² vs 97807 ± 1488 µm², p<0.05), (413.1 ± 9.2 µm vs 354.0 ± 3.0 µm, p<0.05)]. Both the lumen 
area and lumen diameter were significantly reduced in the OBHT+GRT group [(15605 ± 1958 µm² 
vs 19891±1717 µm², p<0.05), (133.0 ± 7.2 µm vs 157.8 ± 7.3 µm, p<0.05)] compared to the untreated 
OBHT group. 
Table 4.6: Histomorphometric analysis of seminiferous tubules and lumen  
 LC LC+GRT OBHT OBHT+GRT OBHT+Captopril 
Johnsen 
scoring 
(Mean for 50 
tubules/testis) 
9.2 ± 0.1 9.1 ± 0.1 9.3 ± 0.1 9.2 ± 0.1 9.1 ± 0.1# 
Seminiferous 
tubule area 
 (µm²) 
118347 ± 
6073 
111270 ± 
1591 
97807 ± 1488* 
7930501 ± 
580820# $ 
93084 ± 3936 
Seminiferous 
tubular 
diameter 
(µm) 
386.2 ± 
9.5 
375.9 ± 
2.7 
354.0 ± 3.0* 413.1 ± 9.2# $$ 354.3 ± 2.2 
Lumen area 
(µm²) 
30058 ± 
3639 
23084 ± 
3561 
19891±1717** 15605 ± 1958# 12986 ± 1194 
Lumen 
diameter 
(µm) 
191.2 ± 
12.2 
178.0 ± 
13.5 
157.8 ± 7.3* 133.0 ± 7.2# 127.6 ± 6.1# 
Epithelial 
height  
(µm) 
115.4 ± 
9.0 
112.3 ± 
6.5 
99.0 ± 4.8* 104.2 ± 5.9 136.7 ± 5.8# 
All data are expressed in mean ± SEM. *p<0.05 vs LC ** p<0.01 vs LC, #p<0.05 vs OBHT, $$p<0.01 vs 
LC+GRT according to one-way-ANOVA. LC: lean control, LC+GRT: lean group treated with GRT, OBHT: 
obesity-induced hypertension group, OBHT+GRT: obesity-induced hypertension animals treated with GRT, 
OBHT+Captopril: obesity-induced hypertension animals treated with Captopril. N=5 per group. 
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4.3.5 Testosterone and estradiol levels  
A significantly higher T level was observed in OBHT animals compared to that of the LC group 
(18.25 ± 0.12ng/mL vs 17.37 ± 0.11 ng/mL, p<0.01). GRT treatment presented a significantly lower 
T in OBHT+GRT group when compared to the OBHT group (16.52 ± 0.15 ng/mL vs 18.25 ± 0.12 
ng/mL, p<0.001). However, there was no significant difference in T between the OBHT+GRT and 
LC, OBHT+GRT and LC+GRT, and L+GRT and LC groups. Captopril reduced T levels in the 
OBHT+Captopril compared to untreated OBHT group (16.93 ± 0.48 ng/mL vs 18.25 ± 0.12 ng/mL, 
p<0.05). There was no difference between GRT treatment and Captopril treatment groups (Figure 
4.53). 
E2 levels were significantly increased in the OBHT group compared to the LC group (0.92 ± 0.06 
ng/mL vs 0.67 ± 0.03 ng/mL, p<0.05). Both GRT- and Captopril-treated OBHT animals respectively 
showed a significant lower E2 level when compared to the untreated OBHT group (p<0.001). 
Additionally, the E2 levels of LC animals treated with GRT did not significantly differ from those of 
the untreated LC group (Figure 4.54). 
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Figure 4.53: Serum testosterone levels 
Data are presented as mean ± SEM. *p<0.05 according to one-way-ANOVA, LC: lean control, LC+GRT: lean 
group treated with GRT, OBHT: obesity-induced hypertension group, OBHT+GRT: obesity-induced 
hypertensive animals treated with GRT, OBHT+Captopril: obesity-induced hypertensive animals treated with 
Captopril. N=6 per group. 
Stellenbosch University https://scholar.sun.ac.za
105 
 
L
C
L
C
+G
R
T
O
B
H
T
O
B
H
T
+G
R
T
O
B
H
T
+C
ap
to
pr
il
0.0
0.5
1.0
1.5
***
***
***
Treatment groups
E
s
tr
a
d
io
l 
le
v
e
ls
n
g
/m
l)
 
Figure 4.54: Serum estradiol levels 
Data are presented as mean ± SEM. ***p<0.001 according to one-way-ANOVA, LC: lean control, LC+GRT: 
lean control group treated with GRT, OBHT: Obesity-induced hypertension group, OBHT+GRT: obesity-
induced hypertension animals treated with GRT, OBHT+Captopril: obesity-induced hypertension animals 
treated with Captopril. N=6 per group. 
 
4.3.6 Testosterone and estradiol ratio 
The T:E2 ratio was significantly reduced in OBHT animals when compared to the LC group (18.29 
± 1.30 vs 23.91 ± 0.58, p< 0.05). Treatment with GRT did not present with a significant difference 
between LC+GRT and LC. However, the T:E2 ratio of OBHT+GRT treated with GRT significantly 
increased in comparison to that of the untreated OBHT group (24.95 ± 0.55 vs 18.29 ± 1.30, p<0.01). 
Treatment with Captopril also resulted in a significantly higher T:E2 when compared to the untreated 
OBHT group (24.39 ± 1.50 vs 18.29 ± 1.30, p<0.01) (Figure 4.55). 
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Figure 4.55: Testosterone and estradiol ratio 
Data are presented as mean ± SEM. *p<0.05, **p<0.01 according to one-way-ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OBHT: obesity-induced hypertension group, OBHT+GRT: obesity-
induced hypertension animals treated with GRT, OBHT+Captopril: obesity-induced hypertension animals 
treated with Captopril. N=6 per group. 
 
4.3.7 Testicular protein expression and phosphorylation 
4.3.7.1 Total PKB expression, PKB phosphorylation and P-PKB:T-PKB ratio 
T-PKB expression was significantly lower in the OBHT group when compared to the LC group (0.64 
± 0.10 densitometry units vs 1.20 ± 0.30 densitometry units, p<0.05). Treatment with either GRT or 
Captopril did not show a significant effect compared to the untreated OBHT group. Additionally, 
LC+GRT animals presented with a significantly lower T-PKB expression than the untreated LC 
group (0.22 ± 0.05 densitometry units vs 1.20 ± 0.30 densitometry units, p<0.001) and OBHT+GRT 
group (0.22 ± 0.05 densitometry units vs 0.75 ± 0.06 densitometry units, p=0.05). There was no 
significant difference between OBHT+GRT and OBHT+Captopril groups (Figure 4.56). 
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Activation of PKB (P-PKB) and P-PKB:T-PKB ratio is presented in Figure 4.57 and Figure 4.58 
respectively. No significant differences were observed in the P-PKB as well as in P-PKB:T-PKB 
ratio. 
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Figure 4.56: Testicular total PKB expression 
Data are presented as mean ± SEM.*p<0.05, ***p<0.001, LC: lean control, LC+GRT: lean group treated 
with GRT, OBHT: Obesity-induced hypertension group, OBHT+GRT: obesity-induced hypertension animals 
treated with GRT, OBHT+Captopril: obesity-induced hypertension animals treated with Captopril. N=3–4 
per group. 
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Figure 4.57: Testicular PKB phosphorylation 
Data are presented as mean ± SEM. p>0.05 according to one-way-ANOVA, LC: lean control, LC+GRT: lean 
group treated with GRT, OBHT: obesity associated with hypertension group, OBHT+GRT: obesity associated 
hypertensive group treated with GRT, OBHT+Captopril: obesity associated with hypertensive group treated 
with Captopril. N=3–4 per group. 
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Figure 4.58: Testicular P-PKB:T-PKB ratio 
Data are presented as mean ± SEM. p>0.05 according to one-way-ANOVA, LC: lean control LC+GRT: lean 
group treated with GRT. OBHT: obesity associated with hypertension group, OBHT+GRT: obesity associated 
hypertensive group treated with GRT, OBHT+Captopril: obesity associated with hypertensive group treated 
with Captopril. N=3–4 per group. 
 
4.3.7.2 T-AMPK and P-AMPK 
A significantly lower T-AMPK expression was observed in the OBHT group when compared to the 
LC group (0.04 ± 0.20 densitometry units vs 1.20 ± 0.20 densitometry units, p<0.001). Treatment 
with either GRT or Captopril did not show any significant change in T-AMPK when compared to the 
untreated OBHT group. However, a significantly lower T-AMPK was observed in LC+GRT animals, 
in OBHT+GRT and in OBHT+Captopril respectively when compared to the LC group (0.05 ± 0.20 
densitometry units vs 1.20 ± 0.20 densitometry units, p<0.01), (0.064 ± 0.013 densitometry units vs 
1.20 ± 0.20 densitometry units, p<0.001) and (0.092 ±0.013 densitometry units vs 1.20 ± 0.20 
densitometry units, p< 0.001) (Figure 4.59). 
P-AMPK was not found in the testicular samples.  
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Figure 4.59: Testicular total AMPK expression 
Data are presented as mean ± SEM. ***p<0.001 according to one-way ANOVA, LC: lean control, LC+GRT: 
lean group treated with GRT, OBHT: obesity-induced hypertensive group, OBHT+GRT: obesity-induced 
hypertensive animals treated with GRT, OBHT+Captopril: obesity-induced hypertension animals treated with 
Captopril. N=3–4 per group. 
 
4.3.7.3 Cleaved PARP expression in testicular tissue 
The presence of Cleaved PARP was significantly reduced in the OBHT group when compared to the 
LC group (0.41 ± 0.02 densitometry units vs 1.90 ± 0.05 densitometry units, p<0.001). Treatment 
with either GRT or Captopril did not show any significant difference when compared to the untreated 
OBHT group. However, treatment with GRT in the LC+GRT group and OBHT+GRT group showed 
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respectively a significant lower Cleaved PARP when compared to the LC group (0.40 ± 0.05 
densitometry units vs 1.90 ± 0.06 densitometry units, p<0.001) and (0.23 ±0.04 densitometry units vs 
1.90 ± 0.06 densitometry units, p<0.001). Treatment with Captopril in the OBHT + Captopril group 
presented a significantly lower Cleaved PARP when compared to the LC group (0.26 ± 0.05 
densitometry units vs 1.90 ± 0.06 densitometry units, p<0.001). There was a significant difference 
between LC+GRT and OBHT+GRT (0.40 ± 0.05 densitometry units vs 0.20 ± 0.04 densitometry 
units, p<0.05) (Figure 4.60). 
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Figure 4.60: Testicular Cleaved PARP expression 
Data are presented as mean ± SEM.*p<0.05, ***p<0.001 according to one-way ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OBHT: obesity-induced hypertensive group, OBHT+GRT: obesity-
induced hypertensive animals treated with GRT, OBHT+Captopril: obesity-induced hypertension animals 
treated with Captopril. N=3–4 per group.  
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4.3.9.4 Caspase 7 expression in testicular tissue 
OBHT animals presented with a significantly lower caspase 7 expression when compared to the 
untreated LC group (0.05 ± 0.30 densitometry units vs 1.20 ± 0.30 densitometry units, p<0.05). The 
treatment of OBHT animals with either GRT or Captopril did not change caspase 7 levels in 
comparison to the untreated OBHT group. However, LC+GRT showed a significantly reduced 
caspase 7 level when compared to the LC group (0.10 ± 0.30 densitometry units vs 1.20 ± 0.30, p< 
0.01). There was also a significantly lower caspase 7 expression in LC+GRT when compared to 
OBHT+GRT (p<0.05) (Figure 4.61). 
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Figure 4.61: Testicular caspase 7 expression 
Data are presented as mean ± SEM. *p<0.05, **p<0.01 according to one-way ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OBHT: obesity-induced hypertension group, OBHT+GRT: obesity-
induced hypertensive animals treated with GRT, OBHT+Captopril: obesity-induced hypertensive animals 
treated with Captopril. N=3–4. 
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4.3.8 Testicular OS  
4.3.8.1 Testicular SOD activity 
SOD activity was significantly lower in the OBHT group when compared to the LC group (40.8 ± 
2.2 U/mg protein vs 98.2 ± 4.2 U/mg protein, p<0.001). Treatment with GRT or Captopril did not 
show any significant effect on SOD activity in treated OBHT+GTR as well as OBHT+Captopril 
group when compared to the OBHT group. On the other hand, GRT treatment resulted in a 
significantly lower SOD activity in the LC+GRT group when compared to that of the LC group (63.5 
± 4.1 U/mg protein vs 98.2 ± 4.2 U/mg protein, p<0.001). A significant difference in SOD activity 
was observed between the LC+GRT and OBHT+GRT groups (63.5 ± 4.1 U/mg protein vs 49.2 ± 1.7 
U/mg protein, p<0.05) (Figure 4.62). 
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Figure 4.62: Testicular total SOD activity 
Data are presented as mean ± SEM. *p<0.05, ***p<0.001 according to one-way ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OBHT: obesity-induced hypertension group, OBHT+GRT: obesity-
induced hypertensive animals treated with GRT, OBHT+Captopril: obesity-induced hypertensive animals 
treated with Captopril. N=7 per group. 
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4.3.8.2 Testicular CAT activity 
The OBHT animals showed significantly lower CAT activity in testicular tissue compared to the LC 
group (36.6 ± 1.8 µmole H2O2 consumed/min/µg protein vs 58.5 ± 2.3 µmole H2O2 consumed/min/µg 
protein., p<0.001). Animals from the OBHT group treated with GRT presented with significantly 
increased CAT activity compared to the untreated OBHT group (66.8 ± 2.0 µmole H2O2 
consumed/min/µg protein vs 36.6 ± 1.8 µmole H2O2 consumed/min/µg protein, p<0.001). Similarly, 
treatment with Captopril significantly elevated CAT activity in the OBHT+Captopril group when 
compared to that of the untreated OBHT group (69.5 ± 2.1 µmole H2O2 consumed/min/µg protein vs 
36.6 ± 1.8 µmole H2O2 consumed/min/µg protein, p<0.001). No significant difference was observed 
between the LC+GRT and LC groups (Figure 4.63). 
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Figure 4.63: Testicular CAT activity 
Data are presented as mean ± SEM. ***p<0.001 according to one-way ANOVA, LC: lean control, LC+GRT: 
lean group treated with GRT, OBHT: obesity-induced hypertensive group, OBHT+GRT: obesity-induced 
hypertensive animals treated with GRT, OBHT+Captopril: obesity-induced hypertensive animals treated with 
Captopril. N=7 per group. 
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4.3.8.3 Testicular MDA levels  
The testicular MDA level was significantly higher in the OBHT group compared to the LC group (6.3 
± 0.5 μmol/mg protein vs 3.1 ± 0.3 μmol/mg protein, p<0.01). There were significantly lower 
testicular MDA levels in the OBHT+GRT group compared to that of the OBHT group (3.2 ± 0.3 
μmol/mg protein vs 6.3 ± 0.5 μmol/mg protein, p<0.001). Treatment with Captopril significantly 
lowered MDA levels compared to that of the untreated OBHT (4.5 ± 0.3 μmol/mg protein vs 6.3 ± 
0.5 μmol/mg protein, p<0.05). The MDA levels in the testes of LC animals supplemented with GRT 
were not significantly different to that of the LC group. It was also noted that there was no significant 
difference in MDA levels between the OBHT+GRT and LC+GRT groups (Figure 4.64). 
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Figure 4.64: Testicular MDA levels 
Data are presented as mean ± SEM.*p<0.05, ***p<0.001 according to one-way ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OBHT: obesity-induced hypertensive group, OBHT+GRT: obesity-
induced hypertensive animals treated with GRT, OBHT+Captopril: obesity-induced hypertension animals 
treated with Captopril. N=7 per group. 
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4.3.9 Epididymal weight 
A significantly higher total epididymal weight was observed in the OBHT compared to the LC group 
(1.28 ± 0.03 g vs 1.14 ± 0.03 g, p<0.05). The OBHT+GRT and OBHT+Captopril groups had lower 
total epididymal weights compared to that of the OBHT group (1.16 ± 0.03 g vs 1.28 ± 0.03 g, 
p<0.05), (0.94 ± 0.03 g vs 1.28 ± 0.03 g, p<0.001). A significant difference was observed between 
the OBHT+GRT and OBHT+Captopril groups (1.16 ± 0.03 g vs 0.94 ± 0.03 g, p<0.001) (Figure 
4.65). Futhermore, GRT supplementation resulted in a significant higher total epididymal weight in the 
LC+GRT group when compared to that of the LC group (1.25 ± 0.025g vs 1.14 ± 0.03 g, p<0.05). 
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Figure 4.65: Total epididymal weights in experimental groups 
Data are presented as mean ± SEM. *p<0.05, ***p<0.001 according to one-way ANOVA, LC: lean control, 
LC+GRT: lean group treated with GRT, OBHT: Obesity-induced hypertensive group, OBHT+GRT: obesity-
induced hypertensive animals treated with GRT, OBHT+Captopril: obesity-induced hypertensive animals 
treated with Captopril. N=7 per group.  
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4.3.10 Epididymal sperm function parameters 
Sperm concentration, viability, total motility, progressive motility, VCL, VSL, VAP, normal 
morphology, head defects, midpiece defects, and teratozoospermy index of caudal epidymal part were 
investigated in the experimental groups (Table 4.8). 
Table 4.7: Summary of basic and functional sperm parameters 
 LC 
LC 
+GRT 
OBHT 
OBHT 
+GRT 
OBHT 
+Captopril 
Sperm concentration 
(10 6sperm /mL) 
1.79 ± 0.15 1.72 ± 0.13 1.40 ± 0.08* 1.80 ± 0.03# 1.49 ± 0.10& 
Viable sperm 
(%) 
57.10 ± 2.70 61.0 ± 3.60 
23.40 
±1.70*** 
57.60 ± 
2.60*** 
55.70 ± 
2.70*** 
Normal morphology 
(%) 
52.60 ± 3.50 56.30 ± 3.20 
27.60 ± 
3.60** 
53.50 ± 
4.40** 
36.10 ± 6.80 
Head defects 
(%) 
47.10 ± 3.30 41.70 ± 3.40 
73.90 ± 
3.70*** 
53.20 ± 
3.50### 
56.80 ± 
5.80# 
Midpiece defects 
(%) 
1.30 ± 0.80 1.70 ± 0.30 6.20 ± 0.90* 2.40 ± 1.00# 5.10 ± 1.40 
Teratozoospermy 
index 
1.02 ± 0.02 1.06 ± 0.01* 1.05 ± 0.02 1.04 ± 0.01 1.07 ± 0.01 
Total motility 
(%) 
81.16 ± 4.91 89.90 ± 2.20 
72.60 ± 
1.20* 
86.70 ± 
2.00# 
94.40 ± 1.10 
Progressive motility 
(%) 
59.21 ± 2.82 72.00 ± 5.00 
47.60 ± 
3.00* 
68.40 ± 
2.60### 
76.00 ± 
5.40## 
VCL 
(µm/s) 
165.20 ± 
6.20 
162.40 ± 
7.60 
208.20 ± 
10.00** 
174.30 ± 
11.00 
62.00 ± 
2.60###&&& 
VSL 
(µm/s) 
47.00 ± 2.40 
55.60 ± 
2.60* 
50.80 ± 2.00 50.70 ± 3.00 
105.10 ± 
4.50### &&& 
VAP 
(µm/s) 
76.10 ± 2.50 
88.30 ± 
3.50* 
84.70 ± 4.20 87.50 ± 3.40 
26.30 ± 
1.40### 
All data is expressed in mean ± SEM. *p<0.05 vs LC, **p<0.01 vs LC, ***p<0.001 LC, #p<0.05 vs OBHT, 
##p<0.01 vs OBHT, ###p<0.001 vs OBHT, &&p<0.01 vs OBHT+GRT. &&&p<0.001vs OBHT+GRT according to 
one-way ANOVA. LC: lean control, LC+GRT: lean group treated with GRT, OBHT: obesity-induced 
hypertensive group, OBHT+GRT: obesity-induced hypertensive animals treated with GRT, OBHT+Captopril: 
obesity-induced hypertensive animals treated with Captopril. N=7 per group. 
Stellenbosch University https://scholar.sun.ac.za
118 
 
4.3.9.1 Sperm concentration  
A significantly lower sperm concentration was observed in the OBHT compared to the LC group 
(1.40 ± 0.08 x 106 sperm/mL vs 1.79 ± 0.15 x 106 sperm/mL, p<0.05). The OBHT+GRT group 
showed a significant higher sperm concentration compared to the untreated OBHT (1.80 ± 0.03 x 106 
sperm/mL vs 1.40 ± 0.08 x 106 sperm/mL, p<0.05). A significant difference in sperm concentration 
was also observed between the OBHT+Captopril and OBHT+GRT groups (1.49 ± 0.11 sperm/mL vs 
1.80 ± 0.03 x 106 sperm/mL, p<0.05). Furthermore, there was no significant difference between the 
OBHT+GRT and LC+GRT groups or between the LC+GRT and LC groups (Table 4.7). 
 
4.3.9.2 Sperm viability 
The animals from the OBHT group showed significantly lower sperm viability compared to that of 
the LC group (23.40 ± 1.70% vs 57.10 ± 2.70%, p<0.001). The sperm viability of the LC+GRT 
animals was not significantly different from that of the LC group. Furthermore, there was a 
significantly higher in sperm viability of the OBHT+GRT group as well as OBHT+Captopril group 
when compared to untreated OBHT group (p<0.001) (Table 4.7). 
 
4.3.9.3 Normal morphology 
Normal sperm morphology was decreased in the OBHT group compared to the lean group (27.60 ± 
3.60% vs 52.60 ± 3.50%, p<0.01). OBHT animals treated with GRT (OBHT+GRT) presented with a 
significantly higher in normal sperm morphology when compared to the untreated OBHT animals 
(53.50 ± 4.40% vs 27.60 ± 3.60%, p< 0.001). Treatment with Captopril did not show any significant 
differences of normal sperm morphology in OBHT+Captopril group when compared to the untreated 
OBHT group. Furthermore, the normal sperm morphology of LC animals subjected to GRT was not 
significantly different to that of the untreated LC animals (Table 4.7). 
 
4.3.9.3.1 Head defects 
OBHT animals had significantly higher sperm head defects than LC animals (73.90 ± 3.70% vs 47.10 
± 3.30%, p<0.001). The same group was treated with GRT (OBHT+GRT), and subsequently the 
percentage of sperm head defects were reduced compared to the untreated OBHT group (43.20 ± 
3.50% vs 73.90 ± 3.70%, p<0.001). Similar to this, treatment with Captopril demonstrated a 
significantly lower the percentage of sperm head defects compared to the untreated OBHT group 
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(56.80 ± 5.80% vs 73.90 ± 3.70%, p<0.05). There were no statistically significant differences between 
the LC+GRT group and the untreated LC group (Table 4.7). 
 
4.3.9.3.2 Midpiece defects  
The percentage of midpiece defects was significantly higher in OBHT animals than in LC animals 
(6.20 ± 0.90% vs 1.30 ± 0.80%, p<0.01). Treatment with GRT reduced the percentage of midpiece 
defects when compared to untreated OBHT (2.40 ± 1.00% vs 6.20 ± 0.90%, p<0.05). No effect of 
Captopril was observed. Additionally, the supplementation of GRT in the LC group did not have any 
significant effect when compared to the untreated LC group (Table 4.7). 
 
4.3.9.3.3 Teratozoospermy index 
The only significant difference in teratozoospermy index was observed between the LC+GRT and 
LC groups (1.06 ± 0.006 vs 1.02 ± 0.015, p<0.05) (Table 4.7). 
 
4.3.9.4 Sperm total motility  
A significantly lower total motility was observed in OBHT animals when compared to LC animals 
(72.6 ± 1.2% vs 81.2± 4.9%, p<0.05). OBHT+GRT presented with a significant higher total motility 
when compared to untreated OBHT group (86.7 ± 2.0% vs 75.9 ± 2.8%, p<0.05). Treatment with 
Captopril also demonstrated a significantly higher total motility when compared to the untreated 
OBHT group (94.4 ± 1.1% vs 75.9 ± 2.8%, p<0.05). No significant difference was observed between 
the LC+GRT and LC animals (Table 4.7). 
 
4.3.9.4.1 Progressive motility 
The progressive motility was significantly lower in OBHT than in the LC group (47.60 ± 3.00% vs 
59.21 ± 2.82%, p<0.05). Treatment with either GRT or Captopril revealed a significantly higher 
progressive motility in treated OBHT animals when compared to the untreated OBHT group (68.4 ± 
2.60% vs 47.60 ± 3.00%, p<0.001 and 76.00 ± 5.40 vs 47.60 ± 3.00 %, p<0.001). There was no 
significant difference in percentage progressive motility between the LC group treated with GRT and 
the untreated LC group (Table 4.7). 
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 4.3.9.4.2 Sperm kinematics 
VCL: There was significantly higher VCL in the OBHT group compared to that of the LC group 
(208.20 ± 10.00 µm/s vs 165.20 ± 6.20 µm/s, p<0.01). Treatment with GRT did not affect VCL when 
compared to the untreated OBHT group. However, the same group treated with Captopril 
(OBHT+Captopril) presented with a significantly lower VCL when compared to untreated OBHT 
(62.00 ± 2.60 µm/s vs 208.20 ± 10.0 µm/s, p<0.05, p<0.001). The OBHT+Captopril group also had 
a significantly lower VCL compared to the OBHT+GRT group (62.00 ± 2.60 µm/s vs 174.30 ± 11.00, 
p<0.001). Lastly, VCL of animals from the LC+GRT group was not significantly different when 
compared to the LC group or the OBHT+GRT group (Table 4.7). 
VSL: No significant difference in VSL was observed between the OBHT and LC groups or between 
the OBHT+GRT groups. A significantly higher in VSL was observed between OBHT+Captopril and 
OBHT group (p<0.001), and OBHT+Captopril and OBHT+GRT (p<0.001). Additionally, VSL was 
significantly higher in the LC+GRT group when compared to the LC group (p<0.05) (Table 4.7). 
VAP: No significant difference in VAP was observed between OBHT and the LC group. A 
significant difference was only observed in treated groups (LC+GRT, OBHT+Captopril) when 
compared to the untreated LC and OBHT groups (Table 4.7). 
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CHAPTER FIVE 
DISCUSSION 
It is known that food is a source of energy, used by the organ systems to perform specific functions. 
However, changes in eating behaviour may cause either calorie restriction or excess. Masek and Fabry 
(1959) were the first persons to discover and confirm that the intake of high calorie food influences 
the development of obesity and its metabolic disorders in animal models, while Buettner et al. (2006) 
claim that these metabolic disorders tend to disturb the body’s entire system. Researchers around the 
world have used diets to create experimental obesity, because it is a simple, inexpensive and available 
method (Salie et al., 2014). 
This chapter is divided into two sections corresponding to two conditions of diet-induced obesity 
(DIO) (Table 3.1). The first DIO group was exposed to a high caloric diet (HCD), containing mostly 
carbohydrates, especially sucrose, which is known to influence the development of obesity and T2DM 
(Barbosa-da-Silva et al., 2014; Walker et al., 2006). The other HCD was rich in fructose and 
cholesterol. A high-fructose diet results in the development of an overlapping of MetS features, with 
obesity playing a central role (Zhang et al., 2017). Additionally, an excess of cholesterol intake is 
transferred to the blood and binds to protein, thereby causing fatty deposits in the arterial walls 
(Simon, 2014). The arteries become hard and narrow, resulting in HT (Matsuura, 2001; Simon, 2014). 
Both diets and the complications of induced metabolic disorders on male reproductive health will be 
discussed in detail in the following sections. Furthermore, the results will be discussed according to 
the objectives cited earlier (Section 1.4). 
The first part of this chapter focusses on the results obtained in DIO associated with insulin resistance, 
followed by a discussion of the results obtained in DIO associated with HT. The last section of this 
chapter will compare all the results generated from induced insulin resistance and/or HT. Finally, 
general conclusions and recommendations will be made at the end of the discussion. 
 
5.1 DIO associated with insulin resistance and a 6-week treatment with GRT  
5.1.1 Food and water intake, body weights (BWs), glucose levels and cytokine levels  
The induction of obesity through a HCD is time-dependent and influenced by the calorie composition 
of the specific carbohydrates included in the prepared diet. The inclusion of sucrose, which is highly 
palatable, further increases food intake and leads to hyperphagia, which impairs body metabolism 
(Du Toit et al., 2008; Huisamen et al., 2013; Nduhirabandi et al., 2014; Salie et al., 2014). In the 
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current study, OB animals demonstrated hyperphagia due to the sweetness of sucrose (Figure 4.1), 
hyperglycaemia (Figure 4.8) and glucose intolerance (Figure 4.9) after ten weeks. Subsequently, these 
animals (Figure 4.1) drank less water (Figure 4.3), more than likely because their food contained 
more moisture. High sucrose food affects the liver and insulin function, thereby affecting glucose 
metabolism and enlarging the entire body (Barbosa-da-Silva et al., 2014; Walker et al., 2006). 
However, BW did not change (Figure 4.5). We therefore suggest that the low protein content in DIO 
(Table 3.1) may affect muscle tissue or the development of subcutaneous fat. The muscle could also 
degenerate because of the low protein. 
In summary, the OB animals were classified as prediabetic because of the elevated glucose levels 
which were slightly increased above the normal levels but remained less than diabetic levels 
(11mmol/L) (Figure 4.8 and Figure 4.9). These values correlated with the values proposed by the 
American Diabetes Association for humans, 2010. Therefore, the OB animals fed with a HCD for 16 
weeks consumed more food than their age-matched controls (Figure 4.2) and became hyperphagic 
and obese, similar to findings reported in previous studies (Du Toit et al., 2008; Nduhirabandi et al., 
2014). The BW (Figure 4.6) and adiposity index (Figure 4.7) increased with the concomitant increase 
in blood glucose levels (Figure 4.10, Figure 11 and Figure 4.12), as previously reported by Huisamen 
et al. (2013). This metabolic dysregulation may be due to the imbalance of calorie intake and 
expenditure. 
It has been reported that an increase in IP fat was accompanied by upregulation of pro-inflammatory 
cytokines, which interfere with insulin signalling (Appari et al., 2017; Jung & Choi, 2014; Koenen et 
al., 2011). In the current study, OB animals presented with elevated IL-1β (Figure 4.13) and IL-18 
(Figure 4.16). These inflammatory cytokines have previously been shown to be associated with the 
development of insulin resistance (Membrez et al., 2009; Osborn et al., 2011). An increase in 
cytokine levels can be ascribed to the hyperplasia and hypertrophy of adipocytes, correlating with the 
increased adiposity index (Figure 4.7). These cytokines and fat interfere with insulin signalling 
pathways in testicular tissue by deactivating intermediates in the pathway, resulting in insulin not 
being able to stimulate glucose uptake into the cells. The glucose therefore remains in circulation, 
leading to hyperglycaemic conditions (Figure 4.10, Figure 11 and Figure 4.12). Insulin levels have 
previously been shown to be higher in OB rat model (Huisamen et al., 2011; Nduhirabandi et al., 
2017), but it is a shortcoming of the current study in the sense that it was not determined. The other 
investigated pro-inflammatory cytokines, including TNF-α levels, were lower in OB animals 
compared to LC animals (Figure 4.17), while the IL-6 (Figure 4.14) and IL-12 (Figure 4.15) levels 
of treatment groups did not differ significantly. These results were different from known literature 
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(Appari et al., in press; Jung & Choi, 2014; Koenen et al., 2011). Unexpected results might be due to 
various critical factors, including the age of animals, exposure time and quantity of given HCD or the 
adaptation mechanisms of the immunity systems of these animals to resist metabolic changes. 
In summary, OB animals presented with dysregulated metabolic parameters, including hyperphagia, 
increased body weight and IP fat, hyperglycaemia and inflammation. These metabolic disorders could 
interact and cause insulin resistance. Therefore, the HCD was successful in inducing insulin resistance 
in the OB group. This insulin resistance influenced the risks of developing diabetes but in fasted and 
unfasted blood samples, glucose levels were less than 11 mmol/L. Therefore, according to the 
American Diabetes Association (2010), the rats in the OB group were not diabetic. 
GRT, administered for six weeks, reduced body weight gain (Figure 4.6) and visceral adiposity 
(Figure 4.7) without influencing food (Figure 4.2) and water intake (Figure 4.4). It also did not affect 
blood glucose levels (Figures 4.10, 4.11 and 4.12). The reduction in visceral adiposity could account 
for the lower body weight as well as IL-1β and IL-18 levels evident for OB animals treated with GRT 
(OB+GRT) (Figure 4.13 and 4.16). In a study conducted on hyperlipidaemic mice, it was shown that 
rooibos has significant anti-obesity potential (Beltrán-Debón et al., 2011). Furthermore, another in 
vitro study showed that rooibos inhibited adipogenesis (Sanderson et al., 2014), which may have been 
associated with the reduced body weight gain and decreased inflammation observed in the current 
study. GRT treatment in LC+GRT animals did not influence metabolic parameters compared to 
untreated LC animals. 
 
5.1.2 Effect of obesity-induced insulin resistance on testicular function parameters  
Prediabetes has shown to impair male reproductive function at different levels (Alves, et al., 2013; 
Rato et al., 2014, 2012). Furthermore, the anatomy and physiology of the testis depend on different 
factors, including nutritional status and energy metabolism (Dupont et al., 2014). In the present study, 
testicular weight (Figure 4.18) and histological features (Table 4.1) in OB animals fed a HCD 
remained unchanged compared to LC animals. These results were consistent with previously reported 
studies (Alves, et al., 2013; Campos-Silva et al., 2015). We suggest that the testicular tissue might 
have undergone mechanistic metabolic adaptations that allow them to minimize the negative effects 
promoted by the disease. OB animals had a low TW:BW ratio (Figure 4.19), which implies that these 
animals had much higher BW (due to fat) compared to the TW. Even if TW did not change, the excess 
BW can impair the feedback regulation of the HPG axis, which may affect testicular function. This 
can also affect sperm quality and quantity, and therefore result in male infertility. Furthermore, the 
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morphometric analysis showed that the area and diameter of the seminiferous tubules of OB animals 
were larger compared to that of the LC group (Table 4.1). These findings are in contrast with evidence 
that DIO is associated with atrophic seminiferous tubules with smaller diameters (Campos-Silva et 
al., 2015; Yan et al., 2015). The changes observed in the current study may be explained by reduced 
expression of apoptotic proteins, including Cleaved PARP and caspase 7 (Figure 4.27 and 4.28). 
Inappropriate or inadequate apoptosis may have led to a greater number of divided cells, which 
accumulated within tubules and caused the increase in size. It is therefore suggested that the changes 
in seminiferous tubules could affect hormone production and spermatogenesis. 
Testicular Leydig cells produce T, which regulates spermatogenesis within Sertoli cells. T is either 
converted to E by the P450 aromatase or to dihydrotestosterone by 5α-reductase (Dong & Hardy, 
2003). Hence, the metabolic changes observed in this study could have caused an imbalance in 
hormonal secretion. The T levels of OB animals were decreased (Figure 4.20) and their E2 levels 
elevated (Figure 4.21) compared to that of LC animals, thus leading to a reduced T:E2 ratio (Figure 
4.22). These findings are in agreement with the literature (Kasum, 2016; Katib, 2015; Du Plessis et 
al., 2010), which showed increased aromatization occurring in adipocytes in response to obesity. This 
hypersecretion of oestrogens results in the inhibition of the HPG axis via kisspeptin neurons and 
subsequently affects testosterone levels negatively, which can impair spermatogenesis. 
Rooibos extract has been used in various studies and is known to possess biological effects or curative 
properties (Awoniyi et al., 2012; Joubert & De Beer, 2011; Muller et al., 2018; Opuwari & Monsees, 
2014). The current study showed that GRT treatment in control animals did not influence TW or 
testicular histomorphometry. This might be due to non-effect of GRT on metabolic parameters 
(Section 5.1.1). Interestingly, treatment with the GRT significantly increased the TW:BW ratio in the 
OB+GRT group when compared to the untreated OB group (Figure 4.19). From these results it is 
evident that the difference between OB and OB+GRT was dependent on BW and not on testicular 
tissue because it was shown that GRT reduced BW gain (Section 5.1.1), which could normalize the 
ratio between TW and BW. Therefore, testicular function was probably also restored. Furthermore, 
the OB animals treated with GRT displayed a reduction in tubule area and a decrease in tubule 
diameter (Table 4.1); subsequently, these changes could affect Leydig cells as well as hormone 
production. These effects of GRT could result from its polyphenol composition, which might interact 
with body metabolism and homeostasis. 
Aspalathus linearis contain flavonoids as major compounds (Joubert, 1996; Opuwari & Monsees, 
2014), many of which are classified as endocrine disruptors. However, rooibos affects the 
steroidogenesis process, depending on experimental conditions where it can activate or inhibit 
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different steps of this process. In the current study, GRT treatment in LC+GRT animals was 
associated with a lower T:E2 ratio, which was expressed in lower T levels and higher E2 levels 
(Figure 4.22) and supports the role of rooibos as anti-androgenic agent in lean animals. This was 
similar to previous findings that showed that green rooibos extract possesses anti-androgenic 
properties in TM3 Leydig cells (Opuwari & Monsees, 2015). We speculate that the GRT could also 
interfere with different steps or reactions occurring in steroidogenesis in normal physiological 
conditions. GRT could affect the cholesterol level, which is a precursor to steroid hormones and might 
also inhibit the conversion of cholesterol to pregnenolone. GRT treatment in the OB group was 
associated with upregulation of T:E ratio towards normal levels (Figure 4.22), which supports the 
role of rooibos as a potential anti-estrogenic agent in obese animals. Anti-estrogenic properties of 
GRT might be due to its beneficial antioxidant activity, which could activate 17α-hydrogenase and 
5α-reductase and inhibit P450 aromatase. 
 
5.1.3 Expression and activation of intermediate molecule of the insulin signalling pathway in 
the insulin resistant testicular tissue 
Insulin-independent AMPK and insulin-dependent PKB pathways control energy metabolism, 
homeostasis and insulin signalling (Berridge, 2014; Dupont et al., 2014; Yu & Cui, 2016). 
The OB group did not differ from the LC group in testicular expression of T-PKB (Figure 4.23) or 
baseline P-PKB (Figure 4.24). The PKB pathway depends on insulin receptor (IR) and insulin 
receptor substrate (IRS) phosphorylation; however, IR and IRS were not investigated, therefore this 
association could not be confirmed. The results suggest that high production of inflammatory 
cytokines (IL-1β and Il-18) could damage IR expression, thereby affecting PKB. In this study, OB 
animals had lower testicular expression of T-AMPK compared to LC (Figure 4.26), and subsequently 
AMPK was not activated in any of the treatment groups. This finding was expected, since 
dysregulation of glucose levels, high adipocyte index and an increase in inflammatory cytokines (IL-1 
and IL-18) could contribute to the inhibition of AMPK phosphorylation, which is consistent with 
previous reports (Nandipati et al., 2017). The AMPK pathway controls the steroidogenesis process, 
and its inhibition was associated with an imbalance of T and E2, as indicated in this study. This 
perturbation can affect sperm production and maturation, which could develop into male infertility. 
Interestingly, hyperoestrogen and AMPK inhibition in testicular tissue, due to adipocyte 
aromatization, is similar to that described for Peutz-Jeghers Syndrome, an autosomal-dominant 
disorder (Ham et al., 2013). 
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GRT administration was associated with significantly lower testicular T-AMPK (Figure 4.26) and T-
PKB (Figure 4.23) expression in LC+GRT, while the GRT did not have a significant effect on T-
AMPK and T-PKB expression in OB+GRT animals. From the data, GRT (used as a supplement) 
could interfere with T-AMPK and T-PKB expression, which were also linked to lower T: E2 ratio in 
normal physiological conditions. This implies that testicular cells could not get energy to perform 
steroidogeneses and spermatogenesis. In prediabetic conditions, GRT treatment did not influence 
expression and activation of the intermediate molecules (PKB and AMPK) of insulin signalling in 
the testis. This might be due to various critical factors, including exposure duration (6 weeks of GRT 
treatment) and GRT dose. 
 
5.1.4 Effect of obesity-induced insulin resistance on testicular apoptosis 
Caspase 7 and its substrate PARP are both activated by internal or external stimuli and can lead to 
apoptosis (Chaitanya et al., 2010; Elmore, 2007). Altered regulation of apoptosis contributes to many 
diseases due to cell accumulation (e.g. cancer, restenosis, inflammation) or cell loss 
(neurodegeneration). Programmed germ cell death plays a key role during fetal, neonatal, postnatal 
and adult spermatogenesis (Bejarano et al., 2018). 
In the present study, cleaved caspase 7 and PARP were significantly lower in the testicular tissue of 
the OB group compared to that of the LC group (Figure 4.27 and 4.28). These findings are in conflict 
with those previously reported for apoptotic protein expression in prediabetic conditions (Banerjee et 
al., 2016; Celik-Ozenci & Tasatargil, 2013; Chaitanya et al., 2010; Sishi et al., 2011). However, our 
study suggests that inappropriate or deficient testicular apoptosis resulted from a disturbance in 
energy homeostasis due to hyperglycaemia (inactivation or dephosphorylating PKB and AMPK) as 
well as OS. Additionally, the study found that the seminiferous tubules were large, which could be 
due to more or bigger germinal or Sertoli cells. Abnormal distribution of these cells could also affect 
Leydig cells as well as the T: E2 ratio and sperm quality. 
In this study, GRT administration was also associated with differences in caspase 7 (Figure 4.28) and 
PARP expression (Figure 4.27) between LC+GRT and LC, and LC+GRT and OB+GRT animals, 
while no differences were observed in the expression between OB+GRT and OB animals (Figure 
4.25 and 26). The effect of GRT observed in treated LC animals may be related to the GRT 
supplementation, which inhibited T-AMPK and T-PKB under normal physiological conditions. The 
GRT dose used in this study might be responsible for downregulating or inhibiting the insulin 
signalling and apoptosis process by suppressing or interfering their intermediate receptors in treated 
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LC animals. Furthermore, as far as we are aware, this is the first time the effect of GRT on testicular 
tissue was investigated and these findings lay the foundation for future investigations. 
 
5.1.5 Effect of obesity-induced insulin resistance on antioxidant activity and lipid peroxidation 
Hyperglycaemia may interfere with natural antioxidant defences by changing intracellular signalling 
in addition to increasing the production of free radicals (Berdja et al., 2016; Rolo & Palmeira, 2006; 
Taheri et al., 2012). Since SOD and CAT enzymes are part of the first line of defence against free 
radicals, it is expected that the activity of these enzymes may be affected by OS before the other 
antioxidant enzymes are (Hamden et al., 2009). The data from this study indicate that SOD (Figure 
4.29) and CAT activity (Figure 4.30) are very significantly lower, with high MDA levels (Figure 
4.31) in OB animals compared to non-obese animals, which define an OS state. The observed 
reduction in antioxidant enzyme activities could be due to the oxidative inactivation of the enzyme 
by ROS or by the glycation of the enzymes (Berdja et al., 2016). Thus, different testicular cells are 
susceptible to the accumulation of O2•- and H2O2, which leads to an oxidative environment and 
cellular damage such as LPO (high level of MDA), DNA fragmentation as well as consequent sperm 
abnormalities and germinal cell apoptosis (Agarwal et al., 2014). Furthermore, the high MDA levels 
might be linked to the increase of IL-1β and IL-18, which was also observed in the OB animals. 
Rooibos has been shown to alleviate OS in diabetic conditions (Ayeleso et al., 2014). Interestingly, 
treatment of OB rats with GRT attenuated testicular oxidative damage by upgrading SOD and CAT 
activity (Figure 4.29 and Figure 4.30), thereby leading to a reduction in LPO and MDA (Figure 4.31), 
similar to findings of a previous study (Awoniyi et al., 2012). The ameliorating effects of GRT on 
testicular OS is probably due its flavonoids, aspalathin, and other potent antioxidant components 
which affect natural antioxidant enzymes by upregulating them and thereby reducing LPO. 
Polyphenols have been reported to suppress ROS formation either by inhibition of NADPH oxidases, 
chelation of trace elements, or upregulation and protection of antioxidant defences (Mishra et al., 
2013), including SOD and CAT enzymes. Furthermore, polyphenols prevent LPO, and could 
therefore act as an anti-oxidant, which was also indicated in the current study. 
 
5.1.6 Effect of obesity-induced insulin resistance on the basic sperm parameters  
Prediabetic conditions impair several male reproductive parameters due to altered testicular 
metabolism and mitochondrial bioenergetics (Rato et al., 2013; 2014). OS, inflammation and 
apoptosis are closely interlinked with hyperglycaemic conditions and consequently may cause 
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testicular cell damage and have a negative impact on hormone and sperm production (Berdja et al., 
2016; Rolo & Palmeira, 2006). Additionally, thermoregulation defects and scrotal lipomatosis may 
result from high accumulation of fat, affecting spermatogenesis and sperm function (Du Plessis et al., 
2010; Oyeyipo et al., 2015). 
In the current study, testicular OS, testicular apoptosis inhibition and histomorphometric changes 
were accompanied by a decrease in the T:E2 ratio. Together, this could contribute to a higher 
epididymal weight (Figure 4.32) and impairment of sperm functional parameters (Table 4.2) in OB 
animals. The current study showed that spermatogenesis and sperm maturation were impaired based 
on the low sperm concentration, and reduction in viability, progressive motility, VSL, VCL and VAP. 
These findings are similar to previous findings (Oyeyipo et al., 2015). Furthermore, morphological 
abnormalities increased with elevated head and midpiece defects in OB animals. Therefore, altered 
basic sperm function parameters may contribute to male infertility in obesity. Co-treatment with GRT 
ameliorated epididymal weight (Figure 4.32) as well as the above-mentioned sperm functional 
parameters in treated OB+GRT animals (Table 4.2). This effect could have resulted from 
bioflavonoids and other potent antioxidants, found in GRT, as well as improved accumulation of fat 
and inflammatory cytokines. 
 
5.1.7 Summary of DIO-associated insulin resistance effect on male fertility 
A diagrammatic summary of the relationship between obesity and insulin resistance and their effects 
on male fertility is depicted in Figure 5.1 (A). From the discussed results, the current findings show 
that HCD with sucrose led to hyperphagia and caused hyperplasia and hypertrophy of WAT. This 
abnormal accumulation of adipose tissue results in elevated FFAs, which cause upregulation of pro-
inflammatory cytokines (IL-1β, IL-18). Altogether, high sucrose intake, fat accumulation and 
inflammation interfere with insulin signalling pathways by deactivating IRs, resulting in insufficient 
glucose uptake by target cells and a build-up of glucose in the bloodstream (hyperglycaemia). 
Hyperglycaemia may interfere with intracellular signalling pathways of testicular tissue by affecting 
energy metabolism (reduced T-PKB, T-AMPK), apoptosis (reduced caspase and PARP), antioxidant 
activities (decreased SOD and CAT) and lipid peroxidation (increased MDA levels). Subsequently, 
seminiferous tubules possibly increased in size due to decreased apoptosis and dysregulated energy 
metabolism. We therefore suggest that the changes observed in the seminiferous tubules could impair 
steroidogenesis (reduced T:E2) by affecting Leydig cells and spermatogenesis (reduced sperm 
function parameters), thereby reducing male fertility. Furthermore, an imbalance of antioxidant 
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activities and MDA levels could also affect sperm functional parameters and consequently reduce 
male fertility. 
Lastly, increased adiposity increases aromatization, which affect steroidogenesis and reduce T:E2. 
The consequent hypersecretion of E2 impairs spermatogenesis and further lead to reduced male 
fertility. 
 
5.1.8 Summary of GRT’s effects on DIO-associated insulin resistance and male fertility 
A diagrammatic summary of the possible ameliorative effect of GRT treatment on the 
pathophysiological mechanisms linked to obesity/insulin resistance and subsequent improvement in 
male reproductive parameters is displayed in Figure 5.1 (B). In this study, adipose tissue was reduced 
(potentially via inhibition of lipidaemia), resulting in lower cytokine levels (IL-1β, IL-18) and 
therefore implicating GRT’s anti-inflammatory effects. Furthermore, SOD and CAT activities were 
improved, while MDA levels were reduced, thus also implicating GRT to have anti-oxidative 
properties. Lastly, the decrease in adipose tissue implies lessened aromatization, thereby reducing E2 
production and normalizing the ratio of T to E2. Therefore, GRT was also anti-oestrogenic. Taken 
together, these factors resulted in subsequent improvements in sperm quantity and quality, which 
associate GRT treatment with the ability to restore male fertility. 
Stellenbosch University https://scholar.sun.ac.za
130 
 
 
Figure 5.1: The mechanisms through which obesity associated with insulin resistance affect 
male reproduction (A) and the possible ameliorating mechanisms of GRT treatment (B) 
CAT: Catalase, Cas 7: Caspase 7, IL-18: Interleukin-18, IL-1β: Interleukin-1 beta, MDA: Malondialdehyde, 
PARP: Poly ADP ribose polymerase, SOD: Superoxide dismutase, T-AMPK: Total adenosine 5′ 
monophosphate-activated protein kinase, T:E2: Ratio of testosterone to estradiol, VAP: Average path velocity, 
VCL: Curvilinear velocity, VSL: Straight line velocity.  
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5.2 DIO associated with hypertension and 6-week treatment with GRT  
5.2.1 Metabolic parameters  
Food intake, water intake, BW, IPF weights, glucose levels, cytokines and blood pressure (BP) were 
used to describe and validate or define an experimental animal model of OBHT. In the present study, 
male Wistar rats were fed a special HCD over a period of 16 weeks to induce obesity and its associated 
metabolic complications, including HT. Similar findings were reported in a previous study (Kant et 
al., 2009). Specifically, OBHT animals consumed more food and drank less water compared to LC 
animals (Figure 4.33, 4.34, 4.35 and 4.36) because the food contained fructose (sweetener) and was 
moist. BW (Figure 4.37 and 4.38) and adiposity index (Figure 4.38) increased significantly in the 
OBHT group compared to the LC group. This was to be expected, since the high-fructose content in 
the diet is associated with hyperphagia and obesity (Codella et al., 2017; Lenoir et al., 2007), which 
was also evident in the current study. We were therefore able to successfully induce obesity in male 
Wistar rats over a period of 16 weeks by using the same dietary protocol as previously used in our 
laboratory (Huisamen et al., 2013; Salie et al., 2014). 
Obesity, especially visceral obesity, is strongly associated with impaired glucose metabolism 
(D’Alessandro et al., 2015), which results in hyperglycaemia. From the present study, OBHT animals 
were hyperglycaemic or glucose intolerant compared to LC animals (Figure 4.40, 4.41, 4.42,4.43 and 
4.44), the result of which is supported by a previous finding (Huisamen et al., 2013). In addition to 
developing hyperglycaemia, the pro-inflammatory cytokines IL-β and IL-18 increased in OBHT 
(Table 4.3). This may be due to the high adiposity index. Both hyperglycaemia and inflammation are 
known to impair insulin sensitivity by interfering with the insulin signalling pathways or inhibiting 
insulin signal transduction (Luca et al., 2009). 
Hypertension results from the pathogenesis of obesity due to activation of the sympathetic nervous 
system and the RAAS, resulting in arterial vasoconstriction and sodium retention and excessive intra-
vascular and intra-abdominal fat, which triggers inflammation (and consequently endothelial 
dysfunction) and physical compression of the kidneys due to the excessive fat accumulation around 
the kidneys (Hall et al., 2015). In the present study, OBHT rats had higher systolic and diastolic BP 
as well as mean arterial pressure compared to LC (Table 4.4 and 4.5). This implies that OBH animals 
developed HT, which could potentially be a result of a greater BW and higher adiposity index, 
hyperglycaemia, glucose intolerance and inflammation, as indicated in this study. These findings are 
consistent with the known association between obesity induced with fructose and HT (Chandra et al., 
2014; Hall et al., 2015). We therefore conclude that we successfully established a model displaying 
both obesity and hypertension, which is in accordance with a previous study that used the same DIO 
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(Huisamen et al., 2013) . It is important to note that the rats in the current study specifically had stage 
1 HT according to the classification of HT development (Giles et al., 2009). 
In summary, OBHT animals presented with dysregulated metabolic parameters (including 
hyperphagia), increased BW and IP fat, hyperglycaemia, inflammation and HT. Additionally, this 
animal model presented with a MetS, which occurs when an animal model has more than three of the 
associated medical conditions (Cheung & Li, 2012). Furthermore, both GRT and Captopril, 
administered for six weeks on MetS features, were evaluated respectively. 
GRT treatment lowered BW and adiposity index in treated OBHT animals (Figure 4.38), which is 
consistent with the anti-obesity potential or adipogenesis inhibition of GRE and is attributable to its 
high polyphenol content (Sanderson et al., 2014). However, GRT treatment did not influence glucose 
uptake in the OBHT+GRT group (Figure 4.42, 4.43 and 4.44). These results were unexpected because 
it had been previously shown that GRE and aspalathin improved glucose uptake and lipid metabolism 
in vivo (Mazibuko et al., 2015). The current results could more than likely be ascribed to several 
reasons, such as GRT dose, time of administration and other environmental conditions of animal 
handling. These factors should be taken into consideration during future studies. 
The OBHT animals treated with GRT had lower BP compared to the untreated OBHT group (Table 
4.5). This GRT effect was expected because previous in vitro and in vivo studies had proved the anti-
hypertensive effects of unfermented rooibos (Persson et al., 2006; Persson, 2012). In the current 
study, the decrease in BP could have been ascribed to the reduction in BW and subsequent less IP fat 
accumulation in these animals. On the other hand, anti-hypertensive properties of GRT are associated 
with its high aspalathin content (Joubert & De Beer, 2011). Furthermore, the inhibition of the RAAS 
system might also be a potential reason for decreased BP; however, this mechanism was not 
investigated in the current study. 
GRT treatment in LC animals did not significantly alter BW (Figure 4.38), adiposity index (Figure 
4.39), glucose levels (Figure 4.42, 4.43 and 4.44) and BP (Table 4.5). We therefore speculate that the 
polyphenols present in GRT did not interfere with body metabolism or altered adipocyte 
differentiation. 
Treatment with Captopril also led to a lower BW and adiposity index (Figure 4.38 and 4.39). This 
reduction could be due to a decrease in food intake and high consumption of water. It has been 
reported that Captopril intake decreases BW via angiotensin-(1–7) (Oh et al., 2012) and could also 
influence lipolysis, which can reduce IP fat and also reflect the reduction of BW. Importantly, it was 
observed that treatment with GRT maintained the BW and adiposity index to close to normal weight, 
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while Captopril reduced body weight and adiposity index to below the normal weight (Figure 4.38 
and 4.38). It therefore appears as if treatment with Captopril could have an outspoken effect on body 
weight. This might be due to the pharmacological RAAS effect, which interferes with energy balance 
and glucose homeostasis.  
Captopril treatment lowered BP in the OBHT+Captopril group compared to the untreated OBHT 
group (Table 4.5), which is consistent with the literature and clinical diagnosis of HT (Foëx & Sear, 
2004). Captopril inhibits the conversion of ATI to ATII, thereby decreasing vasoconstriction and BP. 
In addition, BP was also associated with decreased BW and adipocyte index in OBHT+Captopril 
animals. 
 
5.2.2 Hypertension and testicular histomorphometry 
The OBHT animals had a lower TW:BW ratio (Figure 4.52). However, TW (Figure 4.51) and 
histological features remained unchanged compared to that of LC animals (Table 4.6). The 
differences between LC and OBHT groups in terms of TW:BW was therefore merely dependent on 
BW and not the TW, as these animals were bigger. These findings differed from that of a previous 
study where a higher TW was observed in spontaneously hypertensive rats (Bechara et al. 2015). The 
current study used DIO associated with a hypertensive rat model, while others used spontaneously 
hypertensive rats, which is a genetically selected animal model with naturally high arterial BP and 
with end-organ and vascular alterations. To our best knowledge, this is the first time TW and testicular 
structure were evaluated in obesity associated with HT. The results might be due to the development 
of HT, where the current HT animal model was in stage 1. This means that OBHT animals were not 
chronically HT and therefore the testes could resist and adapt to these metabolic changes. 
Treatment with the GRT did not influence TW:BW in the treated OBHT group when compared to 
the untreated OBHT group (Figure 4.52). This implies that the reduction in BW with GRT treatment 
(Fig 4.38) did not influence TW. This might be due to the GRT dose used in this study, which could 
be too low or high to influence TW. However, treatment with Captopril significantly improved the 
TW:BW ratio in treated OBHT compared to untreated OBHT and OBHT+GRT groups (Figure 4.52). 
As previously discussed, treatment with Captopril reduced BW to below of LC, thus this could have 
a detrimental effect on BW as well as on testicular tissue. This might be due to the pharmacological 
RAAS effect, which interferes with energy balance and glucose homeostasis. 
The testicular histological features of the OBHT animals were unchanged compared to all treated 
groups (Table 4.6), which was consistent with previous findings regarding spontaneously 
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hypertensive rats (Bechara et al. 2015). This unchanged testicular structure might be due to the ability 
of the testicular mechanism to adapt to metabolic disorders. Additionally, the obesity-induced HT 
was in stage 1, which could not be chronically causing changes to the testicular structure. However, 
this HT altered testicular morphometric parameters (Table 4.6). Atrophic seminiferous tubules 
(decreased area and diameter) could be linked to a narrow lumen (decreased lumen area and 
diameter), which is lined with a thinner layer of epithelium in OBHT animals compared to LC 
animals. Similarly, this was the case in the previously reported studies on hypertensive animal models 
(Akagashi et al., 1996; Azu, 2015). The changes that occurred in OBHT animals could possibly be 
attributed to testicular artery damage due to the HT, resulting in hypoperfusion of testicular tissue, 
causing a reduced supply of oxygen and nutrients. It is possible that these testicular morphometric 
changes could impair spermatogenesis and steroidogenesis, and consequently lead to infertility. 
Treatment with GRT reduced the diameter and area measurements of the lumen, which enhanced the 
size of the seminiferous tubules and the epithelium height in treated OBHT+GRT animals compared 
to the untreated OBHT group (Table 4.6), suggesting the favourable effects of treatment on 
spermatogenesis and steroidogenesis due to its high bioflavonoid content. Furthermore, 
OBHT+Captopril animals had a smaller lumen diameter, which might be linked to hypertrophic 
seminiferous tubule diameter and a higher epithelial height (Table 4.6). This side effect could be 
linked to Captopril’s effect of reducing BW. We therefore suggest that the GRT treatment could be 
used as an alternative treatment to Captopril treatment, as the latter could have side effects on 
testicular structure as well as on the overall male reproductive function. Further studies should be 
considered to help elucidate the side effects of anti-hypertensive substances and associated 
mechanisms linked to male reproductive disorders. 
 
5.2.3 Hypertension and male steroid hormone production 
Leydig cells are found in the interstitial spaces between the seminiferous tubules of the testis in the 
male reproductive system and produce T, thereby influencing spermatogenesis (Ye et al., 2017). In 
this study, the high levels of T in the OBHT animals were unexpected (Figure 4.53), since an inverse 
relationship between T production and hypotensive conditions was previously shown (Liu et al., 
2004). However, the difference between the current and previous studies could be the result of the 
methods used to induce HT or the stage of HT development. Liu et al. (2004) used high-salt food to 
induce HT, while the current study used a HCD. We speculated that the overproduction of T in OBHT 
animals could have resulted from the diet that contained additional cholesterol, which acts as the 
universal precursor for steroid hormones. This increase in cholesterol consumption could have 
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affected T production; however, cholesterol was not measured. A higher T level could have also 
resulted from the inhibition of caspase 7 (reduction in apoptosis) and Cleaved PARP (Fig 4.60, 4.61) 
as well as testicular OS (Fig 6.3, 6.4), resulting in impaired or increased proliferation of Leydig cells 
that produce T. It is well-known that in pathophysiology, any biological molecule which has a low or 
high expression or production may have an impact on body metabolism as well as personal behaviour 
(Metallo & Vander Heiden, 2013; Silverman & Deuster, 2014). The abnormal production of T could 
suppress gonadotropin secretion via negative feedback on the hypothalamus and pituitary, leading to 
the alteration of Sertoli cells and spermatogenesis. Moreover, these high levels of T production could 
induce frustration or stress in animals. 
Circulating T in the body is the substrate for E2, which is produced by aromatization in the liver, 
muscles, brain and the fat cells. Furthermore, E2 is proportional to adipocyte aromatization (Li et al., 
2016). The current study shows an increased E2 in OBHT animals because these animals presented 
with a high adiposity index/high adipocyte aromatization, which is consistent with previous reports 
(Hilborn et al., 2015; Vihma et al., 2017). This could have resulted in hypogonadism and induce male 
reproductive disorders. Furthermore, T levels were measured and compared to E2 by determining 
T:E2 ratio (Figure 4.55). It was found that in the OBHT group, T (Figure 4.53) and E2 (Figure 4.54) 
levels were both increased but the E levels remained higher than T, consequently causing a reduction 
in the T:E2 when compared to the LC group (Figure 4.55). The OBHT animals developed HT with 
obesity as a central mechanism, which caused imbalanced hormone secretion, shown by the low T:E 
ratio. This is in accordance with the literature (Hilborn et al., 2015; Katib, 2015; Vihma et al., 2017). 
Importantly, treatment with GRT and Captopril lowered both T (Figure 4.53) and E (Figure 4.54) 
levels, but since T was higher than E, the ratio is higher (Figure 4.55) in OBHT animals. The hormone 
levels of OB+GRT or OB+Captopril were not different from untreated LC animals. This implies that 
the T levels of treated OBHT animals could be improved to normal levels. No other studies reported 
these effects, and the current study suggests that GRT and Captopril could enhance fertility properties 
in male rats – a possible result of their potent antioxidant properties and androgenic activities. GRT 
is rich in polyphenolic compounds, which are known to be an ROS scavenger. Captopril also contains 
a sulfhydryl or thiol group that is able to scavenger ROS. From previous studies, it is evident that 
androgen activity depends on the experimental conditions where polyphenol may activate or inhibit 
testosterone production. In the current study, GRT, rich in polyphenol compounds, improved T levels 
in hypertensive conditions. The mechanism of action by which GRT has increased both T and the 
T:E2 ratio and decreased E2 could have resulted from reduced adipocyte index, antioxidant, anti-
obesogenic and anti-hypertensive properties of GRT which were found in this study. Moreover, the 
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results of the present study indicate that both Captopril and GRT provided significant and comparable 
protective effects against HT-induced hormone aberrations. Therefore, we suggest the use of GRT 
treatment as an alternative therapy. 
 
5.2.4 Hypertension and energy homeostasis 
PKB regulates a variety of cellular responses ranging from metabolism, growth, cell survival and 
intracellular signal transduction (Mansuri et al., 2014). In the present study there were lower levels 
of T-PKB expression in the OBHT group than in the LC group (Figure 4.56), and furthermore, this 
protein did not undergo activation (Figure 4. 57) compared to the LC group. This affected the ratio 
of P-PKB and T-PKB (Figure 4.58). The metabolic changes observed in the OBHT animals could 
interfere with testicular insulin signalling transduction components (IRs and IRS), which initiate PKB 
pathways. This implied that GLUTs were not translocated, which was unfortunately not measured in 
this study. It is therefore speculated that the abnormal functioning of the insulin-dependent PKB 
pathway may be due to the impairment of IRs and IRS, which results in testicular pathologies and 
ultimately male infertility. 
The testicular T-PKB expression of the OBHT+GRT animals was restored to the normal expression 
levels compared to LC (Figure 4.56). This positive effect of GRT reflects some potent health 
properties that could resist or reverse metabolic changes. The supplementary GRT in LC animals 
reduced T-PKB expression compared to that of LC animals. This implies that the GRT dose (60 
mg/kg) used in this experimental study could be harmful to testicular function in lean animals. We 
suggest that this dose could be used to treat testicular pathologies in obesity but that effects on lean 
animals need further elaboration. Furthermore, the T-PKB expression was not influenced by 
Captopril exposure in OBHT+Captopril animals, which linked to T-AMPK results, suggesting that 
Captopril does not have any effect on the insulin-dependent or insulin-independent pathways. 
AMPK, a highly conserved sensor of cellular energy, is activated in response to deficiency in caloric 
energy intake, ischemic conditions or hypoxia (Hardie et al., 2012), some metabolic hormones 
(leptin), and therapeutic substances (plant extract, antidiabetics) (Hardie, 2017; Rice et al., 2013). 
When activated for preserving cellular energy homeostasis, it switches off energy-consuming 
processes and switch on energy-generating pathways (Galardo et al., 2007; Hardie, 2017). In the 
current study, T-AMPK was also less expressed in OBHT rats (Figure 4.59), which is in accordance 
with the shared inter-relationship between hypertension and energy metabolism via underlying 
pathways. Unfortunately, activated (phosphorylated) AMPK was not detected in the testicular 
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sample. Several factors may be responsible for this, including insufficient signals to activate the 
AMPK pathways, the western blot technique or ineffective antibodies. According to our knowledge, 
this is the first time that the AMPK antibody was used to evaluate metabolic disorders in testicular 
tissue. It is recommended that the AMPK pathway should be explored further in future studies of HT 
and testicular pathologies. 
Testicular T-AMPK expression in OBHT animals treated with either GRT or Captopril did not change 
compared to LC animals (Figure 4.59). This may be due to the glucose levels that were not affected 
by GRT treatment. However, LC+GRT animals had a significantly lower T-AMPK expression, which 
might be linked to the lower T-PKB expression and reduced SOD activity. This non-effect and limited 
effect of GRT treatment could be the result of multiple factors, which includes GRT dose 
administration. Therefore, the treated animals could have had dysregulated energy homeostasis, 
thereby contributing to the disturbance of male reproductive health. 
 
5.2.5 Hypertension and testicular apoptosis 
Cleaved PARP and caspase 7 are apoptotic markers involved in spermatogenesis and contribute to 
sperm maturation by eliminating excess germinal cells or abnormal spermatozoa (Agarwal et al., 
2009). With internal or external stimuli, these markers could be slightly or highly activated in 
testicular tissue, thereby generating male infertility indicators. In the current study, Cleaved PARP 
and caspase 7 were also lower in OBHT testicular tissue compared to the LC group (Figure 4.60 and 
4.61). These results are linked to MetS features associated with testicular energy depletion (low T-
PKB and T-AMPK as well their inactivation) and OS. We suggest that the altered testicular 
intracellular signalling can affect its structure as well as sperm production and maturation. 
Treatment with GRT or Captopril did not influence Cleaved PARP or caspase 7 in OBHT animals 
compared to untreated OBHT animals (Figure 4.60 and 4.61). GRT treatment’s inability to affect 
these apoptotic markers may be due to the significantly raised glucose levels. AMPK also did not 
change with GRT treatment. However, GRT reduced Cleaved PARP and caspase 7 levels in treated 
LC controls (Figure 4.60 and 4.61). This finding is linked to the lower expression of T-PKB and T-
AMPK under the same physiological condition, which shows an alteration of energy homeostasis in 
treated LC animals. This implies that GRT supplementation with 60 mg/kg could interfere with 
normal physiological mechanisms. The reduced testicular apoptosis will cause huge proliferation of 
testicular cells or excess of germinal cells and subsequently some abnormalities could develop 
(testicular cancer, etc.). 
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5.2.6 Hypertension and testicular oxidative stress (OS) 
The testis is susceptible to oxidative damage, as the blood vessels supplying these tissues often show 
sclerotic changes when BP increases in the arteries (Azu, 2015). Moreover, all the components of the 
RAAS have been reported to be present in the testis (Bader & Ganten, 2008; Franke et al., 2003), and 
their overexpression or deficiency could be involved in the pathophysiology of testicular tissue. In 
the current study, obesity and insulin resistance, also associated with OS, could stimulate the RAAS 
system and cause HT, which in turn, could exacerbate OS. The ATII, the most active component in 
this system, is a well-known OS inducer that increases the generation of O2•−, H2O2 and hydroxyl 
radicals (HO•) by activating the NADPH oxidase enzyme (Cai et al., 2003). In the current study, the 
MDA levels (Figure 4.64) and CAT activity (Figure 4.63) were higher and the SOD activity was 
lower (Figure 4.62) in OBHT rats than in LC rats. These findings are consistent with other findings 
that found a link between HT and OS (Adedara et al., 2018; Azu, 2015; Berdja et al., 2016; Redón et 
al., 2003; Rolo & Palmeira, 2006). Since SOD and CAT enzymes are part of the first line of defence 
against free radicals, it is expected that the activity of these enzymes may be affected by OS before 
the other antioxidant enzymes are affected (Hamden et al., 2009). The abnormal function or activity 
of SOD and CAT in testis may result in several deleterious effects due to the accumulation of O2•- 
and H2O2 respectively. The H2O2 reacts with lipids, leading to LPO, which in turn results in the 
formation of several products including MDA (Agarwal et al., 2014). This process also occurred in 
the current study. The associated LPO may point to the impairment of the sperm membrane, which 
is more than likely responsible for the morphological alterations found in this study (Table 4.8). 
Moreover, spermatozoa become more permeable to external substances or ROS, which could impair 
intracellular biological components, DNA and protein (Agarwal et al., 2014). 
Previous studies have reported that polyphenol-rich plant extracts might be used to protect the male 
reproductive function against induced OS (Awoniyi et al., 2012; Manirafasha, 2014). The dietary 
antioxidant intake helps to maintain an adequate antioxidant status in the body, thereby protecting 
against OS. In the current study, the protective mechanism of GRT has been examined in the onset 
of OS related to obesity-induced HT, and its effect was compared to that of Captopril. The findings 
from the study showed that both GRT and Captopril treatments attenuated OS, as demonstrated by 
reduced MDA levels and increased CAT activity in treated OBHT rats (Figure 4.64 and 4.63). This 
effect of GRT treatment was expected as polyphenol-rich aspalathin is a known natural antioxidant 
and could offer protective effects against OS (Dludla et al., 2014; Marnewick et al., 2011). These 
findings are in agreement with a previous study, which has shown that both fermented and green 
rooibos extracts could offer a measure of protection against induced oxidative damage by increasing 
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the antioxidant defence (Awoniyi et al., 2012). The ability of polyphenol compounds to act as 
antioxidant results from its ability to donate a hydrogen ion to the peroxyl radical produced as a result 
of LPO (Kumar & Pandey, 2013; Treml & Šmejkal, 2016). 
Captopril’s ability to lower BP, as observed in this study, could reflect male reproductive organ 
function. Captopril, an ACE inhibitor, decreases the circulating and tissue levels of angiotensin II. 
Captopril also possesses antioxidant activity due to its thiol or sulfhydryl group, which acts as a free 
radical scavenger of various ROS and prevents LPO, thereby serving as a protection against OS 
(Fischer et al., 2000; Liu et al., 2007; Scribner et al., 2003). The differences between the results 
obtained with Captopril and GRT were insignificant, suggesting that both treatments equally 
protected the testicular tissue from the detrimental effects of HT of reducing CAT activity and 
inducing LPO. 
Nevertheless, treatment with GRT or Captopril did not affect SOD activity in OBHT+GRT animals, 
while GRT supplementation showed a significantly lower SOD activity in the treated LC+GRT group 
when compared to the matched control animals (Figure 4.62). These findings are linked to the 
discussed findings on T-AMPK, T-PKB, Cleaved PARP and caspase 7 in the same treatment 
conditions. Both rooibos and Captopril are known to have beneficial health properties, therefore we 
speculate that a GRT dose (60mg/kg) and Captopril 50mg/kg were the cause of unexpected findings. 
 
5.2.7 Hypertension and epididymal sperm function 
The epididymis is critical for post-testicular maturation and storage of sperm, and epididymal weight 
is a marker of not only epididymal structure, but also epididymal sperm reserves (De Grava Kempinas 
& Klinefelter, 2014). The current study showed that OBHT animals had heavier epididymides 
compared to the age-matched LC animals (Figure 4.65). This finding differs from that of previous 
studies which found that the epididymal weight did not change due to induced HT with N(G)-Nitro-
L-arginine-methyl ester (Akinyemi et al., 2015). This difference might be due to the diet or method 
used to induce HT. The heavier epididymides in the current study might be due to elevated arterial 
pressure, high E2, testicular OS and reduced Cleaved PARP and caspase 7. Furthermore, these 
disorders could affect sperm quantity and quality. 
The OBHT animals presented with a lower sperm concentration, lower sperm viability and normal 
sperm morphology with an increased percentage of head and midpiece defects as well as impaired 
sperm motility (specifically VCL) when compared to LC animals (Table 4.7). These findings were in 
agreement with literature on the pathophysiology of spermatozoa and MteS features (Schisterman et 
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al., 2014; Sermondade et al., 2013). This implies that spermatozoa of OBHT animals will be unable 
to fertilize an ovum. Abnormal function of sperm could result from hormonal aberrations and OS. 
Furthermore, during hypertensive conditions, increased intracellular calcium, activation of growth 
and inflammatory signalling pathways could impair the sperm membrane; however, these pathways 
were not investigated. Additionally, other velocity parameters, namely VSL and VAP, were not 
significantly changed in OBHT animals, possible due to the stage of induced HT not being strong 
enough to alter these parameters. We suggest that future studies should explore the mechanisms that 
link sperm kinematics and MetS features. 
Treatment with either GRT or Captopril reversed changes in epididymal weight (Figure 4.65), which 
could also influence sperm quality and function (Table 4.7) in OBHT+GRT animals. GRT treatment 
effects are consistent with that of previous studies (Awoniyi et al., 2012; Opuwari & Monsees, 2014). 
GRT could offer protective effects due to its high polyphenolic composition, which could play 
multiple functions, including being antioxidant and anti-oestrogenic. It is well-known that the 
diversity of biological properties of polyphenols depend on the chemical structures and the number, 
nature, position and substituents of hydroxyl groups and unsaturated bonds (Kumar & Pandey, 2013; 
Treml & Šmejkal, 2016). Furthermore, the effect of Captopril on epididymal sperm function might 
be due to its antioxidant activity (Fischer et al., 2000; Liu et al., 2007; Scribner et al., 2003). Captopril 
could stimulate spermatogenesis via inhibition of the kallikrein kinin system and activation of 
bradykinin (Monsees et al., 1996; Okeahialam et al., 2006; Siems et al., 2003). However, the 
differences between the results obtained with Captopril and GRT were insignificant, suggesting that 
both treatments equally protected the epididymal sperm function from the detrimental effects of HT 
due to OS. 
 
5.2.8 Summary of DIO-associated hypertension on male fertility 
A diagrammatic summary of the relationship between obesity and HT and their effects on male 
fertility is depicted in Figure 5.2 (A). The findings show that HCD with fructose and cholesterol leads 
to hyperphagia, which can cause MteS features, including HT. This affects testicular and sperm 
function parameters through different pathophysiological mechanisms. HCD with fructose and 
cholesterol hyperphagia caused hyperplasia and hypertrophy of WAT and hyperglycaemia, which 
both cause upregulation of pro-inflammatory cytokines (IL-1β, IL-18). Due to elevated FFAs, fat 
accumulation and inflammation therefore interfere with insulin signalling pathways by deactivating 
intermediates in these pathways. This is followed by insufficient glucose uptake, which leads to a 
build-up of glucose in the bloodstream (hyperglycaemia). Inflammation-induced insulin resistance 
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also contributes to HT due to the activation of the sympathetic nervous system. Furthermore, a high 
cholesterol intake changes lipid profiles, elevates FFAs and causes inflammation. This contributes to 
endothelial dysfunction and atherosclerosis, ultimately resulting in HT. Additionally, the increased 
adiposity, together with high cholesterol intake, also affects steroidogenesis (reduced T:E2) and 
consequently impairs spermatogenesis and male fertility. HT results in reduced oxygen and nutrient 
supply, which changes testicular signalling pathways and impacts on spermatozoa. Subsequently, 
testicular homeostasis were disturbed through altered energy metabolism (reduced T-PKB and T-
AMPK), apoptosis (reduced caspase and PARP), antioxidant activities (decreased SOD and CAT) 
and lipid peroxidation (increased MDA levels). These factors affect sperm functional parameters, 
thereby reducing male fertility. Furthermore, seminiferous tubules possibly decreased in size due to 
dysregulated energy metabolism. We therefore suggest that the changes in seminiferous tubules could 
impair steroidogenesis (reduced T:E2) by affecting Leydig cells and spermatogenesis and 
consequently reducing male fertility. 
 
5.2.9 Summary of GRT’s effects on DIO-associated hypertension and male fertility 
The possible ameliorative effect of GRT treatment on the pathophysiological mechanisms linked to 
obesity-induced HT and subsequent improvement in male reproductive parameters are displayed in 
Figure 5.2 (B). In this study, the adipose tissue was reduced (potentially via lipidaemia inhibition), 
resulting in low cytokine levels, which lowered BP. This associates GRT with possible anti-
hypertensive properties. Subsequently, CAT activity was improved, while MDA levels were reduced, 
which serves to show that GRT possess anti-oxidative properties. Lastly, the reduction in adipose 
tissue also led to less E2 production, thereby normalizing the T:E2 ratio. Therefore, GRT is to a 
certain extent also anti-oestrogenic. Taking all of this into consideration, it is clear that GRT treatment 
has the ability to restore male fertility as treatment resulted in improved sperm quantity and quality. 
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Figure 5.2: The mechanisms through which obesity associated with hypertension affect male 
reproduction (A) and the possible ameliorating mechanisms of GRT treatment (B) 
CAT: Catalase, Cas 7: Caspase7, IL-18: Interleukin-18, IL-1β: Interleukin-1 beta, MDA: Malondialdehyde, 
PARP: Poly ADP ribose polymerase, SOD: Superoxide dismutase, T-AMPK: Total adenosine 5′ 
monophosphate-activated protein kinase, T:E2: Ratio of testosterone to estradiol, VCL: Curvilinear velocity. 
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CHAPTER 6 
CONCLUSION AND RECOMMENDATIONS 
In the present study, two different diets were used to induce obesity-related insulin resistance and/or 
hypertension in male Wistar rats. The effects of the treatment of these two conditions with GRTon 
the male reproductive system were subsequently investigated. In particular, we explored the potential 
ameliorating effect of GRT on inflammation, OS and apoptosis under physiological and 
pathophysiological conditions. From converging lines of evidence, our findings suggest that GRT 
may have beneficial effects on metabolic risks and male reproductive functioning. GRT could 
attenuate OS by increasing SOD and CAT activity and reducing MDA levels, thereby acting as an 
antioxidant. This results in the amelioration of hormone levels and sperm function. The positive 
effects of GRT on male reproductive health could be due to its anti-lipidemic, anti-obesogenic, anti-
hypertensive, anti-oestrogenic, anti-apoptotic and anti-oxidative effects. To the best of our 
knowledge, this is the very first study that investigated the implicit effects of Afriplex GRTTM on 
male reproductive complications due to obesity-related insulin resistance and/or hypertension. The 
current findings show some of the specific properties of Afriplex GRTTM on male reproductive 
function to be anti-oestrogenic and anti-oxidative. 
In this study, in addition to elevated arterial BP, DIO with HCD is associated with changes in 
metabolic parameters, such as weight gain, increased adiposity index, high IL-1β secretion and a 
reduction in glucose tolerance. Therefore, we were successful at inducing obesity-related insulin 
resistance and/or hypertension by exposing male Wistar rats to different diets. These animals 
presented with typical MetS features, which result in the development of OS and inflammation, and 
the inhibition of apoptosis. These mechanisms were mainly linked to testicular and sperm 
dysfunction. Furthermore, it was important to identify therapeutic compounds capable of modulating 
these metabolic disorders in order to reduce or reverse these associated pathophysiological 
mechanisms and restore male reproductive health. The main findings of this study were that co-
treatment with GRT counteracted the detrimental effects of both DIO-associated insulin resistance 
and hypertension on OS, apoptosis, hormonal levels and sperm functional parameters. The dietary 
GRT treatment could serve as protection against the damage caused by LPO due to OS through its 
influence on antioxidant enzyme activities. The improvement of antioxidant enzyme activities in DIO 
insulin resistant and hypertensive rats was intended to overcome the effect of ROS on intracellular 
pathways including apoptosis, PKB and AMPK. Treatment with GRT was able to stimulate caspase 
7 and PARP; subsequently, sperm function parameters were restored. However, the effects of GRT 
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on blood glucose levels, AMPK and PKB were limited to both insulin resistant and hypertensive rats. 
In addition, we found that the impact of GRT treatment was dependent on the physiological status of 
the animals. Interestingly, in some instances, GRT treatment negatively affected certain parameters 
of physiological normal animals, while it had a positive effect on the same parameters in obese 
animals showing signs of insulin resistance and/or hypertension. Thus, GRT treatment can be 
therapeutic when used by obese patients to prevent insulin resistance, HT and the associated 
complications on male reproductive health. 
 
6.1 Strengths and limitations 
We acknowledge several limitations inherent to our study, including the lack of follow-up 
assessments over time, a small sample size and a resource-constrained research setting. Lastly, our 
findings are not necessarily generalizable to other animal models or humans. However, the strength 
of our study lies in the novelty of our findings (anti-oxidative and anti-oestrogenic potential of GRT), 
the inclusion of a control group, the assessment of multiple outcomes in one group, and use of 
standardized green rooibos extract. Future studies would do well to elucidate the mechanisms behind 
our findings by respecting the directions below. 
 
6.2 Recommendations for future studies 
In keeping with our study limitations, there are a number of recommendations for future studies based 
on our findings. It is advised that future studies should use larger sample sizes and make use of 
advanced techniques to a) further investigate DIO associated with insulin resistance and HT; b) clarify 
pathophysiological mechanisms that link MetS features and male reproductive dysfunction and 
properties of GRT treatment directly to male reproductive function. These suggestions could be used 
to advance the current knowledge, which could also be extended to clinical research. Furthermore, 
some of the following points should be included in future studies:  
 Extend the period of DIO, thereby allowing animals to develop a more chronic form of insulin 
resistance and hypertension  
 Extend the GRT administration period and use different doses of GRT (lower and higher than 
what was used in current study) 
 Evaluate a wide range of intracellular signalling molecules including IRS, GLUT8 and 
GLUT3 
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 Measure leptin levels in serum and tissue in order to monitor food intake  
 Determine insulin levels in order to calculate a homeostatic model assessment index 
 Evaluate serum and testicular lipid profiles, namely high-density lipoprotein, low-density 
lipoprotein, total cholesterol and triglycerides, as well as aromatase enzymes, for evaluating 
androgen biosynthesis in order to provide insight into male reproductive function  
 Measure pro-inflammatory cytokine and anti-inflammatory cytokines in the serum and 
testicular tissue 
 Measure ROS production, glutathione peroxidase and redox potential in the testis and 
spermatozoa to elucidate the antioxidant effect of GRT  
 Investigate DNA fragmentation for extending knowledge on sperm function during in vitro 
fertilization 
 Perform both in vivo and in vitro studies in order to translate the finding into clinical settings 
 Use a data analysis with correlation for understanding the relationship between variables 
 
6.3 Conclusions 
DIO due to the HCD predisposes an animal or human to the development of insulin resistance and or 
hypertension. These metabolic disorders affect male reproductive function and cause testicular 
oxidative stress, hormone dysregulation and impaired epididymal sperm quality and function in 
particular. GRT may have a beneficial effect on male reproductive function, attributable in part to its 
potential antioxidant activity, which has anti-oestrogenic effects. Our findings support the use of GRT 
as an alternative therapeutic treatment under pathological conditions. This study sheds more light on 
the disease-causing mechanisms of the chosen non-communicable disease models on the male 
reproductive system and on a possible treatment or supplementation that may target any of the 
observed phenotypic changes. It furthermore provides insight into the pharmacological effects of 
GRT in the treatment of pathophysiological changes that occur in DIO associated with insulin 
resistance and/or hypertension. These findings will hopefully ignite further research in the clinical 
setting related to the GRT and could possibly lead to the development of new drugs from this 
compound. 
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Research outputs  
 
Conference presentation  
Manirafasha C, Smit SE, Huisamen B, Aboua YP, Du Plessis SS. 2018. Protective effects of Afriplex 
GRT extract on male reproductive parameters in an obesity-induced pre-diabetic rat model. 
Conference of Biomedical and Natural Sciences and Therapeutics, 7–10 OCTOBER, Stellenbosch, 
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